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Abstract 
Mathematical modelling of biological systems is an essential tool for better understanding and for 
optimizing biological processes. Simulating the experiments before performing them is a time-saving 
strategy when seeking for optimal operating conditions.  
Dynamic flux balance analysis (DFBA) is a constraint-based dynamic modelling approach where the cell 
is assumed to act as an optimizing agent that allocates resources to maximize/minimize a suitable biological 
objective. In this modelling approach a linear programming (LP) problem is solved at each time interval 
involving the optimization of an objective function subject to constraints. This is a significantly different 
modelling approach than the one generally adopted for biochemical systems where dynamic mass balances 
are formulated for each metabolite.  An important advantage of the dynamic metabolic flux models as 
compared to the more conventional models reported before is that DFBA models do not depend heavily on 
accurate kinetic information. The ultimate purpose of this research was to develop DFBA type models with 
a minimal number of parameters to fit and predict experimental data.  Two main challenges had to be 
addressed: (i) - finding the biologically meaningful objective function that cells are trying to 
maximize/minimize and (ii) - finding a minimal set of limiting constraints. Limiting constraints includes 
any limit that potentially reduces the solution space such as kinetics, thermodynamics, gene expression, etc. 
The focus on this thesis was to develop algorithms to address these challenges in a systematic fashion. In 
the first published paper from this thesis (Chapter 5), I present two approaches for finding the kinetic 
constraints, an algorithm based on Lagrange multipliers and a parametric sensitivity algorithm. Both 
algorithms were applied using two case studies, one for E.coli that used a simplified metabolic network and 
a second for B. Pertussis with a more comprehensive metabolic network. Although both algorithms were 
capable of finding the constraints for the simple E.coli example, for the more complicated metabolic 
network used with B.Pertussis, the parametric sensitivity approach was found to be inefficient and 
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numerically challenging. Thus, it was concluded that the Lagrange multiplier approach is preferable when 
considering metabolic networks of large dimensions. 
In the second paper published from this work (Chapter 6) I proposed a method for systematically and 
simultaneously finding the objective function and the limiting constraints necessary to describe data.   To 
that aim, a set based approach that accounts for the errors in the experiments were proposed. Using this 
method both the active kinetic constraints and biological objective function were identified simultaneously 
using a bilinear optimization formulation.  
In the final stage of this research, the developed algorithms were applied for building a DFBA model for 
CHO cell culture (Chapter 9). We systematically found an objective function for mammalian cells that 
involve the simultaneous maximization of growth and minimization of apoptosis.  We argued in this part 
of the work that this objective function correlates well with reported phenomena for CHO cells including 
the occurrence of the Warburg effect that involves the preferable conversion of glucose to lactate.  
In terms of experimental work we conducted an initial study to investigate the damaging effect of effect of 
CO2 accumulation on CHO cell culture. This preliminary study motivated us to develop a perfusion process 
for high cell density culture of CHO cells based on an ATF filtration system. In this development work we 
identified different challenges for effective perfusion operation and we propose some practical measures to 
address these challenges. 
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Chapter 1 
Introduction 
 Research Motivation 
The modern biopharmaceutical industry that started with the discovery of Penicillin, the first antibiotic, 
received new momentum by the introduction of recombinant DNA technology. This technology 
emerged after Paul Berg presented his gene-splicing experiment and the idea progressed when Herbert 
Boyer and Stanley Cohen put forward the idea of inserting the recombinant DNA into bacteria. 
Genentech was the first biopharmaceutical company that used this technology for large-scale 
production of recombinant DNA. Genentech’s first product was recombinant Insulin, the first human 
protein therapeutic using DNA technology. Five years later in 1982, USA Food and Drug 
Administration (FDA) approved the recombinant DNA based insulin and the product was further 
marketed by Eli Lilly. Since then many other therapeutic proteins including blood factors VII and VIII, 
interferons and many other life-saving drugs have been approved.  The market of biopharmaceuticals 
has increased at an unprecedented rate. For example, in 2009, 200 biopharmaceuticals were reported in 
the market with more than US $99 billion sales, and in 2016 it reached to US $228 billion (Moorkens 
et al., 2017). Protein based biopharmaceuticals are in the top 5 the best-selling drugs (Craven, Whelan, 
& Glennon, 2014). 
Monoclonal antibodies (mAbs) are a major group of therapeutic proteins that have a major role in 
today’s biopharma industry. They are used for diagnostic purposes and research but their main role is 
treatment of various range of diseases from infections to inflammatory diseases and cancers. The 
success of monoclonal antibodies such as Infliximab (Remicade), Etanercept (Enbrel), Bevacizumab 
(Avastine), Rituximab (Rituxan), Adalimumab (Humira), Trustuzumab (Herceptin) has led to increased 
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demand of these products to more than 100kg/year and created a need for improving production yield 
through the improvement of cell lines and manufacturing processes.   
To produce recombinant protein therapeutics proteins including mAbs, a host cell is required that is 
engineered to contain the gene of interest which is responsible for the production of the desired protein. 
The choice of host cell is very critical for producing the therapeutic proteins with the right efficacy and 
that can be safely used as a therapeutic agent.  
The first host used for production of recombinant proteins was the bacteria Escherichia coli                  
(E.coli) followed later by other hosts including mammalian cells, insect cells, fungal cells and plants. 
Nowadays the majority of recombinant therapeutic proteins are produced in mammalian cell lines such 
as Chinese hamster ovary (CHO), baby hamster kidney (BHK), human embryonic kidney (HEK-293), 
human retina derived (PERC6) and mouse myeloma (NS0). One of the main reasons for choosing 
mammalian cells as the host cell line for producing therapeutic proteins is their capability to provide 
post-translational modifications such as proper glycosylation of the protein of interest. Glycosylation 
is a process whereby different glycans are attached to proteins in particular configurations thus 
conferring recombinant glycoproteins with particular physical and functional properties (Butler & 
Spearman, 2014). More than 70% of recombinant therapeutic proteins are produced in CHO cells. 
Among the special features of CHO cells that has made them popular for large scale manufacturing are 
their ability to grow in a suspension culture, their inherent resistance to infection by viruses and their 
gene amplification qualities that makes them able to express larger quantities of proteins (Butler & 
Spearman, 2014). 
In recent years, some of the ‘blockbuster’ mAbs have gone off patent so there is an opportunity for 
generic (biosimilar) manufacturing companies entering this market to further increasing the 
competition. Delays in market entry due to time spent on cell line and bioprocess development impacts 
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profitability and also increases the risk of loss of market share. This further motivates originator 
companies to optimize their manufacturing processes and to achieve better product quality. 
Mathematical models are essential tools for improving the understanding of the cell metabolism and 
cell culture behavior and for their use in model based bioprocess optimization. 
Biopharmaceutical process optimization is often more challenging as compared to other chemical 
manufacturing processes as biological organisms that are used for producing the desirable products 
exhibit significant variability in their responses to environmental conditions. Moreover, a particular 
combination of different environmental perturbations can heavily impact the intracellular level of these 
producing cells. Thus, to understand biological systems, it is not sufficient to just analyze each 
environmental factor individually as the interactions between those factors are of special importance. 
The discipline of System Biology studies a biological system as an integrated system of interacting 
parts (Tomar & De, 2013). 
Since the introduction of mammalian cells for the production of biopharmaceuticals, different 
metabolic models have been used for the systematic understanding of cellular behavior at different 
conditions. These reported models have been generally used for describing a limited set of process 
conditions and also for some process optimization targets like finding the most appropriate feeding 
regime in fed-batch operation. Chinese hamster ovary (CHO) cell have been modelled using different 
approaches and, to a lesser degree, other models have been developed for the study of less utilized cell 
hosts such as hybridoma and HEK 293.  
These metabolic models have been mostly developed for describing a static state of the biosystem 
which make it less useful for actual manufacturing processes that are of a dynamic nature. A few 
available dynamic models are available that only consider the metabolism loosely and instead they 
involve unstructured mass balances with many kinetic terms of the Monod form. These kinetic terms 
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generally involve a large number of parameters which makes these models highly sensitive to model 
error and measurement noise in the data used for model calibration, especially when data is scarce as it 
is often the case in biochemical operations (Ghorbaniaghdam, Henry, & Jolicoeur, 2013). Thus there is 
a genuine motivation to seek for structured models that correctly account for metabolic interactions 
while resulting in more parsimonious expressions with a smaller number of calibration parameters. 
Such models are expected to be more robust and better suited for model based prediction and 
optimization over a large range of operating parameters.  
 Objective 
In this research, the object was to develop necessary algorithms required for building a Dynamic Flux 
Balance Analysis model to be used for mammalian cells. Unlike the conventional dynamic unstructured 
models which, as mentioned above, use many kinetic expressions involving a large set of tuning 
parameters, the currently proposed approach is based on using Dynamic Flux Balance Analysis (DFBA) 
algorithm (Mahadevan, Edwards, & Doyle, 2002). DFBA is based on the formulation of an 
optimization problem where a particular flux distribution in a metabolic network is sought such as a 
specific objective function is optimized subject to certain constraints. The rationale behind DFBA is 
that natural evolution had conditioned the cell to act as an agent that optimally allocates resources to 
satisfy a certain biological objectives. For bacterial and microbial organisms typical objectives that 
have been successfully used to describe experiments were maximization of growth and maintenance of 
a particular redox potential. However, optimization objectives have not been proposed as yet for 
mammalian cells due to their relative higher complexity as compared to bacteria. For example, 
mammalian cells exhibit particular regulatory mechanisms such as programmed cell death (apoptosis) 
or cell death by autophagy that have to be accounted for when defining an objective function for 
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optimization.  Thus, a main goal of this proposed study is to find an objective function and specific 
metabolic constraints that can be combined together to formulate a suitable optimization problem which 
solution describes the experimental behavior of the mammalian cells.  
Then, the resulting DFBA model can be employed in future process optimization approaches for genetic 
modification, media design or bioprocess operation.  
Although the final goal was to formulate a dynamic metabolic flux model for CHO, I initially developed 
the model calibration approach for E. coli and Bordetella Pertussis. The reasons for developing the 
initial approach for these microorganisms were: (i)- a simple calibrated dynamic metabolic flux model 
of E.coli was available (Mahadevan et al., 2002) thus allowing us to test our identification approach on 
an a priori known model, (ii)- the metabolic network of reactions was a priori known for Pertussis with 
reasonable accuracy (Budman, Patel, Tamer, & Al-Gherwi, 2013) and was provided by a collaborating 
company, (iii)- considerable data were already available at the beginning of this project and iv- the 
assumption of growth rate as the objective function to be maximized within the model has been reported 
to work well for bacteria whereas the objective functions that are suitable for CHO have not been clearly 
identified as yet.  
Using the data available for Pertussis or in silico data (simulated data) generated by the available E. 
coli model, we developed systematic approaches to identify the constraints and objective functions that 
are the basic elements of the dynamic metabolic flux models. Then, using the approaches for systematic 
identification of constraints and objective function, we developed a DFBA model for CHO. To calibrate 
this model two sets of data collected during two different batch operation were used. The use of batch 
mode was preferred over continuous operation since the data spans in the former a larger range of 
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operating conditions over the duration of the batch thus providing richer information for model 
calibration. 
An additional part of the current project is a continuation of a study of CHO cell death under a mimicked 
perfusion cell culture. The perfusion operation was initially implemented by conducting intermittent 
replacements of part of the supernatant volume during a batch culture. Although the fed-batch operation 
is the most common type of operation in the biopharmaceutical industry due to a  lower risk of 
contamination and the simplicity of operation, in recent years perfusion mode of operation has become 
very popular (Chotteau, 2015) especially by introduction of new perfusion systems. Perfusion processes 
are generally better able to maintain constant growth conditions over a larger range of cell densities. In 
the experiments it was realized that limitation in nutrients is not the only limiting factor and other 
factors such as higher concentration of carbon dioxide might play a critical role. Recognizing the 
importance of perfusion and following the results described above using an emulated perfusion system, 
the final part of the thesis involved the construction and experimentation of a continuous perfusion 
bioreactor system. Data collected from this perfusion system was used together with batch data to 
calibrate the proposed dynamic metabolic flux model described above. 
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Chapter 2 
Literature review 
 Monoclonal antibodies 
In the early twentieth century, Paul Ehrlich proposed the idea of “magic bullets” that referred to drug 
substances that will be able to specifically target an agent causing disease in the body and destroy it. 
The first monoclonal antibody was for use in patients with a kidney transplant to prevent the organ 
rejection by immune system. This product was developed in 1975 and approved in 1986 and the new 
era of developing monoclonal antibodies for different diseases including various type of cancers started 
(Liu, 2014). Among the ten best selling drugs of 2016, seven of them were monoclonal antibodies 
(Philippidis, 2017). 
 Chinese Hamster Ovary (CHO) cells  
Chinese hamster was first used in 1919 for research on pneumococci. Chinese hamster was recognized 
as a suitable research host due to their low number of chromosomes. The Chinese hamster ovary (CHO) 
cell line was developed by Theodore T. Puck in 1957 (Marcus, Sato, Ham, & Patterson, 2006). Since 
their introduction CHO cells had many applications in biomedical research. They grow well in in vitro 
culture and can be grown in both adherent and suspension cultures. The first approved therapeutic 
protein obtained from recombinant mammalian cells, human tissue plasminogen activator, was 
produced using CHO cells. Since their approval in 1986, CHO cells have been recognized as the 
workhorse for producing recombinant therapeutic proteins including mAbs (Kim, Kim, & Lee, 2012). 
Other mammalian cells also have been used for this purpose but none of them are as popular as CHO 
cells. CHO cells are the host cell line for about 70% of all the recombinant therapeutic produced 
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(Jayapal, Wlaschin, Hu, & Yap, 2007). The reasons for their popularity are that CHO cells are well-
studied and they are considered safe by drug agencies. They exhibit good gene amplification thus 
resulting in increased protein productivity, they support the necessary post translation modifications 
such as glycosylation and they adapt well to serum free media (Kim et al., 2012). 
 Vaccines 
Vaccines are biological material enhances the immunity to a specific disease. Vaccines are one of the 
most important inventions of humankind. Edward Jenner introduced the first vaccine against smallpox 
in 1796 and since then vaccines have had a vital role in eradication of the disease (Nabel, 2013). Rabies 
vaccine was the next vaccine that is produced in the cultured cells (Plotkin, 2014). More than 70 
vaccines are in the market to be used against about 30 types of microbes. Main groups of vaccines are 
live or attenuated organisms and killed (inactivated organisms) based vaccines. In some cases when the 
antigen responsible for immunity against the target disease is known purified or recombinant subunits 
of the vaccine could be used instead of the whole live or killed organism. Killed vaccines cannot 
replicate inside the body so they are usually administered in combination with a compound called 
adjuvant to increase their potency. Aluminum salts are among common adjuvants used in vaccine 
industry (Ulmer, Valley, & Rappuoli, 2006). 
 Bordetella pertussis 
Bordetella pertussis is a gram negative bacteria. This bacteria is responsible for whooping cough, a 
potentially fatal bacterial disease. Two types of vaccines for whooping cough are available: whole-cell 
and acellular vaccines. Acellular vaccines are advantageous in terms of having fewer side effects thus 
they are normally the vaccines of choice. The acellular vaccine generally is composed of 1–4 protein 
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virulence factors: pertussis toxin (PT), pertactin (PRN), fimbriae (FIM) and filamentous hemagglutinin 
(FHA). 
 Cell metabolism  
Mammalian and bacterial cells need energy for driving the cell functions. This energy is provided by 
several biochemical reactions that involve carbon and nitrogen sources (mainly carbohydrates and 
amino acids, lipids) that are normally consumed by the cells and are converted to energy carrier 
molecules (e.g. ATP and ADP) and other intermediate materials required for cell activities. The 
reactions occurring in the cell are generally classified into catabolic and anabolic. Catabolism is the 
process of breaking down the large molecules (e.g. glucose) into other useful molecules, energy and 
redox potential (e.g. NADH), and anabolism is the process of formation of new molecules that are 
required for cell functions using the biomolecules resulted from catabolism (Alberts, 2008). Figure (2-
1) shows schematically the catabolic and anabolic pathways in the cell. 
Enzymes, mostly made of proteins, are biochemical catalysts involved in regulating (e.g. accelerating) 
the biochemical reactions.  Metabolic pathways generally referred to groups of biochemical reactions. 
For example, glycolysis, citric acid cycle (also known as TCA cycle or Krebs’s cycle), oxidative 
phosphorylation, pentose phosphate pathway and urea cycle are among the main metabolic pathways. 
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Figure 2-1 Catabolism and anabolism in cells. Catabolism is the process of breaking down the 
large molecules into other useful molecules, energy and redox potential, and anabolism is the 
process of formation of new molecules that are required for cell functions using the 
biomolecules resulted from catabolism. 
 Glycolysis 
Glycolysis is the first and main pathway in glucose metabolism. In glycolysis, for each mole of glucose 
consumes, two moles of pyruvate and two moles of ATP are generated. Glycolysis takes place in the 
cytosol. The net reaction summarizing the glycolytic pathway, after canceling out intermediate 
reactions along the pathway, is: 
Glucose + 2 NAD+ + 2 Pi + 2 ADP → 2 Pyruvate + 2 NADH + 2 ATP + 2 H+ + 2 H2O 
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 Pentose phosphate  
The pentose phosphate pathway (PPP) branches out from the glycolytic pathway and its main goal is 
to provide the NADPH needed for reductive biosynthesis such as synthesis of lipid and nucleic acid 
and also reduction of glutathione. PPP has two phases: an oxidative phase that generates NADPH (while 
oxidizing glucose-6-phosphate to ribose 5-phosphate) and a non-oxidative phase that interconverts 
sugars (Berg, Tymoczko, Stryer, & Stryer, 2002). The net reaction of the oxidative PPP phase can be 
written as: 
Glucose 6-phosphate + 2 NADP+ + H2O → ribulose 5-phosphate + 2 NADPH + 2 H+ + CO2 
The ratio of NADPH to NADP+ has been often suggested as the main factor for controlling the pentose 
phosphate pathway (Barcia-Vieitez & Ramos-Martinez, 2014). The pentose phosphate pathway occurs 
in the cytoplasm. 
 TCA cycle 
Citric acid cycle, also known as TCA cycle, or Krebs’s cycle is another important pathway in cell 
metabolism located in the mitochondria. The TCA cycle describes an aerobic process occurring in the 
cells which the main goal is the production of NADH needed for ATP production.  In microorganisms 
that undergo glycolysis Pyruvate both converts to Acetyl- CoA and also feeds into TCA cycle. The net 
reaction is as follows: 
Pyruvate + 2 NAD + 2 CoA → 2 Acetyl CoA + 2 NADH + 2 CO2 
Some microorganisms such as Pertussis undergo gluconeogenesis where the reactions occur in reverse 
order to glycolysis, i.e. from pyruvate towards the generation of glucose (Hu & Zhou, 2012).  
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Acetyl-CoA is also generated by oxidation of fatty acids. After formation, Acetyl-CoA breaks into two 
molecules of CO2.  As mentioned above, the TCA cycle provides reducing NADH that will be used in 
other reactions such as the oxidative phosphorylation pathway and it also has an important role in 
providing the precursors required for synthesis of some of the amino acids such as glutamine (Hu & 
Zhou, 2012). The TCA cycle net reaction can be written as follows: 
Acetyl CoA + 3 NAD+ + FAD + ADP + Pi + H2O → 2 CO2 + 3 NADH + FADH2 + ATP + CoA 
 Oxidative phosphorylation pathway 
The oxidative phosphorylation pathway is an important pathway in producing energy for the cell. In 
this pathway, nutrients are oxidized to produce energy storage molecules of ATP. In fact, at this stage 
electrons that are released in glycolysis are consumed in the TCA cycle. It should be remembered that 
while oxidative phosphorylation has an important role in providing energy for the cell, reactive oxygen 
species (ROS) such as superoxide and hydrogen peroxide are also produced in this pathway resulting 
in an increase of free radicals that have detrimental effects on the cell including aging (cellular 
senescence)  and also some diseases.  
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Figure 2-2 Summary of ATP production from one mole of glucose. This figure shows ATP 
production in each pathway of glycolysis and TCA cycle. 
  Metabolic regulation  
Cells convert nutrients, mainly glucose, to energy for survival, proliferation and protein production. 
Glycolysis, the TCA cycle, and oxidative phosphorylation are the key pathways used by the cell to 
produce up to 36 moles ATP per mole of glucose consumed. Ammonia, lactate and CO2 molecules are 
also key by-products of these pathways (Figure 2-3). 
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Figure 2-3 Schematic representing the differences between oxidative phosphorylation and 
anaerobic glycolysis 
In the absence of enough oxygen, the carbon molecules follow from the pyruvate branch point an 
anaerobic metabolic pathway in which lactate production occurs instead of CO2. In this situation, only 
two moles of ATPs are produced for every one mole of glucose being consumed (Figure 2-3). 
Surprisingly, proliferative mammalian cells such as tumor cells and most cell lines for producing 
recombinant proteins have been found to metabolize glucose to lactate even in the presence of sufficient 
amounts of available oxygen. This phenomenon has been referred to as the ‘Warburg effect” or aerobic 
glycolysis. In fact the Warburg effect is viewed as an inefficient metabolic pathway since in the 
conversion of one mole of glucose to lactate only 4ATP are produced, as compared to oxidative 
phosphorylation where up to 36 moles of ATP are produced for each consumed mole of glucose (Figure 
2-3) (Quek, Dietmair, Kromer, & Nielsen, 2010; Vander Heiden, Cantley, & Thompson, 2009). It has 
also been observed that the lactate resulting from glucose consumption is an important inhibition factor 
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for cell growth and product formation due mostly to increased acidity of the medium and increased 
osmolality (Ahn & Antoniewicz, 2012b). 
On the other hand and despite the resulting inefficient ATP production the Warburg effect has some 
beneficial consequences since through a set of signaling and regulatory pathways it protects fast-
growing cells by reducing mitochondrial activity, which is known to be partially responsible for 
apoptosis.  Beyond ATP additional requirements for proliferating cells are nucleotides, amino acids, 
and lipids for growth. Amino acids need more equivalents of carbon and NADPH, as compared to ATP, 
to be synthesized inside the cell. Therefore, instead of converting all the glucose through the oxidative 
phosphorylation pathway to CO2 in the mitochondria, cells allocate some glucose derived resources to 
macromolecular precursors such as acetyl-CoA. 
 
Figure 2-4 Schematic representing the aerobic glycolysis pathway in proliferative cells. These 
cells produce large amount of lactate and 4mol of ATP. 
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Glycolytic intermediates are required for anabolism of nonessential amino acids and ribose that is 
necessary for nucleotides’ synthesis. Also glycolytic intermediates are needed for synthesis of fatty 
acids (Vander Heiden et al., 2009). 
Another example of an energetically inefficient metabolic pathway in mammalian cells is partial 
oxidization by transamination of glutamine to ammonia and to non-essential amino acids such as 
alanine and aspartate (Quek et al., 2010).  This phenomenon is actually associated with a truncated 
TCA cycle, where lower fluxes occur between pyruvate to citrate flux but a higher flux occurs from α-
ketoglutarate to oxaloacetate (Lake-Ee & and Lars Keld, 2009). 
As already mentioned above the by-products from incomplete metabolism of mammalian cells, mainly 
lactate and ammonia, create unfavorable living conditions for cells in the media. They have been 
generally found to be inhibitory for cell growth and protein production. Several strategies have been 
developed to cope with these challenges ranging from molecular biology methods for cell line 
modification to process optimization strategies (Quek et al., 2010), as described below. 
 Lactate reduction and control 
Generally, in CHO cells producing proteins, it has been observed that lactate is produced during the 
growth phase when cells are growing faster as compared to the post-exponential phase of growth. It has 
been also observed that in some of the CHO cell lines there is a metabolic shift from lactate production 
to lactate consumption. There are different hypotheses on how this shift is regulated. For example, 
oxidative stress in the cells and/or lack of some key nutrient such as copper has been mentioned as 
possible factors (Luo et al., 2012). 
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Altamirano et al (2006), studied the lactate response by comparing two different culture conditions: 1- 
a combination of 20 mM glucose with 6mM glutamate and 2- a combination of 5mM glucose and 
20mM galactose with 6 mM glutamate. They observed that for the second culture where part of the 
glucose used in the first culture was substituted with galactose, the formation of lactate was lower where 
glucose was initially used and then galactose was used. During the phase of galactose consumption 
they also observed consumption of endogenous lactate in the culture. To explain the results, they 
performed metabolic flux analysis (MFA) study and suggested that lactate is not consumed as a source 
of energy and hypothesized that other pathways exist involving the non-oxidative decarboxylation of 
pyruvate. These pathways have been also reported in cancer cells (Altamirano, Illanes, Becerra, Cairo, 
& Godia, 2006; Galleguillos et al., 2017). However in a separate modelling study based on flux balance 
analysis (FBA), Martinez et al. compared the fluxes during two phases, before and after shifting from 
lactate production to lactate consumption, and suggested that during the lactate production phase most 
of acetyl-CoA produced by pyruvate dehydrogenase (PDH) was used for the production of fatty acids 
and steroids while during the lactate consumption phase only 32% of the produced acetyl-CoA was 
later used for production of fatty acid and steroids while majority of  acetyl-CoA went through the TCA 
cycle and was oxidized there. They suggested that the discrepancy between their findings with the study 
by Altamirano might be due to over-simplification of the metabolic network that was used in 
Altamirano’s work (Martinez et al., 2013). Sengupta et al (2011) applied both MFA and isotopomer 
labeling for mapping the flux of CHO cell culture during the post-exponential phase of low growth. 
They observed that the majority of glucose was metabolized into NADPH. They suggested that the 
reason for this preferential pathway might be the higher demand of NADPH for reducing the oxidative 
stress. This research also indicated that lactate is not produced at this stage as most of the material flux 
originating from pyruvate was directed into TCA cycle (Sengupta, Rose, & Morgan, 2011). Templeton 
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et al. (2013) used MFA in combination with 13C to study the different phases of cell growth and 
antibody production in CHO cell culture. They found that in the fast-growing phase, lactate was 
produced in higher amounts as compared to the post-exponential phase and the activity in the TCA 
cycle was minimal during the growth phase. Also, they observed that following a metabolism shift from 
higher growth to higher antibody production, the lactate response changed from production to 
consumption. Oxidative phosphorylation was the main source of energy production when antibody 
production was at its highest level but also the oxidative pentose phosphate pathway was observed to 
be highly active during this time period. This study also found that during the stationary phase while 
the growth rate declined, the TCA cycle and the oxidative pentose phosphate pathway remained active. 
They argue that during the time with the highest antibody production, cells were in their highest 
oxidative state (Templeton, Dean, Reddy, & Young, 2013). Wilkens et al performed a metabolic flux 
analysis for two different CHO culture conditions wherein one of them only glucose was fed to the 
culture and in the other glucose was fed together with galactose. In the culture fed with the combination 
of galactose and glucose after the initial consumption of glucose, galactose started to be consumed. 
This suggested that in the galactose consumption phase not enough pyruvate was available for the cells 
to use as energy source so the produced lactate was converted to pyruvate by changing the direction of 
the corresponding reaction regulated by lactate dehydrogenase. The resulting pyruvate was 
subsequently directed into the TCA cycle (Wilkens, Altamirano, & Gerdtzen, 2011). In a study by Xing 
et al in 2011, a CHO cell line expressing an antibody fusion protein (B1) metabolic flux analysis was 
used to optimize the amino acid composition in the cell culture medium. They increased the 
concentration of methionine, tryptophan, asparagine and serine that were considered as limiting and 
reduced the concentration of arginine, alanine and glycine with the goal of reducing the ammonia 
production. Then, as a result of the lower concentration of ammonia, both the cell density and protein 
 19 
 
production were increased (Xing et al., 2011). Hefzi et al developed a genome-scale flux balance 
analysis model for CHO cells where they included 4455 metabolites, 6663 reactions and 1766 annotated 
genes in their model. This model connected the genotype and phenotype of CHO cells and showed the 
potential for protein production by engineered CHO cells that would utilize the resources optimally 
(Hefzi et al., 2016). 
 Genetic modification of mammalian cells 
Knowledge about the cell metabolism has been often used to develop genetic modification strategies 
that would result in larger growth and productivity. For example, in a study on hybridoma cells 
producing monoclonal antibodies it was found that knocking down the lactate dehydrogenase (LDH) 
gene resulted in decreased lactate production and substantial improvements in cell viability and protein 
production (Chen, Liu, Xie, Sharp, & Wang, 2001).  
In another investigation, the overexpression of yeast pyruvate carboxylase (PYC2) gene in BHK-21 
cells transfected with Erythropoietin (EPO) gene was induced to enhance the activity of pyruvate 
carboxylase that promotes growth under glucose reduced conditions thus resulting in decrease lactate 
formation. Pyruvate carboxylase activity has not been observed in mammalian cells, however its gene 
does exist (Lake-Ee & and Lars Keld, 2009). The over-expression of the gene also resulted in about 
doubling of the efficiency of consumed glucose towards the production of EPO (Irani, Beccaria, & 
Wagner, 2002; Irani, Wirth, van Den Heuvel, & Wagner, 1999). Toussaint et al designed a CHO cell 
line producing a monoclonal antibody that resulted in a shift towards lactate consumption, extended 
growth phase and, higher cell concentration and productivity in fed-batch operation (Toussaint, Henry, 
& Durocher, 2016). 
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The glutamine pathway has also been considered as a target for cell line genetic engineering studies. 
The enzymatic reaction led by the glutamine synthetase (GS) enzyme is responsible for the synthesis 
of glutamine from glutamate and ammonia and it is the only reaction occurring in mammalian cells that 
synthesize glutamine. The GS enzyme becomes essential for mammalian cell survival when the 
medium is not externally supplied with glutamine. In some cell lines such as mouse myeloma, there is 
not sufficient expression of GS for survival thus glutamine has to be added. In CHO cells the GS 
expression is just enough for survival thus requiring the addition of glutamine. In these cells, 
Methionine sulphoximine (MSX) is added to inhibit endogenous GS activity and only cell lines 
transfected with the overexpressed GS survive in this medium. In summary, mammalian cells 
transfected using the GS system can be grown in a glutamine-free medium with just glutamate added 
as a substitute. Reduced glutamine usage results in the lower formation of toxic ammonia thus resulting 
in improved growth. This method has been commercialized by the Lonza Company and has gained 
wide acceptance in the industry (Bebbington et al., 1992; Fan et al., 2012; Quek et al., 2010). 
 Methods to increase cell density 
Since productivity is often associated with cell mass, there is often a motivation to increase cell density. 
Also for experimental studies, it is important to obtain high density so as to increase the sensitivity of 
the experiment to changes in experimental conditions.  
The mode of cell cultivation has a significant effect on viable cell density. Fed-batch and perfusion are 
the most common modes of operation in the industry for obtaining higher cell density. Fed-batch culture 
is nowadays the dominant approach in the biopharmaceutical industry for controlling the cell-specific 
growth rate and residual nutrient concentrations while leading to high cell density. A concentrated feed 
is typically used to provide enough nutrients and to maximize viable cell density and product titer. Cell 
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densities of ~10 million cells/ml can be attained in fed-batch by extending the productive state for long 
periods of time. A fed-batch culture consists of two phases: an initial growth phase followed by a cell 
density decline phase. The reason that perfusion culture is nowadays less common comparing to fed-
batch is that perfusion operation is more complicated to run comparing to fed-batch. Also, the risk of 
contamination in perfusion is relatively higher and the right equipment for perfusion scale-up was not 
available until recently (Bonham-Carter, 2011). 
Feeding is used as a strategy to increase cell density but cell growth can be hindered by the 
accumulation of inhibitory agents such as ammonia and lactate and also by elevated osmolality resulting 
from the addition of a base needed for pH control (Newland, Kamal, Greenfield, & Nielsen, 1994). 
Unlike microbial cells’ cultures for which limiting the feed can be helpful in controlling the cultivation 
and limiting the by-products formation, in mammalian cells excessive starvation may induce apoptosis 
which results in a  high cellular death rate (𝑘𝐷) and decreased productivity. Based on these limitations 
some strategies have been developed for mammalian cells such as initial over-supply of nutrients 
followed by a cell arrest phase obtained by adding growth inhibitors or decreasing temperature. As 
mentioned above, perfusion is another mode of operation used to increase cell density. Because of its 
importance in the current research, it is described separately in the following chapter. 
 Mathematical metabolic modelling 
In order to develop and optimize a process, a thorough understanding of the process is a critical step. 
Mathematical metabolic models are useful for describing and better understanding biological processes. 
A simple and well-developed model is often helpful in reducing the number of experiments required 
for developing and optimizing the process. Generally, models should be easy to build and use and the 
type of model to be developed may also depend on the specific expected application. 
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For example in order to find the best targets for genetic manipulation metabolic models could be used 
to rationally identify needed knock out/in/up/down of genes responsible for specific enzymes in the 
metabolic pathway to increase the production of desired metabolites. Without having a systematic view 
based on a model such a manipulation might need a higher number of trial and error based experiments. 
Instead, by forecasting the best targets based on mathematical modelling, recombinant DNA techniques 
can be implemented to change or delete the genetic function of a specific target (Zomorrodi, Suthers, 
Ranganathan, & Maranas, 2012). On the other hand, at the bioprocess level, models can also be used 
to design the feeding regime in a fed-batch operation or the perfusion rate schedule in a perfusion 
operation to maximize growth and/or productivity.   
 Mathematical model categories 
Mathematical models for biochemical systems can be classified, according to their specifications and 
applications, into different groups: Structured or unstructured, segregated or unsegregated, 
deterministic or stochastic (Sidoli, Mantalaris, & Asprey, 2004). Structured models explicitly take into 
account the intracellular reactions reported for a particular organism unlike unstructured models than 
just describe mass balances of specific metabolites using empirical yields and Monod expressions but 
do not account for the different reactions involving a specific metabolite either as a reactant or as a 
product. Segregated cell models account for the heterogeneity of the cell culture thus assuming that 
different cells are at different metabolic stages at any given time. On the other hand un-segregated 
models assume that the cell population is homogeneous and thus describe an average status of the cell 
population within the culture. Unlike deterministic models where parameter and initial conditions 
values are fixed, stochastic models assumed these values to be random. The choice of the modelling 
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approach for a particular problem depends on the purpose of the model, the situation of the process and 
available data (Sidoli et al., 2004). 
 Kinetic Models 
A common approach in biochemical modeling is to identify main reactions involved in the process and 
to describe each of the reaction rates by kinetic expressions of Monod or other types. These kinetic 
expressions are then combined together into a system of differential equations that represent dynamic 
mass balances of each of the metabolites participating in the identified reactions as substrates or 
products. These models are deterministic since they involve deterministic parameters and initial 
conditions. In some cases, simple unstructured empirical mass balances are used where the 
consumption of the metabolite towards biomass or towards another metabolite is determined by 
empirical Monod kinetic terms and yields. For example, a simple kinetic model that has been used 
extensively for glucose consumption for producing biomass by using Monod type equations is given as 
follows: 
S→X           (2-1) 
𝑑𝑠
𝑑𝑡
= −
µ𝑚𝑎𝑥
𝑘𝑠+𝑠
𝑋
𝑌𝑋 𝑆⁄
         (2-2) 
where 
𝑑𝑆
𝑑𝑡
 is the consumption rate of glucose, µmax⁡  is the maximum specific growth rate, S and X are 
glucose and biomass concentration, 𝑘𝑠 is the value of S when μ/μmax = 0.5, 𝑌𝑋 𝑆⁄  is the rate of biomass 
formation from substrate (glucose) consumption.  
When considering many metabolites, these types of kinetic models are generally heavily parameterized. 
Then, in the presence of a large set of kinetic parameters, the downside of these models is their 
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sensitivity to model structure error and measurement noise especially when data is scarce. Also, the 
parameter estimation step is challenging since the kinetic equations are mostly expressed in non-linear 
forms thus necessitating nonlinear estimation techniques, e.g. when using Michaelis-Menten type 
equations (Sidoli et al., 2004). An additional problem is that parameters in the numerator and 
denominator of Michaelis-Menten expressions are highly correlated necessitating experiments at very 
low concentrations to determine the half-saturation constants while at low concentrations the data is 
generally inaccurate. 
 Metabolic flux analysis (MFA) 
Metabolic flux analysis (MFA) is a modelling approach that identifies the distribution of flux rates at 
steady-state conditions. Based on stoichiometric relations among metabolites, dynamic mass balances 
can be written for the metabolites as follows: 
𝑑𝐱
𝑑𝑡
= 𝑺. 𝒗          (2-3) 
where S is the stoichiometric matrix, x is the vector representing the concentration of the metabolites, 
𝒗  is the vector for metabolic fluxes and µ is the cell specific growth rate. In MFA it is usually assumed 
that the intracellular environment is at a quasi-steady state (
𝑑𝐱
𝑑𝑡
= 0). 
 This assumption is based on the fact that changes in intracellular fluxes (within the cells) occur much 
faster comparing to extracellular ones but this may not be always accurate.  
𝑺. 𝒗 = 0          (2-4) 
Generally, input and output fluxes into and from the cell can be experimentally measured whereas 
intracellular fluxes are more difficult to measure. Following the assumption of quasi-steady state, it is 
possible to cancel out the reactions among intracellular intermediates and establish relations between 
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input and output fluxes but the resulting model is generally underdetermined given by equation 2-5 
since the degrees of freedom are larger than zero: 
d=n-k-m          (2-5) 
where d is the degree of freedom, n is the number of fluxes, k is the number of constraints and m is the 
number of measurable fluxes.  
There are two major approaches to address the under-determinacy problem or lack of measurements 
for calibrating stoichiometric models: 
a) Using labelling data to experimentally find important/negligible intracellular fluxes 
b) Fit extracellular data with a mathematical and biologically meaningful objective function 
subject to constraints where the latter are based on the stoichiometry and kinetic rate limits. 
These two approaches are further discussed in the following sections. 
Isotope-based metabolic flux analysis is a technique to measure intracellular metabolic ﬂuxes. 13C-
based metabolic flux analysis has been applied in different prokaryotic and eukaryotic systems (Yang, 
2013). 13C-MFA technique involves the following steps: (1) selecting appropriate tracers for the 
system under study (2) implementing isotopic labeling experiments, (3) quantifying isotopic labeling 
distributions in metabolic products, (4) estimating metabolic ﬂuxes using least-squares regression, and 
(5) evaluating the goodness of ﬁt and computing conﬁdence intervals for estimated ﬂuxes 
(Antoniewicz, 2013). 
Although promising the “Application of MFA technique using 13C” poses several challenges as 
follows: 
a) Dilution of isotopic labels of intracellular metabolites  
b) High flow rate of extracellular metabolites such as lactate may result in lower intracellular 
labeling due to the high exchange rate between intracellular and extracellular lactate.  
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c) Compartmentalization of metabolism since some metabolites like pyruvate, citrate, malate, and 
amino acids are involved in different metabolic pathways whereas current techniques cannot label them 
separately. Hence, just the sum of the individual contributions can be quantified (Ahn & Antoniewicz, 
2012b). 
The second approach is called flux balance analysis that is discussed in the next section. 
 Flux Balance Analysis (FBA) modelling 
Flux Balance Analysis (FBA) is one of the modelling methods that has been extensively used for 
studying metabolic activities in a wide range of systems ranging from microbes to human cells. FBA 
is categorized among the type of models referred to as “constraint-based” models. By imposing various 
meaningful constraints on the system, the solution space of an underdetermined system of equations 
can be reduced to reach a unique solution. The main advantage of FBA type models is their capability 
of predicting the behaviour of metabolites in metabolic networks without a need for excessive kinetic 
information about that network. FBA mathematically describes the system under study by developing 
a matrix of stoichiometric coefficients. This matrix is used for formulating mass balances in terms of 
the fluxes associated with the different reactions involved in the metabolic network. The initial FBA 
approach was proposed for describing a steady state situation according to which the production rates 
of produced metabolites are equal to the consumption rates of consumed nutrients as already presented 
in equations (2-3) and (2-4). As explained in the former section, the resulting system of stoichiometric 
equations is usually underdetermined (i.e. more unknowns than equations). To partially address this 
problem it is considered that cells are trying to maximize/minimize an objective function subject to 
stoichiometric or other constraints and the resulting optimization problem will force a solution at 
particular constraints. Accordingly, the FBA can be formulated as an optimization problem as follows: 
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max  𝑪𝑻𝒗          (2-6) 
       Subject to    𝑺. 𝒗 = 0 
                         0 ≤ 𝒗 ≤ 𝒗𝒎𝒂𝒙 
where 𝑪𝑻𝒗  is an objective function which has to be maximized,  𝑪𝑻is a  vector of weights for each flux 
in the objective function that reflects the relative contributions of amino acids or other metabolites to 
biomass and 𝒗 is the set of reaction fluxes that are subject to constraints. Constraints like the availability 
of substrates are usually the most common ones used in previously reported work. Upper and lower 
bounds for each reaction flux are associated to reaction rate limitations. As for all FBA problems setting 
a biological meaningful objective function is very important. For example, maximization of biomass is 
a common optimization objective that has been used to predict the system behavior in some 
microorganisms especially for bacteria. It should be noticed that FBA can only solve for the fluxes 
between reactants and products for each reaction but it cannot provide information about the individual 
metabolites’ concentrations (Mahadevan et al., 2002).  
There are some extension models to FBA that will be briefly discussed in the following subsections. 
 Flux variability analysis 
Due to a lack of a sufficient number of constraints FBA may lead to multiple solutions. This situation 
might have a negligible impact on the prediction of the model or it could be an important one depending 
on the proximity of the solutions to each other and to the importance of the fluxes that are not 
determined uniquely.  
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 Dynamic Flux Balance Analysis 
FBA is only capable of modelling the flux distribution at steady state. Hence, it is not able to determine 
the evolution with time of the metabolites’ concentrations. To capture the dynamics of the system, a 
dynamic extension of FBA has been proposed that is referred to as Dynamic flux balance analysis 
(DFBA). In the original DFBA formulation proposed by Palsson group (Savinell & Palsson, 1992) it 
was assumed that the fluxes are piecewise constant, i.e. they remain constant during short time intervals. 
Hence, the resulting fluxes calculated at each time interval T can be used to calculate the concentrations 
in a recursive fashion using the Euler discretization of the corresponding dynamic balance as follows: 
𝛹𝑖+1 = 𝛹𝑖 +⁡(S. 𝑣𝑖)⁡⁡𝑋𝑖. ∆𝑡  (T= time interval)    (2-7) 
For example, a dynamic model for the diauxic growth of E.coli on glucose and acetate (Mahadevan et 
al., 2002) was formulated by using DFBA as follows: 
@ each sampling time i          (2-8) 
max 𝑐𝑇𝑣  
        Subject to 𝑣𝑖 >⁡0                                                                        
                          
1
?̅?
⁡
𝑑𝛹
𝑑𝑡ℎ𝑖𝑔ℎ𝑒𝑟
 ≤⁡
1
∆𝑡.𝑋𝑖
(𝛹𝑖+1 − 𝛹𝑖) =S. 𝑣𝑖 ≤ 
1
?̅?
⁡
𝑑𝛹
𝑑𝑡𝑙𝑜𝑤𝑒𝑟
        
                         𝛹𝑖+1 = 𝛹𝑖 +⁡(S. 𝑣𝑖)⁡𝑋𝑖 ⁡T⁡⁡⁡⁡⁡⁡⁡⁡          (T= time interval)    
where here ?̅? is an average biomass concentration over a given period of time (e.g. duration of 
exponential phase or post-exponential phase), 𝑋𝑖⁡is the biomass at time i, (dΨ/dt) higher  and (dΨ/dt)lower  
are higher and lower bounds on consumption or production rates. These limiting metabolic rates can be 
defined as a function of concentration/s of metabolites participating in the corresponding reaction. 
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These rate constraints are determined from experiments. T is a time interval value used for discrete 
numerical integration (Budman et al., 2013). 
The key advantage of DFBA, and the reason that is chosen for the current research is that it often needs 
a limited number of constraints to describe the evolution of metabolites thus often requiring a small 
number of parameters to describe the system (Mahadevan et al., 2002). This may be a significant 
advantage as compared to kinetic models that were reviewed in the previous sections and that require 
many parameters thus making them sensitive to noise and also to regular FBA models that do not model 
the process dynamics. These advantages make DFBA a promising modeling method for optimization 
purposes but its application to experimental systems poses several challenges. First, the models that 
have been proposed in the literature such as the E.coli model given above, generally involve a small 
number of metabolites. For this case, the constraint and objective function are generally determined by 
trial and error. On the other hand when the number of metabolites that need to be modeled is much 
larger as compared to the E.coli model given above, finding the biological function and the constraints 
necessary to explain the experimental data is much more challenging. Finding systematically the 
minimal number of constraints of the DFBA model is a main focus of the current work. 
 Challenges regarding the DFBA modelling of mammalian cells 
 Modeling of mammalian cells is generally more challenging as compared to other microorganisms 
such as bacteria. Mammalian cells are subject to death mechanisms such as apoptosis (programmed 
cell death) that significantly limit their long term viability. Also, due to their slow growth as compared 
to bacteria, experiments are slow with the resulting increased chances of contamination while viability 
limitations impose serious constraints on the ability to collect data for model calibration.  
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Bacterial cells are generally grown in relatively simple chemically defined media. Most flux constraints 
that have been used within metabolic models of bacteria were generally related to the uptake rate of a 
major ingredient such as glucose. On the other hand, in mammalian cells, media is much more complex. 
This complexity combined with the fact that manufacturers of medium for mammalian cells do not 
reveal the media composition poses challenges for the formulation and calibration of mathematical 
models.   
 The choice of the objective function 
FBA type models have generally adopted the optimality assumption of evolutionary biology whereby 
cells are using resources optimally to maximize or minimize a specific objective function in order to 
survive. A common objective function used especially for bacterial systems is the maximization of 
growth or final biomass at the end of a batch (Orth, Thiele, & Palsson, 2010). However, several other 
objective functions also have been investigated such as minimization of the production rate of redox 
potential, minimization of ATP production rate, maximization of ATP production rate, maximization, 
and minimization of nutrient uptake rate, maximization of biomass yield per unit ﬂux) maximization 
of ATP yield (maximal energy efficiency), minimization of the overall intracellular flux, maximization 
of ATP yield per flux unit (maximizing ATP yield while minimizing enzyme usage), maximization of 
biomass yield per flux unit (maximizing biomass yield while minimizing enzyme usage), minimization 
of glucose  consumption (more efficient usage of substrate) and minimization of reaction steps 
(minimization of the number of reaction steps for cell growth) (Schuetz, Kuepfer, & Sauer, 2007). The 
FBA modeling studies involving different objective functions have been mostly done based on the 
central metabolic network or genome-scale network of E.coli. Defining the right objective function has 
been reported to greatly impact the model prediction accuracy. In certain studies the minimization of 
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the production rate of redox potential under nutrient limitations, the linear maximization of the overall 
ATP or biomass yields have been found to more accurately predict the system behavior as compared to 
the objective of maximizing growth or final biomass (Pramanik & Keasling, 1997; Schuetz et al., 2007) 
. 
Mammalian cells might accomplish different functionalities during their time evolution comparing to 
bacteria. A previous study for finding a suitable objective function on hybridoma cell central 
metabolism studied the following possibilities: 1) minimization of ATP production, 2) minimizing total 
nutrient uptake and 3) minimizing redox metabolism through minimizing NADH production.  That 
study suggested that while not a single objective could solely rule the cell behavior, minimizing the 
NADH production can better describe the typical characteristic behavior of hybridoma cells such as 
their inefficient use of nutrients. Such inefficient use of resources translates into higher rates of 
consumption of glutamine and production of alanine (Savinell & Palsson, 1992) . 
Burgard et al. proposed a systematic approach using a bi-level optimization principle in which while at 
the upper level minimized the sum of square errors between the experimentally measured fluxes and 
the predicted fluxes, FBA model equations were used in the lower level (Burgard & Maranas, 2003). 
Where 𝑣𝑗⁡represent the flux of reaction j (obtained from optimization problem), 𝑣𝑗
𝑒𝑥𝑝
 experimentally 
determined flux of j,𝑐𝑗 are weights determining the contribution of each flux to the objective function 
which are adjusted by the outer optimization problem such as to minimize the sum of the squared error 
between the experimental and optimization flux rates and 𝑆𝑖𝑗⁡is the stoichiometric coefficient of 
metabolite i in reaction j.  The work was based on experimental data from the central metabolic network 
of E.coli using isotopomer analysis. The cost of the lower level optimization problem in equation (2-7) 
is a linear combination of fluxes multiplied by different weights where the latter are also decision 
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variables. For example, if the correct objective function following optimization would be the 
maximization of growth, those fluxes which contribute to biomass production would be multiplied by 
the weights corresponding to the relative contributions of fluxes to growth while all other weights 
would be zero. This approach can be potentially used to both identify the hypothesized objective 
function and to examine how the objective function may change by changing environmental conditions 
(Burgard & Maranas, 2003).  It should be noted that this latter work was done for continuous operation 
where the system is at steady state. 
To the knowledge of the authors, systematic approaches to find the most suitable objective function for 
dynamic cultures have not been proposed. The bi-level optimization formulation given above has been 
used in the current thesis for comparison with the new methodologies proposed in the current work. 
Furthermore, Dynamic Metabolic Flux Models have not been formulated as yet for mammalian cells 
and it remains an open area of research that will be addressed in the current work. 
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Chapter 3 
Methodology 
 Cell line 
Two cell lines were used: dihydrofolate reductase-deficient CHO cell line (dhfr- CHO) able to produce 
anti-RhD MAb that was originally provided by Cangene Corporation (Mississauga, ON) and a CHOZN 
ZFN-modified GS-/- CHO cell producing anti-rabies IgG provided by SAFC/MilliporeSigma (St Louis, 
MO). The latter has been reported to provide much higher titer as compared to the former. 
 Cell culture media 
Both cell lines were cultivated in serum-free media.  The medium used for (dhfr- CHO) was HyClone 
SFX-CHO by Thermo Fisher Scientific (Waltham, MA), a liquid serum-free medium designed for 
CHO cells. For CHOZN ZFN, the medium used was EX-CELL-CD CHO Fusion by 
SAFC/MilliporeSigma (St Louis, MO). Since (dhfr- CHO) cannot to synthesize glutamine, and cells 
need glutamine for growth, 1mM glutamine (Thermo Fisher Scientific, Waltham, MA) was added to 
the medium before its use in the cell culture experiments. CHOZN ZFN is a GS cell line which can to 
synthesize glutamine so addition to the medium for growth is not required.  
 Seed culture 
To prepare the seed culture, a cryogenic vial of cells (containing 1ml of cells at a density of 5-10 ×106 
cells/ml) was rapidly thawed in a water bath at 37 °C under a laminar flow hood and quickly diluted in 
a 125 ml shaker flask containing 30 ml of pre-warmed serum-free media.  
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 Cell count 
To determine the cell density and viable cell density of the culture a Trypan blue exclusion method was 
used. 100 µl of Trypan blue (0.4%) was mixed with 100 µl of the cells (in their medium) and a 20 µl 
of this mixture was loaded into a hemocytometer. The total number of cells and the blue stained (viable) 
cells and the blue stained (viable) cells were counted under a microscope.  
 Sub-culturing 
Based on growth rate, the cells should be passaged 2 to 3 times a week. The passaging step involves 
removing some part of the old medium (containing cells) and adding a new medium to the flask to 
lower the cell density to approximately 0.25×106 cells/ml at any single passaging operation. This 
procedure maintains the cells within their exponential growth phase. During the exponential growth 
phase, the cell viability was above 95%. 
 Weaning of the cells (adaptation to low serum media) 
(dhfr- CHO) used in this study were an adherent cell line and required 10% serum. To adapt it to the 
suspension condition in spinner flask, it was necessary to gradually decrease the amount of the serum 
in the medium. For this purpose, a sequential process was used. First cells were cultured in was 
monolayer in a T-flask containing cell culture medium to which 10% fetal bovine serum (Invitrogen, 
CA, USA) was added. Following two sub-cultur steps under these conditions and once the cells were 
identified to be in their growth phase with more than 90% viability, they were sequentially sub-cultured 
gradually and adapted to 7.5%, 5%, 2.5% and finally 1% serum. For each of these subcultures, the cells 
were dislodged by trypsin-EDTA solution (Sigma, MI, USA), centrifuged at 100 X g for 4 min and the 
trypsin-EDTA were aspirated from the flask. After adapting to 1% serum in T-flask, cells in their mid-
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growth phase with more than 90% viability were transferred to a spinner flask with a cell density of 
around 0.3 million cells/mL and the experiment was started (Radford, Niloperbowo, Reid, & 
Greenfield, 1991). 
 Metabolites analysis 
Lactate, ammonia, glucose and glutamine were analyzed using a BioProfile 400 (Nova Biomedical, 
MA, USA).  
 Quantification of mAb 
Quantification of monoclonal antibody was done in MilliporeSigma (MI, USA) by using a ForteBio 
(Pall ForteBio LLC, CA, USA). 
 Amino acid analysis 
To remove the cell debris from the cell culture medium, samples from the cell culture medium were 
centrifuged at 4500rpm for 4 minutes. The amino acid analysis was performed with a pre-column 
derivatization method using 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate (AQC) Waters 
AccQFluor Reagent (Waters, MA.USA).  Sample preparation was done by mixing 70 µL of AccQFluor 
borate buffer in a 10 µL volume of sample. After vortexing the sample for approximately 10 seconds, 
20 µL of AccQFluor reagent was added to the mixture and further vortexed, for 10 seconds the mixture 
was incubated for 1 minute at room temperature and later it was placed in a water bath at 55o C for 10 
min. This step was done to hydrolyze the excess AccQFluor reagent to 6-Aminoquinolone (AMQ), N-
hydroxysuccinimide (NHS) and carbon dioxide. A five-point standard calibration curve was prepared 
by successive dilution and analysis of a mixture of standard amino acids that contains a 2.5 mM of each 
of the hydrolysate amino acids and 1.25 mM of cysteine (Sigma Aldrich, MI, USA). 
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For amino acid analysis, a Waters 1525 chromatography system (Waters Corporation) with a 
fluorescence detector (W2475; Waters 1525; Waters Corporation) was used. An excitation wavelength 
of 250 nm and an emission wavelength of 400 nm was applied. Also, the gain value was set to 1.0 and 
a filter value of 0.5. The volume of each sample was 5 µl that was provided by placing an insert inside 
the sample bottles. A Waters AccQ.Tag Amino Acid Analysis Column C18 (4 µm; 3.9 mm × 150 mm), 
specifically designed for this amino acid analysis method was used. As this analysis involves separation 
of 19-22 different amino acids and compounds, the procedure requires attention to the following steps: 
1) The column is kept at conditions suggested by the manufacturer,  
2) The water used for buffer preparation must be Millipore grade water with a resistivity 
of 18.2 MΩ.cm (at 25°C)  
3) All the glassware including the buffer glasses is washed carefully,  
4) All the buffers should be filtered and degassed properly before usage. Buffers being used are 
Buffer A: an acetate-phosphate buffer which is a mix of 100 mL AccQTag A concentrate with 
1-liter Millipore water) and Buffer B: a mix of acetonitrile and water (60:40%).  
5) The column temperature was set to 37 oC and the column was conditioned with buffer B for 10 
minutes at a flow rate of 1 mL/min. Before every run, the column was equilibrated for 10 
minutes at a 1 mL/min flow with 100 % of Buffer A (Carrillo-Cocom et al., 2015; Cohen, 
2000). A Gradient table for the HPLC runs is presented in Table 3-1. 
 
 
 
 37 
 
Table 3-1 Gradient table for the HPLC runs, buffers AccQ.Tag buffer A and B 
 Time (min) Flow rate (mL/min) A% B% 
Initial 1.0 100 0 
0.5 1.0 98 2 
15 1.0 93 7 
19 1.0 90 10 
32 1.0 67 33 
33 1.0 67 33 
34 1.0 0 100 
37 1.0 0 100 
38 1.0 100 0 
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Chapter 4 
Perfusion process development 
 The basics of perfusion operation 
The perfusion mode of operation unlike the batch and fed-batch operating modes is considered a 
continuous operation. In perfusion operation the spent medium is continuously removed from the 
bioreactor and replaced by fresh medium, while cells are kept inside the bioreactor using a cell retention 
device. During medium replacement, the nutrients consumed as a result of cell metabolism are usually 
replenished by feeding of the new medium.  A key advantage of perfusion processing is that lactate and 
ammonia, the most common by-products of cell metabolism that usually have a toxic or inhibitory 
effect on cell growth and protein production, are regularly removed. Thus perfusion operation generally 
promotes higher cell growth and lower cells death thus leading to much higher cell densities.  Since the 
product titer is generally correlated with cell mass, higher cell density in the bioreactor generally 
translates to higher productivity per volume. The perfusion operation is generally implemented in two 
phases. During the first phase, the goal is to achieve a certain level of cell density while in the 
subsequent second phase the goal is to keep the cell density at a steady state (plateau) for a longer 
period of protein production. The level of cell density during this second phase is usually adjusted by 
regulating the perfusion rate and harvest rate and by bleeding out a certain amount of cells, including 
the dead cells. The overall equation for the perfusion process is shown in equation (4-1). 
dX
dt
= µX − 𝑘𝐷X − D𝑋𝐻 −
𝐶𝐵𝑅
𝑉
𝑋        (4-1) 
where µ is the specific growth rate,⁡𝑘𝐷 is the cell specific death rate, X is the concentration of biomass, 
D is the dilution (perfusion) rate, XH is the biomass concentration of the harvested stream. If the cell 
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retention device has 100% efficiency in retaining the cells this value should be equal to zero 
(Konstantinov et al., 2006). 
In the early days of the modern biopharmaceutical industry, i.e. during the 1980s and 1990s, perfusion 
systems were initially introduced and they attracted significant attention as on those days the product 
yields of the available industrial cell lines were only a few milligrams to few hundreds milligram. 
Hence, perfusion was considered as an attractive option for producing a larger amount of products. The 
most common cell retention devices used at that time were spin filters, which will be introduced in the 
next section. However, those devices were not really efficient, especially due to scale-up challenges. 
When product yield was significantly improved as a result of cell engineering advancements, perfusion 
systems became less popular compared to fed-batch operations due to the relative operating complexity, 
additional hardware requirements and potential contamination of perfusion systems. For some products 
that were not stable, such as recombinant Antihemophilic Factor VIII, perfusion remained almost the 
only viable process option because the medium containing the expressed protein must be taken out of 
the bioreactor and sent directly for purification before it denatures inside the bioreactor.  
Beyond these special applications, perfusion is gaining attention once again mainly because the 
development of new cell retention devices that are scalable. Other factors that have motivated the use 
of perfusion are the need for increasing amounts of therapeutic proteins, the availability of novel single-
use bioprocess systems that make it possible to use only one manufacturing line for the production of 
multiple products and advancement in continuous purification systems to match the continuous 
production from perfusion (Bonham-Carter, 2011; Jacquemart et al., 2016).  
Beyond their use in the large-scale production of proteins, in recent years perfusion processes have 
been found to be very useful in development of personal cancer treatment especially in immunotherapy 
using chimeric antigen receptor-modified T cell (CAR-T cell) in which it is critical to produce sufficient 
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amount of patients’ modified  T cells in a short amount time (Levine, Miskin, Wonnacott, & Keir, 2017; 
Wang & Riviere, 2016). 
 Cell retention devices 
The lack of effective scalable cell retention device has been the main obstacle for using perfusion mode 
in bio-manufacturing operations. Cell retention devices can be based on different physical principles 
such as filtration, gravity, and acceleration. A cell retention system should be able to separate close to 
100% of the cells from the effluent stream and it has to keep this efficiency even at high-density cell 
conditions (Woodside, Bowen, & Piret, 1998). Several factors should be considered regarding the 
choice of cell retention systems such as cell retention and cell density capacity, the residence time of 
cells in the bioreactor, mechanical shear stress and the retention of the protein of interest inside the 
bioreactor. Some of the cell retention devices have a re-circulation loop in which the medium containing 
cells is circulated inside this loop and only part of that stream will be extracted out for the protein 
harvesting. However, this recirculation process combined with the use of peristaltic pumps may result 
in detrimental mechanical shear stress on cells. The cell retention time during cell separation is another 
factor that may have negative effects on cell culture conditions as during this time cells may be exposed 
to stressful culture conditions.  For example, oxygen shortage might occur during the time the cells are 
within the cell retention devices (Chotteau, 2015). Some of the cell retention systems available are 
reviewed below. 
 Gravitation/Acceleration based devices 
These devices are working based on acceleration or gravity where the media is usually pumped through 
a peristaltic pump to these settlers. These devices are normally used for anchorage-dependent cells 
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attached on micro- carriers due to the higher solid density in these cases as compared to suspension cell 
systems without micro-carriers that cannot be effectively separated with gravitational devices. 
 Inclined settler 
Inclined settlers consisted of inclined plates on which the cell sedimentation occurs. The cell culture 
medium containing cells is pumped into the lower part of the settler. Then, sedimented cells are sent 
back to the bioreactor and the cell-free media is pumped out from the top part of the settler to the harvest 
tank. The main advantage of inclined settlers is that cell bleeding, i.e. elimination of dead cells from 
the bioreactor, is possible in this type of settling device. Also, inclined settlers contribute negligible 
shear stress to the cells. On the other hand, cells in an inclined settler usually adhere to the plates 
resulting in an increase of the residence time within the settler in the range of 30 minutes to few hours. 
To mitigate this problem, vibration can be applied to the system and also the cell metabolism can be 
manipulated to inhibit the cell adhesion to the settler plates. Manipulation of the metabolism might be 
accomplished by using a heat exchanger to lower the temperature of the media that goes to the settler. 
Despite these possible modifications, the cell perfusion capacity within inclined settlers is relatively 
low and thus scale-up is considered a challenge (Chotteau, 2015; Woodside et al., 1998). 
 Acoustic Settler 
In this type of settlers, acoustic waves are applied to a chamber where the cell broth has been previously 
pumped in. The cells are concentrated to a particular density so they experience resonance at the 
frequencies of the imposed acoustic waves. When the waves are interrupted, the aggregated cells settle 
rapidly, falling back into the bioreactor. This settling device needs significant power to generate the 
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waves and the transfer of this vibrational energy to the cells may damage them. The use of this device 
has been reported in pilot scale applications only (Chotteau, 2015). 
 Filtration based devices 
Filters have been developed and used for separation of mammalian cells from culture medium but 
fouling remains a major challenge for long-term operation. Different modifications have been proposed 
to address fouling. 
 Spin-filters 
Spin filters consist of a cylindrical membrane rotating within the bioreactor around the same centerline 
axis as the impeller. The spent culture medium is drawn from the culture volume into the cylinder and 
then out of the reactor while the cells are retained by the membrane. Spin-filters differ from cross-flow 
filters in two major aspects: the fluid flow relative to the filtration surface is produced by the rotation 
of the cylinder and the filtration surface is typically inside the reactor. Hence, the trans-membrane 
pressure drop can be manipulated independently from the cross-flow velocity, the retentate cell 
concentration is more uniform over the whole filter surface and the cells remain within the controlled 
environment (Woodside et al., 1998). 
 Cross-flow filters  
Cross-flow filtration or tangential flow filtration is a common filtration methodology that has been used 
in many applications. Unlike normal dead-end filtration where the flow passes through the filter, in 
cross-flow filtration the feed flows tangentially to the filter surface. Hence, in tangential flow filtration, 
fouling is reduced as compared to processes involving dead-end filters and thus the process can be 
operated continuously since intermittent washing is not required.  
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ATF perfusion system (ATF: Alternating tangential flow) is a particular perfusion system manufactured 
by Repligen that has been used in the current research. Membrane fouling is significantly reduced in 
this system due to the use of a special diaphragm that produces an alternating tangential flow (Kelly et 
al., 2014) .Hollow-fiber cartridges are typical choices of cross-flow filters for cell retention in 
mammalian cell perfusion applications. In these systems, the suspension is pumped to an external 
cartridge and it is concentrated as it flows across a membrane. The concentrated material containing 
the cells is recycled back to the reactor, while the cell-free permeate exits the system. The pressure drop 
between the inlet and recycle streams drives the cross-flow across the membrane and determines the 
surface shear rate. The resulting trans-membrane pressure difference is the highest near the inlet of 
membrane and it may even be reversed at the filter outlet thus generating a non-uniform permeate flux. 
The permeate flux has been reported to be the most important parameter in determining the filter’s 
fouling. 
Among all the aforementioned cell retention systems, ATF perfusion system is currently viewed as 
especially advantageous as it is usually easier to use and control and it is amenable to scale- up. Thus, 
the ATF perfusion system has been chosen for the perfusion experimentation conducted in the current 
thesis. 
 Challenges in the operation of a perfusion bioreactor: 
 Level control: 
As mentioned earlier, in perfusion operation the media is continuously substituted by fresh medium. 
In order to keep the level in the bioreactor constant during this exchange of contents the flow of fresh 
medium entering the bioreactor should match the flow of spent medium.  Although the use of the same 
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peristaltic pump and the same tubing would be expected to result in a balance of the flows, due to 
several factors such as fatigue in the tubing (Chotteau, 2015) or differences between the pressure in the 
bioreactor and the harvest tank this balance is not always maintained. The resulting deviations from the 
balance between fresh medium and spent medium flowrates might cause during long term operation to 
overflow or to a critical reduction of the medium level inside the bioreactor. To address this problem 
two solutions are available. A first option is to control the level by using by adjusting the feeding pump 
based on a level sensor’s measurements. This method is only partially effective because due to foaming 
at the top of the bioreactor, especially at higher cell density, the readings from the level sensor are 
highly inaccurate. A second solution used in the current work is to place the bioreactor on top 
of a scale and use the weight as an indicator for the level inside the bioreactor. Based on the 
weight a level controlling system was designed using a PID controller that based on the weight 
measurement sends corrective actions to a feeding peristaltic pump.  
 Oxygen and Carbon dioxide transfer 
Providing enough oxygen for the cells in a perfusion operation is a key challenge, especially in a smaller 
scale bioreactor, since cell density is substantially higher than a batch or fed-batch operation (up to 
hundred times). As a result of this high density, the overall oxygen consumption rate (OUR) is generally 
high as per the balance equation for oxygen (equation 4-2).  Also,  according to the dynamic balance 
of oxygen within the bioreactor (equation 4-3), it is evident that a higher oxygen transfer rate (OTR) is 
required to keep the oxygen level above the critical point of dissolved oxygen (C in equation 4-2) which 
is normally 20- 50 % of saturation for CHO cells.  
OUR=𝑞𝑂2𝑋          (4-2) 
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dC
dt
= OTR − OUR         (4-3) 
The OTR is often empirically calculated based on the volumetric transfer coefficient (𝑘𝐿𝑎) as given in 
equation 4-4. According to this equation, it is possible to increase OTR by increasing⁡𝑘𝐿𝑎. Some of the 
factors affecting 𝑘𝐿𝑎 are the rotational speed of the impeller, the bioreactor geometry, temperature and 
pressure and the amount of surfactants used to mitigate foaming. 
OTR = 𝑘𝐿𝑎(𝐶𝑠 − 𝐶)         (4-4) 
Although increasing the impeller speed (rpm) is an easy way to increase OTR it should be noted that 
mammalian cells are more susceptible to damage resulting from shear stress. Thus, there is a limit on 
the speed of impeller that usually depends on the type of cells being cultured. Also decreasing the 
bubble size by manipulating the sparger operation results in more surface for oxygen transfer with a 
resulting increase of 𝑘𝐿𝑎 but it also produces foam that has a detrimental effect on cells. Manipulating 
the amount of surfactants is also a common practice to increase 𝑘𝐿𝑎  but it also has drawbacks. First 
surfactants may be toxic to the cells and also its addition to filter-based perfusion systems might cause 
clogging of the filter. 
In addition to oxygen control, regulating the amount of CO2 in the bioreactor is essential for effective 
operation of mammalian cell cultures. As a result of the cell metabolism carbon dioxide usually 
accumulates inside the bioreactor and lowers the pH. For example, Gary et al suggested that when pCo2 
was in the range of 30-76 mmHg it better supported the protein production in CHO cells growing in 
perfusion culture and higher level of pCO2 (> 105 mm Hg) had an inhibitive and destructive effect on 
the cell growth (Gray, Chen, Howarth, Inlow, & Maiorella, 1996). An initial project of the current thesis 
addressed this issue and is reported later in Chapter 7. It was found that the accumulation of carbonic 
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acid caused the reduction of pH to values that were found to be inhibitory to cell growth in spinner 
flask cultures of CHO cells. 
To tackle OTR limitations and accumulation of CO2 we have proposed in the current work to use two 
different type of impeller with different agitation profile, one Rushton at the bottom and one Marine 
type closer to the surface of the liquid in the bioreactor. Following this design, the oxygen had a higher 
chance of being dissolved in the medium.  
 
Figure 4-1 Idealized mixing profile in the bioreactor with two different impellers 
Also, we used a ring sparger that by producing larger bubble size helped to expel the CO2 from the 
bioreactor and in addition, a microsparger with smaller pore size was used to provide enough oxygen 
to the culture. Thus, the effect of the addition of the microsparger was to increase the 𝑘𝐿𝑎 as compared 
to the values obtained with the ring sparger alone. 
At the earlier batch phase occurring before the perfusion phase, the ring sparger was sufficient. This 
sparger is connected to the air supply and as mentioned above promotes the stripping of CO2 from the 
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culture while providing enough dissolved oxygen (DO). During the second phase of operation when 
perfusion starts pure oxygen was provided through the microsparger while the ring pipe sparger was 
still providing regular air. The reason for switching the flow from air to pure oxygen was to satisfy the 
higher oxygen demand at this stage thus maintaining a suitable air/oxygen ratio that ensures the right 
level of DO while avoiding excessive foam formation inside the bioreactor.  
  Antifoam addition 
Excess foam formation is detrimental to cell growth and protein. Bursting of the bubbles within the 
foam can damage the cells and decrease the cell viability (Routledge, Hewitt, Bora, & Bill, 2011). 
Inside the bioreactor, foaming can block the filters and increase the pressure inside. Addition of 
antifoam is a common practice in bioprocess engineering to decrease the foam formation. However, 
there are some points that should be considered regarding antifoam usage. Antifoam addition will 
decrease the oxygen transfer inside the bioreactor, and addition of antifoam could be an issue for the 
downstream and purification process because antifoams are known to foul the membranes. Also 
depending on the cell line, some antifoams might have toxic effects on the cells. Thus, it is generally 
recommended to perform a toxicity test for the antifoam to be used in the bioreactor by adding a 
different concentration of the antifoam to the cell line in the flask and assessing the resulting toxicity. 
 Effect of peristaltic pumps and tubing 
In the perfusion operation used in the current work, the cells were extracted from the bioreactor by 
using a peristaltic pump and then they were filtered using an ATF filter. Both the pumping and filtering 
operation result in shear stress that is potentially damaging to the cells. One way to reduce this shear 
stress was to use tubes with larger diameters, however it could result in an increase of the loop volume. 
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A useful strategy utilized to mitigate the shear effects was to use tubes with a larger diameter but with 
a shorter length that while reducing the shear stress they are also able to minimize the residence time 
in the circulation loop. It should be noted that generally it is suggested to keep the residence time less 
than 2 minutes (Chotteau, 2015). 
 Materials and methods 
  Cell preparation for inoculum 
For this study, a CHOZN ZFN-modified GS-/- CHO cell line (SAFC/MilliporeSigma, MO, USA) was 
used. Cells were thawed and suspended in a 125 ml flask containing 30 mL of medium, shaker condition 
of 36.9oC, 5% CO2 and rpm of 100 were used during the cell expansion. After two days, cells were 
dispensed to two 125 ml flasks with the cell density of 0.3 million cells/ml and were fed with fresh 
medium. Cell expansion continued for almost two weeks so as enough cells were available for 
inoculation of the bioreactor and that the cells were in their growth phase with more than 95% viability. 
Cell count and cell viability were performed using a hemocytometer under the microscope and the 
Trypan blue method (Strober, 2001).  
 Preparation of the bioreactor and ATF perfusion system 
The bioreactor’s vessel was connected to different sections of tubing required for feed, inoculum, 
harvest, perfusion, cell bleed, gases, base addition and antifoam. Each of these lines was connected to 
a disk filter with an easy connector (Figure 4-2). 
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Figure 4-2 End tube connection to disk filter. 
For each run the ATF perfusion’s filtration set-up was equipped with a new diaphragm and connected 
to the bioreactor vessel using a dip tube went to the bottom of the vessel that was connected to the top 
of the filter. The port at the bottom of the filter was equipped with a tube with an easy connector to 
allow for connectivity to the harvest tank. The bioreactor vessel and the ATF filter were autoclaved 
while connected together. The bioreactor’s vessel was connected to the controller and the probes were 
calibrated. The pipeline considered for the cell bleed was designed to be closer to the surface of the cell 
culture media where usually the cell debris was found to accumulate (Figure 4-3). 
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Figure 4-3 Schematic of perfusion set-up. 
  Bioreactor operation set points 
The bioreactor was inoculated to a cell density of about 1 million cells/ml, the temperature was set to 
36.9oC , DO to 40%, pH to 6.9 and the impeller agitation speed was set at 150 rpm. 
  pH control by base addition 
Following the above discussion about the need for reducing the CO2 level in section 4-3-2 with its 
resulting detrimental effect on pH and cell viability, it was required to add a base to keep the pH at its 
desired level. For the cell line used in this study, a pH of 6.9-7.0 was recommended by the supplier. 
Sodium carbonate (Na2CO3) and Sodium hydroxide (NaOH) were used as recommended for 
mammalian cell cultures. Sodium carbonate is milder compared to sodium hydroxide but it is known 
to increase the osmolality, that could be detrimental to a high cell density culture. Hence, 1M sodium 
hydroxide was used. As sodium hydroxide could be detrimental to the cell culture at the feeding location 
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the base addition line was positioned immediately above the impeller, i.e. at a region that is considered 
to be well mixed inside the bioreactor. 
 Perfusion rate 
The perfusion rate is an important factor in running perfusion processes. This rate has a great impact 
on cell growth and protein production and quality since it determines whether enough nutrients are 
available for the cells and whether toxic by-products are removed fast enough from the bioreactor. 
From an economic perspective consuming less cell culture medium is highly desired but this 
consideration should not come with the price of sacrificing cell growth, protein production, and protein 
quality. Hence, finding the optimum perfusion rate is critical for a successful operation. There are a few 
common criteria for adjusting the perfusion rate that is discussed here as follows: 
1) Based on the level of key nutrients such as glucose 
2) Based on trial and error and former experience; this method usually needs extensive 
experimentation so it was not pursued in the current work  
3) Based on a desired cell-specific perfusion rate (CSPR). This is the most common method in the 
industry where perfusion rate is adjusted based on the cell density and by using the parameter 
CSPR(pL/Cell/Day) that relates the perfusion rate to the cell density as per the following 
formula: 
CSPR =
𝐷
𝐶𝑣
         (4-5) 
In equation (4-5), D is the perfusion rate in units of (Reactor volume/Day, RV/Day), and Cv is viable 
cell density (millions of viable cells/ml, MVC/mL). Generally, the CSPR is kept constant by changing 
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the perfusion rate (D) as a function of the measured cell density. As mentioned earlier it is desired to 
use less medium while supporting cell growth and protein production and quality. Thus, keeping the 
CSPR at the lowest possible rate is an important goal. An acceptable CSPR for the industry is around 
40-100 pL/cell/day. Konstantinov and colleagues introduced a method called “push-to-low” that is 
acceptable for products for which a longer residence time will not adversely affect the protein quality. 
In this method, CSPR is decreased in an iterative-stepwise fashion to find the minimum CSPR that is 
also acceptable in terms of cell growth and protein production quantity and quality (Konstantinov et 
al., 2006). 
To find the perfusion rate in this research, the following approach was taken.  The two different 
phases of operation, i.e. the initial growth in a batch operation and the second phase involving perfusion 
while maintaining a constant cell density were approached differently.  
1) For the growth phase, the bioreactor was sampled each day for cell counting. Based on the 
counted cells and a prediction of the viable cells for the following day was estimated from 
equation (4-6). 
𝐶2 = 𝐶1𝑒
µ𝑡         (4-6) 
2) The prediction provided an estimate of the time that the cell density will reach the desired level 
at which the second phase of perfusion should be started. For the perfusion operation where 
the cell density was kept approximately constant, perfusion was started and bleeding of the 
cells was implemented to remove the dead cells and to keep the cell density at steady-state. The 
perfusion rate was found based on the desired CSPR. In the current study, we were aiming at a 
CSPR of 80 pL/day/cell. The harvest rate was calculated from the mass balance based on the 
perfusion and the bleeding rates. 
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 Results, discussion, and suggestions for a perfusion run 
During a two weeks perfusion experiment, the highest cell density reached at day 12 was 51 million 
cells per mL (Figure 4-4) starting from about one million cell per mL. The cell viability at this point 
was about 80%. Subsequently, the viable cell density dropped to around 35 million cells/ml on the last 
day of this experiment (day 14) with a cell viability of 75%.  The perfusion operation started at day 3, 
when the viable cell density was around 4.7 million cells/ml with around 98% cell viability and the 
glucose concentration as the main carbohydrate source decreased to approximately 3.2 g/l (~16 mM) 
from its initial level of 5 g/l (Figure 4-5). As mentioned above, the desired CSPR in this study was 
80pL/cell/day and thus based on the measured the cell density the perfusion rate that started at 0.67 
RV/Day was increased to around 3 RV/Day. The cell bleed rate was started at day 9 when the cell 
viability dropped to about 80%. The bleed rate started at 0.07 RV/Day and it was gradually increased 
to 0.18 RV/Day. Up to day 4, the ring sparger was enough to keep the DO at the set point but after that, 
the microsparger with pure oxygen was required and at this point, foam formation started to become a 
challenge. The addition of antifoam (Antifoam C from MilliporeSigma) was done based on the 
observed layer of foam that formed at the top of the working volume in the bioreactor. The observed 
thickness of the foam layer was 1 cm at day 5, 3 cm of foam at day 8 and approximately 6-8 cm of 
foam at day 10. Antifoam addition (0.1 % Antifoam C (MilliporeSigma, MI, USA)) was performed 
using a peristaltic pump and its flow rate was adjusted based on the relative amount of foam that was 
observed at the top of the culture.   
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Figure 4-4. Viable cell density vs. time. Cells reach to their maximum cell density of around 50 
million cells per mL. 
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Figure 4-5 Glucose profile in perfusion culture. Glucose level is kept above critical level for cell 
growth. 
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Figure 4-6 Lactate profile in perfusion culture. It was tried to keep the lactate level lower than 
harmful level. 
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Figure 4-7 Ammonia profile in perfusion culture. It was tried to keep the ammonia level lower 
than harmful level. 
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Figure 4-8 Amino acid concentration profile in perfusion culture. 
During this perfusion run glucose concentration for most of them were kept above 3 g/l (16.7 mM), 
which is an acceptable range for glucose concentration. Lactate concentration was mostly between 1-
1.5 g/l (11-16 mM) (Figure 4-6) and ammonia concentration was kept mainly under 2.4 mM (Figure 4-
7). Asparagine was consumed very quickly during the batch phase from 6.4 mM to less than 2mM 
(Figure 4-8). Similar results were observed previously by Duarte et al. and the reason might be that 
asparagine and serine are the major nitrogen sources for the GS-CHO cells (Duarte et al., 2014). 
Compared to other reported perfusion experiments with CHO cells (Clincke et al., 2013) which reached 
to about 30 million cells/mL in a two week experiment, in this study we reached a higher cell density 
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(50 million cells/mL). Among the reasons for this improvement in cell density might be that in this 
experiment by having the lactate and ammonia as the toxic by-products of the culture concentrations 
were kept lower, which favored increased cell growth. It has been discussed by several groups 
(Aghamohseni et al., 2014; Andersen & Goochee, 1995; Butler, 2006) that accumulation of ammonia 
could impact the protein quality in the culture especially by affecting the glycosylation. It has been 
shown higher ammonia will decrease the terminal sialylation so in this experiment by controlling the 
level of production of ammonia the quality of the produced protein has potentially been improved.   
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Chapter 5 
Identification of Active Constraints in Dynamic Flux Balance 
Analysis 
1This study deals with the calibration of dynamic metabolic flux models that are formulated as the 
maximization of an objective, subject to constraints. Two approaches were applied for identifying the 
constraints from data. In the first approach a minimal active number of limiting constraints is found 
based on data that are assumed to be bounded within sets, whereas in the second approach, the limiting 
constraints are found based on parametric sensitivity analysis. 
The ability of these approaches to finding the active limiting constraints was verified through their 
application to two case studies:  an in-silico (simulated) study describing the growth of E.coli and an 
experimental study for Bordetella pertussis (B.pertussis).  
 Introduction 
Living cells can be described as complex biological systems involving a combination of different 
molecular elements such as proteins, lipids, sugars, and nucleic acids. These species interact with each 
other through biochemical reactions involving different metabolites according to pre-defined metabolic 
networks (Toya, Kono, Arakawa, & Tomita, 2011). Cells use these metabolites for growth and function. 
The fluxes associated with biochemical reactions involving these metabolites are highly dependent on 
                                                     
1 This chapter has been published as the paper: Nikdel, A., & Budman, H. (2016). Identification of 
active constraints in dynamic flux balance analysis. Biotechnol Prog. doi: 
10.1002/btpr.2388 
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environmental conditions. The ability to mathematically describe the changes in the fluxes due to 
different environmental perturbations would allow for systematic understanding and optimization of 
the biological system under study.  
Stoichiometric-based metabolic models are an important group of structured metabolic modeling 
consisting of systems of mass balance equations that are based on stoichiometric relations among 
metabolites. Stoichiometric models generally assume that the intracellular environment is at a quasi-
steady state (Baroukh, Muñoz-Tamayo, Steyer, & Bernard, 2014). Following this assumption, it is 
possible to establish relations between input and output fluxes, but the resulting model is generally 
underdetermined since the degrees of freedom are larger than zero (more fluxes than balanced 
metabolites existed in the metabolic network): 
d = n-k           (5-1) 
where d is the degrees of freedom, n is the number of fluxes and k is the number of constraints.  To 
partially address the under-determinacy it has been proposed to formulate the problem as a 
maximization or minimization of a biologically meaningful objective function subject to constraints. 
This method is referred to as flux balance analysis (Orth et al., 2010; Raman & Chandra, 2009; Sidoli 
et al., 2004). Because most biotechnological processes are transient in nature, dynamic models are 
sought to describe them (Ahn & Antoniewicz, 2012a). Most reported dynamic metabolic models are 
based on dynamic mass balances of dominant metabolites involving kinetic expressions of the 
biochemical reactions involved in the metabolic network. The identification of this type of models is 
normally posed as an optimization problem where the unknown kinetic parameters are sought by 
minimizing the least squared differences between experimental and simulated data (Borchers et al., 
2013; Nolan & Lee, 2011). Since the resulting optimization problems are often non-linear and non-
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convex, finding the global solutions is challenging. Also, with increasing number of kinetic parameters, 
these models are often difficult to calibrate and more sensitive to sensor noise (Moles, Mendes, & 
Banga, 2003). 
An alternative to these extensive dynamic kinetic models is to use the dynamic extension of the FBA 
modeling approach, referred to as dynamic flux balance (DFB), which is the focus of the current study 
and it can be used to calculate the dynamic evolution of the metabolic fluxes. In contrast to the 
aforementioned dynamic models that are based on dynamic mass balances of dominant metabolites, 
DFB does not require extensive kinetic information (Mahadevan et al., 2002; Schuetz et al., 2007). The 
key idea in the DFB approach is to solve the FBA model at discrete sampling intervals where at each 
interval we seek to optimize a biological meaningful objective function subject to certain constraints 
(Budman et al., 2013; Mahadevan et al., 2002). A typical DFB formulation is as follows: 
@ each time interval k  (k=1,…, T)      (5-2) 
     max
vk
𝒄𝑻𝐯𝐤   ( 𝐯𝐤=(𝑣1,𝑣2, … , 𝑣𝑛)k ) 
Subject to: 
𝑔(𝜓𝑘) ≤ |𝐒. 𝐯𝐤| ≤ 𝑓(𝜓𝑘)  
 𝐯k ≥ 0 
Where S is the matrix of stoichiometric coefficients,⁡𝐯k is the vector of fluxes at time k,  𝒄
𝑇𝐯k  is an 
expression for a biologically motivated objective function, e.g. growth, ATP consumption etc. that have 
to be maximized or minimized (objective function),⁡𝜓𝑘 represents a concentrations of extracellular 
metabolites and f and g are vector functions of the metabolites concentrations at each time interval that 
could be of Michaelis-Menten or other type.  
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Hence, it is not necessary with this modeling approach to calibrating kinetic expressions for all the 
metabolites of interest but only for a few limiting ones participating as arguments in the functions f and 
g in (5-2) while the evolutions of the other metabolites and the fluxes are determined by stoichiometric 
relations.  
However, the main challenge for calibrating such models is to identify the limiting constraints that will 
result in a good fit of experimental data.  A study by Mahadevan et al (Mahadevan & Schilling, 2003b) 
proposed a method to find upper and lower limits on fluxes at steady state but the application of flux 
models to dynamic situations requires the identification of kinetic constraints that are dependent on 
metabolites’ concentrations. Kinetic and metabolic concentration related constraints are of particular 
importance for non-genome scale based models where gene regulatory limitations are not explicitly 
considered in the model (Bordbar, Monk, King, & Palsson, 2014; Mahadevan & Schilling, 2003a; Reed, 
2012). A simple DFB model reported for E.coli (Mahadevan et al., 2002) showed that few constraints 
such as rate limits on glucose or oxygen consumption can be sufficient to describe the processes under 
study. Since the metabolic networks considered in the previous studies were relatively small, the 
constraints given by functions f and g in (5-2) were mostly identified by trial and error.  
For systems represented by more complex metabolic networks, identifying the limiting constraints by 
trial and error is challenging. For example, a DFB model of a Bordetella pertussis microorganism as 
used in one of the case studies of the current work is described by over 40 reactions. In previous work 
by one of the authors (Budman et al., 2013), a DFB model for Bordetella Pertussis was formulated 
where the necessary limiting constraints to explain the experimental data were found by a trial and error 
based search.  This procedure was computationally expensive and prone to errors since it was found 
that the data could be explained by many combinations involving redundant constraints. Since each of 
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the constraints has to be expressed by the functions f and g in equation (5-2) and these functions 
involved kinetic parameters that must be identified from data, including redundant constraints in the 
DFB model will result in a larger than necessary number of kinetic expressions and parameters thus 
leading to higher sensitivity to measurement noise. In this work, we are presenting and comparing two 
data-based approaches for finding the limiting constraints required for formulating DFB models: one 
based on convex sets and the other is based on parametric sensitivity analysis. 
 Materials and methods: 
Two different approaches are presented and compared: i- a convex set-based approach and ii- a 
parametric sensitivity analysis based approach. 
i. Sets based approach 
The key idea for finding the limiting constraints in the DFB model by this method is to represent the 
data by convex sets. To this purpose, it is assumed that because of measurement error or unmeasured 
disturbances, the metabolite concentrations are bounded by upper and lower limits at each time interval 
for which data is collected. For example, typical set constraints for glucose concentrations for the E-
coli diauxic metabolism with 10% bounds are depicted in Figure 5-1. 
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Figure 5-1. Set constraints for glucose concentrations for the E-coli diauxic metabolism 
(Mahadevan et al., 2002) with 10% wide bound. 
By this representation, the actual value of metabolite concentrations at each time interval is assumed to 
be always contained within these constraints and all the possible data points, bounded by them, are 
referred heretofore as sets. Equivalently the maximal uptake or consumption rates of metabolites can 
be calculated from the upper and lower bounds on metabolite concentrations and can then be added as 
linear constraints in the optimization problem formulated for the DFB model.  
Using this set-based approach the following 3-step procedure is proposed to find a DFB model to 
describe the experimental data: 
Step 1: Find a flux distribution that maximizes the objective function to be chosen for the process, e.g. 
maximization of growth subject to the set based constraints. These constraints can be given in terms of 
upper or lower bounds on concentrations as explained above or as upper and lower limits of uptake rate 
or production rate of external metabolites. Mathematically, the problem is expressed based on (5-2) as 
follows: 
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@ all T intervals  (k=1,…,T)      (5-3) 
     max
𝐯𝐤
𝐜𝐓. 𝐯𝐤  
     Subject to:        
1
∆𝑡.𝑋𝑘
(ѱ𝑘 − ѱ𝑘+1
𝐿 ) ≤ 𝐒. 𝐯𝐤 ≤
1
∆𝑡.𝑋𝑘
(ѱ𝑘 − ѱ𝑘+1
𝑈 )           
 Where matrix S is the stoichiometric coefficients, 𝐯𝐤 = (𝒗𝟏,𝒗𝟐, … , 𝒗𝒏)𝐤 is the vector of fluxes⁡⁡of n 
metabolites at the time interval of k. 𝒄𝑻. 𝐯𝐤 : is the cost to be maximized or minimized (objective 
function),⁡ѱ𝑘 and 𝑋𝑘 are representing measured concentrations of extracellular metabolites and 
biomass at the time of k. The inequality constraint in (5-3) is derived from the discretization of the 
general mass balance equation for metabolites (
𝑑𝝍
𝑑𝑡
= 𝐒𝒗𝑋). The inequality in equation (5-3) is for a 
metabolite being consumed whereas for a metabolite that is being produced, the inequality operators 
have to be inverted. It should be noticed that in both (5-2) and (5-3) the same objective is optimized but 
while in (5-2) the constraints are given as a function of the concentrations through the vector functions 
f and g, in (5-3) these functions are not known a priori and they have to be identified from 
measurements. For that purpose, in (5-3) the constraints are set to measured upper and lower bounds 
on specific rates of consumption/production of metabolites. 
Step 2: Find the key metabolites such that by only imposing kinetic constraints on those metabolites 
the experimental data, represented by convex sets as explained above, can be properly simulated by the 
DFB model.   
For finding the uptake or production rates which are limiting the solution space of the optimization 
problem, at the optimal point, a Lagrange multiplier approach (Bertsimas & Tsitsiklis, 1997) is used. 
The optimization (minimization or maximization) of an objective function as in here f (𝐯𝐤) = ⁡ 𝐜
𝐓𝐯𝐤⁡⁡can 
be formulated as follows: 
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 𝐯𝐤=argmin
𝐯𝐤
𝐜𝐓𝐯𝐤         (5-4a) 
Subject to: 
GLI(𝐯𝐤) ≤ 0         (5-4b) 
GLI(𝐯𝐤) ≤ 0  are the inequality constraints(lower and upper bounds of the production or the uptake rate 
of measured metabolites . The Lagrange multipliers (λ) and Lagrange function (Lagrangian) are defined 
as per the following equation: 
𝐿(𝐯𝐤, λ) = ⁡ 𝐜
𝐓𝐯𝐤 − λ⁡GLI(𝐯𝐤)  
Which is equivalent to the following set of conditions: 
𝜆 ≤ 0           (5-4c) 
GLI(𝐯𝐤) ≤ 0          (5-4d) 
𝜆× GLI(𝐯𝐤) = 0          (5-4e) 
∇𝐯𝐤L(𝐯𝐤, 𝜆) = 0          (5-4f) 
Where GLI(𝐯𝐤) is an inequality constraint, 𝐯𝐤  is the vector of decision variables, 𝐯𝐤 is the optimal 
solution of the fluxes. By solving equations (4c-4f) the value of the Lagrange multipliers (λ) for each 
of the constraints can be calculated. Equation (5-4e) represents the complementarity condition that 
forces either the Lagrange multiplier or the corresponding inequality to be zero. The value of the 
Lagrange multiplier at the optimum is equal to the rate of change in the value of the objective function 
as the constraint is relaxed. A value of zero for λ implies that by relaxing the constraint the value of the 
function which is intended to be maximized does not change and thus, this constraint is not active. In 
contrast, a higher value of the Lagrange multiplier is an indicator that the constraint is active since the 
objective function changes as a result of deviations from the value of that constraint. 
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By identifying the active constraints, it is possible to assess which metabolite’s consumption or 
production rates are limiting constraints at each interval of the solution of the DFB model. 
Step 3- The goal of the final step of this method is finding kinetic expressions as a function of 
metabolites that mathematically describe the active constraints found in step 2. To this purpose, at each 
interval, uptake or production rates of the active constraints are formulated as Michaelis-Menten-type 
or another type of kinetic model as a function of the corresponding concentration of metabolite 
associated to the active constraint: 
dѱm
dt
=
Vm,max.ѱ𝑚
Km+ѱ𝑚
𝑋         (5-5) 
Where here 
𝑑ѱ𝑚
𝑑𝑡
 is the uptake or production rates of a metabolite (active constraints) identified in step 
2 as a function of its concentrations ѱ𝑚⁡at each corresponding time interval and Vm,max, Km⁡ are the 
kinetic parameter values to be identified. The consumption rates or production rates of metabolites are 
assumed in this work to be bounded by a function of the extracellular metabolite concentration (please 
see the last equation in the set of equation 5-3). This is strictly a model assumption that has been 
previously done in other reported metabolic flux models e.g. (Mahadevan et al., 2002). The validity of 
this assumption is assessed by the ability of the model to capture the data. The Lineweaver-Burk and 
Eadie-Hofstee plots are graphical methods that can be used for identifying the constants in (5-5) (Shuler 
& Kargi, 1992) if the kinetics is of Michaelis-Menten type. Using the identified kinetic parameters of 
active metabolic constraints (i.e. uptake or production rate of active constraints), it is possible to 
generate a predictive dynamic metabolic flux model for given initial conditions of the concentrations 
of all metabolites. For the case that Michaelis-Menten kinetics is found unsuitable for representing the 
dependency of the metabolite rate of change with respect to concentration, other nonlinear functions 
are fitted using the lsqcurvefit function in MATLAB. 
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The key numerical advantages of this set-based approach, are: i- step 1 and step 2 involve the solutions 
of a linear programming problems and therefore are simple to compute and ii-step 3 involves separated 
fitting of each metabolite profile as compared to other modelling approaches that require simultaneous 
fitting of all the metabolites by simultaneous calibration of a larger number of model parameters. 
For each of the microorganisms under study, we created the sets of upper and lower bounds of uptake 
and production rates based on measurements of extracellular concentrations of metabolites at two 
consecutive time intervals. 
For the E. coli example in silico data generated with a reported model (Mahadevan & Schilling, 2003b) 
was used for model calibration. The reason for using in silico instead of actual experimental data was 
to test the ability of the proposed methodology to correctly identify the constraints and parameters of 
the model. To generate the in silico data a 10 percent Gaussian random noise was introduced to simulate 
noisy data and used in lieu of experimental data.  
For B. pertussis, two sets of experimental data of metabolite concentrations at regular time intervals 
were available. The available data included amino acids and biomass concentrations at different time 
points. However, we found that the sampling frequency of the experimental data was insufficient for 
generating smooth estimates of the uptake rates bounds. Therefore, we applied a non-linear polynomial 
regression function in MATLAB to interpolate the data and generate smoother estimates of uptake 
rates.  
One of the limitations of this proposed approach is that due to stoichiometric correlations the activation 
of constraints is sensitive to measurement noise. For instance, in the presence of noise, the concentration 
of several metabolites may reach constraint values at the same time. To provide robustness on noise 
related errors we performed the identification of the active constraints as per the 3-step procedure 
described above for progressively smaller sets of values contained within the original convex sets. For 
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example, if the maximum noise levels in the data were ±10% with respect to an average value between 
the upper and lower bound of concentration at each time interval, we performed the identification of 
the limiting constraints for sets with magnitudes of ±10%, ±7%, ±5%, and ±2% of the measurements. 
In case that at a particular time interval different limiting constraints were obtained for different 
assumed noise levels, we selected as limiting constraints the ones that occur most times.    
Finally, for both E.coli and B.Pertussis, as commonly assumed for bacteria (Feist & Palsson, 2010a, 
2010b; Meadows, Karnik, Lam, Forestell, & Snedecor, 2010) we considered the maximization of the 
growth rate as the objective function for the DFB model. The linear programs defined in this section 
were solved using the cplexlp solver (‘interior-point’ algorithm) of IBM ILOG CPLEX for 
MATLAB Toolbox. 
ii- Parametric sensitivity analysis based approach  
We adopted the idea of bi-level optimization that previously was used by Burgard et al. (Burgard & 
Maranas, 2003) for finding the objective function in FBA models and Raghunathan et al. (Arvind U. 
Raghunathan, PÉRez-Correa, Agosin, & Biegler, 2006; A. U. Raghunathan, Perez-Correa, & Biegler, 
2003) for parameter estimation in FBA for a parametric sensitivity analysis based approach as a 
comparison to our proposed set-based approach. 
The idea behind this approach is to calculate the sensitivity of a function describing the level of fit 
between data and model predictions on different possible kinetic constraints. Then, the degree by which 
the constraint affects the quality of fit function is used as an indicator for whether the specific constraint 
should be considered or ignored in the DFB model. To assess the sensitivity,  ±10⁡%⁡ changes were 
introduced in the uptake or production rates of external metabolites with respect to a set of nominal 
values calculated in a bi-level optimization problem as explained below (Model of (Mahadevan et al., 
2002). Then, the effects of the deviations from these nominal parameter values on the sum of squared 
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errors (SSE) of predicted metabolites concentrations were calculated and compared. All possible 
combinations of constraints on the different metabolites were tested for parametric sensitivity.  
The uptake and production rates were initially assumed to be described by Michaelis-Menten type 
kinetics as a function of the concentration of the metabolite (m) being produced or consumed as in 
equation (5-5). 
The sensitivity of the SSE was calculated with respect to deviations of the maximum uptake or 
production rate of a metabolite from its nominal value, i.e. changes in the coefficient of the numerators 
of the Michaelis-Menten expressions in equation (5-5) on their nominal values calculated in an outer 
optimization level. 
A key challenge for the application of this method is to find the nominal values of the parameters to be 
used in the Michaelis-Menten expressions describing the uptake and consumption rates.  
The nominal parameters’ values for calculating the sensitivities were obtained from the following bi-
level optimization problem: 
Min
𝑉𝑚1,𝑚𝑎𝑥,..,𝑉𝑚𝑁,𝑚𝑎𝑥,𝐾𝑚1,…,𝐾𝑚𝑁
SSE=∑ ((
ѱ𝑚1𝑘
−ѱ𝑚1𝑘
𝑒
ѱ𝑚1𝑘
𝑒̅̅ ̅̅ ̅̅ ̅̅ )
2 +⋯+ (
ѱ𝑚𝑁𝑘
−ѱ𝑚𝑁𝑘
𝑒
ѱ𝑚𝑁𝑘
𝑒̅̅ ̅̅ ̅̅ ̅̅ ̅̅̅ ̅̅ ̅̅ ̅̅ ̅
)2)𝑇𝑘=1   (5-6) 
s.t: 
    @ each T interval 
⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡max
vk
𝐜𝐓. 𝐯𝐤 
s.t:        
|
⁡⁡
⁡𝐒
𝐦𝐢 . 𝐯𝐤| ≤
Vmi,max.ѱ𝑚𝑖,𝑘
Kmi+ѱ𝑚𝑖,𝑘
  
mmol
gdw.hr
   (i=1, 2,…, N)  N: total number of metabolites 
Where, ѱ𝑚𝑁𝑘
𝑒̅̅ ̅̅ ̅̅ ̅ is the mean value of the concentration of metabolite i at time interval k. The division by 
the average was done for the purpose of normalization of each metabolite with respect to the others. In 
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this bi-level or nested optimization problem, the inner optimization problem solves the DFB model by 
maximizing (or minimizing) the objective function subject to kinetic constraints. The parameters 
defining the kinetic constraints (Michaelis-Menten expressions) are calculated from the outer 
optimization problem in which the sum of square error (SSE) between model predictions and 
experimental data of metabolites are minimized. This bi-level optimization problem is solved in 
MATLAB. A linear programming algorithm was used to solve the inner level using an ‘interior–point’ 
algorithm implemented by the MATLAB function linprog function. The nonlinear upper level 
optimization problem was solved using the fmincon function. Due to the nonlinearity of the 
optimization problem involving a quadratic objective and nonlinear constraints, we found that the 
results are highly dependent on the initial guesses. Thus, to avoid local optimal solutions, we conducted 
a global search over a large range of initial guesses using the globalsearch function in the MATLAB 
Global Optimization Toolbox. 
An additional obvious difficulty with the parametric sensitivity approach based on the solution of the 
bi-level optimization (5-6) is that initially the consumption rates and production rates of all metabolites 
must be assumed to be limiting thus requiring the calibration of many nominal parameters’ values. 
Although some of these constraints were found ultimately to be redundant and eliminated following 
the parametric sensitivity analysis, the required initial search of nominal values partially neutralizes the 
key advantage of DFB models, which aim to describe the system with few constraints. Also, all 
combinations of constraints have to be tested to eliminate redundant constraints. Accordingly, the 
parametric sensitivity approach is impractical for problems involving many metabolites. For that 
reason, it is applied in this work only for the E.coli case study that involves four reactions but it is not 
pursued in the B. pertussis system that involves over 40 metabolites. 
 75 
 
 Results and discussion 
To verify the two approaches presented above, we consider two case studies for two different 
microorganisms: E. coli and B. pertussis (Budman et al., 2013; Mahadevan et al., 2002). The set-based 
approach was applied to both, whereas the parametric sensitivity approach was only applied for E.coli 
for the purpose of comparison with the set-based technique. 
For the E.coli model, we considered three extracellular metabolites present in the network: glucose, 
acetate and oxygen as potential limiting constraints and for B.Pertussis we considered 16 external 
metabolites as possible active constraints: alanine, arginine, aspartate, glutamate, glycine, histidine, 
isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tyrosine, and valine.  
The E.coli case study was an easy tool to verify the correctness of the methods since the solution was 
known a priori. The model was used to generate in silico data that was artificially corrupted by noise 
to simulate actual data. Then, we check whether the original DFB model of E-coli proposed in 
(Mahadevan et al., 2002) could be recovered based on the simulated data with noise. For the B. pertussis 
case study, actual experimental data and a preliminary DFB model were available (Budman et al., 
2013). However, the latter model was previously calibrated by trial and error as reported in (Budman 
et al., 2013) and thus it was not known a priori whether the assumed limiting constraints for that 
preliminary model were the best ones for fitting the available data. Accordingly, the set-based 
methodology was used to produce a better model that resulted in improved fitting between data and 
predictions as compared to the previously reported model. 
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 Case study 1: E.coli 
 Set based approach 
The model assumes four species: glucose, acetate, oxygen, and biomass. The stoichiometric matrix for 
the problem is given in Appendix A.  Glucose and oxygen are consumed throughout the batch culture 
while acetate is first produced and it is only consumed after glucose is depleted. Initially, a total of three 
candidate constraints were considered for glucose, acetate, and oxygen.  
In order to provide robustness to noise, as explained in the previous section, the identification of the 
active constraints was done for different levels of noise in the measurements, i.e. for ±2%, ±5%, ±7% 
and ±10% with respect to the average value of the upper and lower bound at each point. By comparing 
the Lagrange multipliers for all the possible constraints, i.e. glucose, acetate and oxygen, during the 
first two hours of the culture only oxygen transfer was found to be a limiting constraint until time=4.2 
hours at which time glucose became the dominant constraint and, towards the end of the batch, oxygen 
again became an active constraint. By the end of the culture, only for the ±10% noise level, acetate was 
also identified as an active constraint for a few time intervals but for all other levels of noise, it was 
identified that only glucose and oxygen remain as the active constraints while the acetate constraint 
remains inactive. 
Since the dependency of the identified limiting rate in glucose with respect to the corresponding glucose 
concentrations appear to be of Michaelis-Menten type the kinetic expressions were obtained using the 
Lineweaver-Burk and Eadie-Hofstee plots. Lineweaver-Burk, a plot of 
1
𝑉
 versus⁡
1
ѱ
  (Figure 5-2), was 
used for finding V𝑚𝑎𝑥. To find 𝐾𝑚 we used the Eadie-Hofstee plot, a plot of V versus 
𝑉
[ѱ]
 (Figure 5-3) 
in which⁡𝐾𝑚 is the slope of this plot. Confidence intervals for the parameters were calculated for the 
 77 
 
bounds on data corresponding to the maximal level of noise of ±10% error in metabolic data and were 
as follows:⁡𝑉𝑚𝑎𝑥= [10.6, 10.7] and 𝐾𝑚= [0.0123, 0.0195]. The constraint on oxygen rate was found to 
be constant and equal to OUR=13.5 
 
 
Figure 5-2 Lineweaver-Burk plot for determining⁡𝑽𝒎. Blue line is plot without noise in the data, 
red and black lines are the plot with ±10 noise in the data 
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Figure 5-3 Eadie -Hofstee plot for determining Km. Blue line is plot without noise in the data, 
red and green lines are the plot with ±10 noise in the data 
The two constraints in glucose and oxygen were found to be sufficient for building a DFB model that 
was able to explain the experimental data. This coincides with the constraints that were considered in 
the original model used to generate the in silico data thus demonstrating that the method identified the 
correct constraints. The identified parameters are also very similar to the ones used in the original model 
(Vm= 10 and Km=0.015). The model with the identified kinetics was used to simulate a batch as shown 
in Figure 4, which is in agreement with the model results shown in (Mahadevan et al., 2002). It should 
be noticed that in this process, glucose is preferentially used until it is completely depleted at 7.5 hours. 
Subsequently acetate is used as nutrient until it is completely depleted at time=10 hours. As illustrated 
in Figure 5-4, the consumption of oxygen during the glucose consumption period is considerably higher 
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comparing to the period during which acetate is consumed which is expected from the stoichiometric 
relations among the metabolites. 
 
Figure 5-4 Metabolic concentration profiles resulted from the DFB model for E.coli; red is the 
original model and blue is the one that resulted by introducing the noise 
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 Parametric sensitivity analysis approach for E.coli 
Following the general formulation given in (5-6) the nominal parameters values were solved from the 
following bi-level optimization problem: 
min
𝑉𝐺𝑙𝑢,𝑚𝑎𝑥,𝐾𝐺𝑙𝑢,𝑉𝐴𝑐𝑒,𝑚𝑎𝑥 ,𝐾𝐴𝑐𝑒
SSE=∑ ((
ѱ𝐴𝑐𝑒𝑘−ѱ𝐴𝑐𝑒𝑘
𝑒
ѱ𝐴𝑐𝑒𝑘
𝑒̅̅ ̅̅ ̅̅ ̅̅ ̅ )
2 + (
ѱ𝐺𝑙𝑐𝑘−ѱ𝐺𝑙𝑐𝑘
𝑒
ѱ𝐺𝑙𝑐𝑘
𝑒̅̅ ̅̅ ̅̅ ̅̅ )
2 + (
ѱ𝑋𝑘−ѱ𝑋𝑘
𝑒
ѱ𝑋𝑘
𝑒̅̅ ̅̅ ̅̅ )
2 +𝑇𝑘=1
(
ѱ𝑂2𝑘
−ѱ𝑂2𝑘
𝑒
ѱ𝑂2𝑘
𝑒̅̅ ̅̅ ̅̅ ̅̅ )
2)          (5-7) 
Subject to: 
    @ All T intervals 
⁡max
v
cT. v 
⁡|𝐒𝐆𝐥𝐜. 𝐯𝐤| ≤
VGlc,max.ѱ𝐺𝑙𝑐,𝑘
KGlc + ѱ𝐺𝑙𝑐,𝑘
𝑚𝑚𝑜𝑙
𝑔𝑑𝑤. ℎ𝑟
 
⁡|𝐒𝐀𝐜. 𝐯𝐤| ≤
VAc,max.ѱAc,k
KAc + ѱAc,k
𝑚𝑚𝑜𝑙
𝑔𝑑𝑤. ℎ𝑟
 
 |
⁡⁡⁡⁡
𝐒
𝑶𝟐 . 𝐯𝐤| ≤ 𝑂𝑈𝑅⁡
𝑚𝑚𝑜𝑙
𝑔𝑑𝑤.ℎ𝑟
 
The nominal parameters’ values are listed in Table 5-1 and resulted in a minimal sum of square errors 
of SSE=94.63. These parameters are identical to the original parameter values used in Mahadevan et 
al. (Mahadevan et al., 2002). Although the acetate related constraint is not present in the original 
mathematical model, it was initially assumed to be non-zero with the intention to test whether the 
parametric sensitivity analysis proposed here shows it to be a redundant constraint.  
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Table 5-1 Estimated kinetic parameters for E.coli model 
Parameter Value 
𝑉𝐺𝑙𝑐,𝑚𝑎𝑥 10 
𝐾𝐺𝑙𝑐 0.02 
OUR 15 
𝑉𝐴𝑐,𝑚𝑎𝑥 0.1 
𝐾𝐴𝑐 2.2 
 
As depicted in Figure 5-1, for glucose, either 10% increases or decreases in the glucose uptake 
constraint caused a sharp increase in the value of SSE around the minimal value i.e. VGlc,max=10. This 
indicates that the glucose uptake rate is an active constraint around that nominal value of the kinetic 
parameter. Then, it was found that a 10 % decrease in the oxygen uptake rate (OUR) around the value 
of OUR=15, increased the SSE from 94.6 to 121.94 (Figure 5-6), but increasing the oxygen uptake rate 
did not affect the SSE. Similarly, it was observed that a 10% decrease in VAc,max from a nominal value 
of 2.2, resulted in an increase in the SSE from 94.6 to 101.86 (Figure 5-7). On the other hand a 10% 
increase in 𝑉𝐴𝑐,𝑚𝑎𝑥⁡ did not affect the SSE indicating that beyond this value its impact on the SSE is 
null. When only a glucose constraint was used the SSE increased to 206.13. On the other hand, when 
constraints on both glucose and acetate were used without a constraint on oxygen the SSE was 95 
slightly higher than the value of SSE obtained when using glucose and oxygen together which resulted 
in an SSE = 94.69. Therefore, it was concluded that the acetate constraint is redundant because it cannot 
be used to further reduce the SSE as compared to the use of a glucose and oxygen constraints. 
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Figure 5-5 parametric sensitivity analysis of glucose kinetics. With perturbation in 𝑽𝒎𝒂𝒙 of 
glucose around the estimated value, SSE increases sharply. 
 
Figure 5-6. Parametric sensitivity analysis of acetate kinetics. Perturbation in 𝑽𝒎𝒂𝒙 of acetate 
around the estimated value does not have a big impact on the SSE value. 
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Figure 5-7 parametric sensitivity analysis for oxygen uptake rate.  
In summary, it is evident that both the set-based and parametric sensitivity approaches are successful 
in identifying the limiting constraints for this relatively simple model of E.coli comprising only four 
reactions. However, this case study clearly illustrated that the parametric sensitivity approach is 
numerically more complex for two main reasons: i- It requires a priori calculation of nominal values 
for the parameters from a nonlinear bi-level optimization problem and ii- It requires testing different 
combinations of constraints and their effect on the value of the SSE. This numerical complexity is of 
particular importance when trying to solve problems of much higher dimensions, i.e. a large number of 
metabolites, than the E.coli case such as the second case study presented below. Furthermore, for 
simplicity, the parametric sensitivity analysis that was used in this work was local in nature thus 
correlations among parameters were ignored. Global sensitivity analysis is possible (Rand, 2008) but it 
will further increase the numerical complexity of the parametric sensitivity approach. 
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An additional significant advantage of the set-based method is that the kinetic parameters involved in 
each constraint are identified separately using data related to the metabolite involved in the specific 
constraint whereas in the parametric sensitivity method the parameters of all the constraints must be 
identified together by solving a bi-level optimization. 
 Case study 2: Bordetella pertussis  
Bordetella Pertussis is a gram-negative bacteria causing the whooping cough disease (Thalen et al., 
2006). A metabolic network of Pertussis has been previously proposed by one of the authors (Budman 
et al., 2013). The model involves 47 metabolites with 49 reactions as listed in Appendix B. The system 
under study was operated in batch mode during the exponential growth phase followed by fed-batch 
operation after the main nutrient, glutamate, was depleted. The feeding of glutamate during the fed-
batch phase occurred at a rate 4.3 g/h. Replicated data for 16 amino acids was available at the times of 
0, 6, 24, 29, 31.1, 32, 34, 48.3, 51.9 and 55.6 hours.  
The application of the parametric sensitivity based approach for this case involving 49 reactions was 
found to be very challenging since it required the solution of a bi-level non-convex optimization 
problem with multiple parameters if the uptake/consumption rates of all the measured metabolites 
would be initially assumed as potential limiting constraints. Therefore, only the set based method was 
investigated for this case study. 
In the set-based approach applied for B. pertussis, first, all of the 16 measured external metabolites 
were considered as potential active constraints. Following the application of the three-step set based 
approach, the Lagrange multipliers had higher values for phenylalanine uptake rate, compared to the 
multipliers associated with the other metabolites. However, through the end of culture (greater than 45 
hrs), some other Lagrange multipliers related to alanine, serine, leucine, lysine, isoleucine threonine, 
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proline, valine, aspartate at their higher bound of uptake rate (which correlates to their production rate) 
are becoming important. Hence, we limited the production rate of these metabolites by imposing a zero 
production rate constraint.    
Based on the dependency of uptake rates of phenylalanine and histidine as a function of its 
concentration identified in step 2 of the method and shown in Figure 5-8 and Figure 5-9, it appeared 
that the consumption of phenylalanine could not be described by a Michaelis-Menten type kinetics. 
Instead, the uptake rate of this metabolite seems to follow an exponential type of dependency between 
the uptake rate and the corresponding concentration. It should be remembered that the kinetic constraint 
on the consumption/production rates of metabolites may describe a combination of different reactions 
thus explaining a kinetic model that is not of Michaelis-Menten type. It seems that saturation will occur 
at some higher concentration of the metabolites. We used MATLAB lsqcurvefit function to fit a Hill 
function as follows. We have shown a possible saturation behavior of the curve with a dashed line in 
Figure 5-8. 
rPhe =
0.0066ѱ𝑃ℎ𝑒
3.2
0.0223.2+ѱ𝑃ℎ𝑒
3.2         (5-8) 
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Figure 5-8 Phenylalanine kinetic curve. Data points is based on the nonlinear regression on the 
experimental data 
To verify the need for all the constraints, identified by the Lagrange multipliers solution, we 
investigated two models: i- a model that uses only a constraint on the uptake rate of phenylalanine. ii- 
a model that uses phenylalanine constraint together with maximal zero production rates of alanine, 
serine, leucine, lysine, isoleucine threonine, proline, valine, aspartate. When only phenylalanine and 
was considered as the only active constraint although the resulting model was able to describe most of 
the experimental data, alanine, serine, leucine, lysine, isoleucine, threonine, proline, valine, aspartate 
were slightly overestimated. On the other hand, the second model with the mentioned zero production 
rates’ constraints on metabolites above could describe the experimental data with very good fitting 
accuracy (SSE=8.84) between the model predictions and the experimental data. Chapman et al. 
(Chapman, Paget, Johnson, & Schwartz, 2016) also have mentioned the possible necessity of such 
constraints. The metabolic profiles resulted from this new DFB model is shown in Figure 5-9. For 
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confidential purposes, the data shown in this figure is normalized based on the glutamate concentration 
at time=0 of the batch. It is noteworthy that this model showed better fitting of the experimental data 
(SSE=8.84) as compared to the SSE=15.42 obtained with the earlier model reported by Budman et al. 
(Budman et al., 2013) where the necessary rate limiting constraints were obtained by trial and error. In 
order to gain an understanding for the reason that a kinetic constraint based on phenylalanine is needed 
to improve the fit between data and predictions, we conducted the model simulation with all the 
maximum consumption/production rates but without the kinetic constraint (phenylalanine). The result 
of this simulation is that most amino acids were depleted much earlier, at about 25 hours from the 
beginning of the batch instead of 31 hours as obtained with the phenylalanine constraint and as observed 
in the data. For example, the glutamate evolution without the kinetic constraints is shown in Figure 5-
10 and compared to data. In fact, the discrepancies observed between the data and model without the 
phenylalanine constraint were solely observed at lower concentrations of amino acids but the difference 
in the sum of square errors is very significant, SSE=252 without phenylalanine constraint versus 
SSE=8.84 with phenylalanine constraint. The need for the kinetic constraints to describe the evolution 
of metabolites at lower concentrations values is related to the fact that amino acids are strongly 
correlated with the biomass formation equation. This correlation is because all the amino acids 
contribute to biomass and from the fact that the mass balances of metabolites are calculated from 
specific consumption/production rates multiplied by the biomass concentration. Phenylalanine, cannot 
be biosynthesized according to the metabolic network and thus the depletion of phenylalanine 
determines the stoppage of biomass growth thus affecting all other amino acids at low concentration 
values. Only a few amino acids that contribute to biomass cannot be produced: phenylalanine, histidine 
and methionine and phenylalanine have the largest share in the biomass composition among these three. 
It is not surprising that other amino acids that can be synthesized, such as glutamate or proline, are not 
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limiting constraints since their depletion does not necessarily result in stoppage of growth as it is the 
case with phenylalanine.  
Furthermore, to show the correctness of the model regarding biomass formation, biomass as a 
function of time obtained with the model is given in Figure 5-11 showing good agreement with 
data (circles in the figure). It should be noted that biomass was not used for calibration of the model.  
Sources of remaining errors between data and model predictions are HPLC measurement error, 
possible inaccuracy of the metabolic network and inaccuracy of the biomass equation (see (Budman 
et al., 2013), for how the biomass equation was formulated based on protein/lipids/nucleotides 
estimated split and elemental analysis of biomass). Also, it should be remembered that the biomass 
composition may change along with time (Dikicioglu, Kirdar, & Oliver, 2015). 
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Figure 5-9 DFB model of B. pertussis in Fed-Batch mode. Blue circles are the experimental data 
and red line is the model simulation  
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Figure 5-10 Glutamate concentration evolution (without the use of kinetic constraints). As it 
shows without the use of kinetic constraints, the model is not able to predict the glutamate 
properly especially after the first day of the experiment 
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Figure 5-11 Evolution of biomass by time. Circles are experimental data and line is model 
prediction. 
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 Conclusions 
We presented two approaches for identifying limiting constraints required for the formulation of DFB 
models. Both methods were successful in identifying the same set of limiting constraints to describe 
the simulated and experimental data. However, the parametric sensitivity analysis based approach was 
found computationally challenging for identifying limiting constraints for the B. pertussis culture, 
which involved a large number of reactions.  
The parametric sensitivity analysis exhibit two main computational challenges: i- it required the initial 
calculation of nominal parameters values from a non-convex bi-linear optimization and ii-requires 
testing the effect of all combinations of possible constraints on the value of the sum of square errors 
between measurements and predictions. Therefore it was concluded that the approach is not practical 
for large metabolic networks such as the B. pertussis system considered in the second case study.  The 
calculations in the set-based approach are significantly simplified by assuming the data to lie within 
sets. This method is numerically advantageous since it involves the solution of LP problems and also 
finding of the kinetic expressions describing the constraints, can be done one at a time. Beyond its use 
for the formulation of the DFB models, the knowledge about the limiting constraints could also be used 
in the future for targeted genetic manipulations of the organisms under study. 
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Chapter 6 
A Systematic Approach for Finding the Objective Function and 
active constraints for Dynamic Flux Balance Analysis 
2Dynamic flux balance analysis (DFBA) has become an instrumental modeling tool for describing the 
dynamic behavior of bioprocesses. DFBA involves the maximization of a biologically meaningful 
objective subject to kinetic constraints on the rate of consumption/production of metabolites. In this 
chapter, we propose a systematic data-based approach for finding both the biological objective function 
and a minimum set of active constraints necessary for matching the model predictions to the 
experimental data. The proposed algorithm accounts for the errors in the experiments and eliminates 
the need for ad-hoc choices of objective function and constraints as done in previous studies. The 
method is illustrated for two cases: (i) for in silico (simulated) data generated by a mathematical model 
for E. coli and (ii) for actual experimental data collected from the batch fermentation of Bordetella 
pertussis (whooping cough).  
 Introduction 
Cell metabolism is generally described by a complex network of biochemical reactions involving 
different metabolites interacting with each other (Schilling, Edwards, Letscher, & Palsson, 2000; 
Schilling, Letscher, & Palsson, 2000). Different levels of cellular control orchestrate the evolution of 
                                                     
2 This chapter has been published as the paper: Nikdel, A., Braatz, R. D., & Budman, H. M. 
(2018). A systematic approach for finding the objective function and active constraints for 
dynamic flux balance analysis. Bioprocess Biosyst Eng. doi: 10.1007/s00449-018-1899-y 
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these reactions within kinetic or thermodynamic constraints. Systems biology elucidates the 
combinatorial role of different level of interaction between the reactions inside the cell as a system and 
its response to the changes in the surrounding environment of the cell (Jaqaman & Danuser, 2006). This 
systematic understanding is instrumental for optimizing the growth and productivity of existing cell 
lines or for designing new cell lines. 
Various metabolic models have been presented for an understanding of biological systems, including 
constraint-based flux balance analysis (FBA) as an important category of metabolic models. FBA 
models are used to describe the fluxes at steady state based on the optimality assumption of evolutionary 
biology whereby cells are using resources optimally to maximize or minimize a specific objective 
function in order to survive (Orth et al., 2010). 
Since most of the biological processes are dynamic in their nature, e.g. batch operations, models that 
represent these processes during transients are sought. Dynamic flux balance analysis (DFBA) is the 
dynamic extension of flux balance analysis (FBA) models to have the ability to estimate the 
metabolites’ concentrations over time (Foguet et al., 2016; Llaneras, Sala, & Picó, 2012).  
Models of dynamic biological systems have traditionally consisted of systems of differential equations, 
each describing a dynamic balance of a main nutrient or important byproduct that is being consumed 
or produced generally following Michaelis-Menten reaction kinetics. These models have been often 
found lacking since they involve a large number of kinetic parameters that need to be calibrated to fit 
the experimental data. Being based on an optimization with few limiting constraints, DFBA models are 
advantageous over these traditional dynamic models because they typically required a smaller number 
of calibration parameters (Mahadevan et al., 2002; Varma & Palsson, 1995). 
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Typically, DFBA models involve the solution at each time interval k of the optimization: 
max
𝒗𝒌
𝒄T𝒗𝒌,          (6-1) 
Subject to: 
𝒈(ѱ𝒌) ≤ |𝑺𝒗𝒌| ≤ 𝒇(ѱ𝒌) 
𝒗𝒌 ≥ 𝟎 
ѱ𝒌⁡ ≥ 0 
where S is the stoichiometric matrix, 𝒗𝒌 = (𝑣1, … , 𝑣𝑛)𝑘 is a vector of fluxes (moles/hr·mole of 
biomass) at time instance 𝑘, 𝑛 is the number of reactions, and the biological objective function is 
expressed as a specific linear combination of fluxes, 𝒄T𝒗𝒌. This objective function is generally related 
to a biological variable that is representative of the overall evolution of the culture such as growth rate, 
ATP production, etc. The constraints given by functions 𝒇 and 𝒈 that are dependent on specific 
metabolites’ concentrations at time k ѱ𝑘 are describing kinetic limitations associated to the 
consumption or production of these metabolites. 
Thus, the formulation of a DFBA model involves the choice of two main elements: 
1) A biological meaningful objective function 
2) A set of limiting constraints 
The stoichiometric matrix (S), generally available from public sources such as the KEGG (Kyoto 
Encyclopedia of Genes and Genomes), describes the metabolic reactions among species for any 
microorganism of interest. The idea behind the use of the constraints in this model is that only a few 
key metabolites are limiting in terms of their rate of consumption or production whereas all other 
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metabolites will follow the dynamic behavior of the limiting metabolites based on static stoichiometric 
relations among all metabolites. 
The formulation of the model as a constrained optimization is based on the assumption that cells have 
evolved through time to act as optimizers that allocate their resources through maximizing/minimizing 
an objective function subject to some kinetic constraints.  
The choice of a biological meaningful objective function (Sanchez & Saez, 2014) is of key importance 
for formulating an accurate DFBA that will not require a large number of associated constraints and 
calibrating parameters. The choice of the objective function has been reported to greatly impact the 
model prediction accuracy (Sanchez & Saez, 2014). 
Common objective functions used in previous studies, mainly for bacterial systems, are the 
maximization of growth rate or final biomass at the end of a batch (Orth et al., 2010). However, several 
other objective functions were found, by trial and error, to more accurately predict the system behavior 
such as minimization of the production rate of redox potential, minimization of ATP production rate, 
maximization of ATP production rate, maximization and minimization of nutrient uptake rate, 
maximization of biomass yield per unit ﬂux, maximization of ATP yield (maximal energy efficiency), 
minimization of the overall intracellular flux, maximization of ATP yield per flux unit (maximizing 
ATP yield while minimizing enzyme usage), maximization of biomass yield per flux unit (maximizing 
biomass yield while minimizing enzyme usage), minimization of glucose consumption (more efficient 
usage of substrate), and minimization of reaction steps (minimization of the number of reaction steps 
for cell growth) (Knorr, Jain, & Srivastava, 2007; Pramanik & Keasling, 1997; Sanchez & Saez, 2014; 
Schuetz et al., 2007). Furthermore, it has been suggested that the objective function that rules the cell 
behavior may be a nonlinear combination of different specific objectives such as redox minimization, 
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growth maximization, or ATP production (Burgard & Maranas, 2003) rather than a linear combination 
as used in earlier DFBA models. 
In terms of the choice of a suitable objective function, mammalian cells might accomplish different 
functionalities during the course of the fermentation comparing to bacteria. For example, a previous 
study on hybridoma cell central metabolism (Burgard & Maranas, 2003) studied the three choices of 
objective function: 1) minimizing ATP production, 2) minimizing total nutrient uptake, and 3) 
minimizing redox metabolism through minimizing NADH production. That study concluded that, while 
no single objective could solely rule the cell behavior, minimizing the NADH production can better 
describe the typical characteristic behavior of hybridoma cells such as their inefficient use of nutrients. 
This inefficient use of resources translates into higher rates of consumption of glutamine and production 
of alanine (Savinell & Palsson, 1992). 
Some methods have been proposed for systematically finding the biological objective function. For 
example, an approach referred to as ObjFind has been reported (Knorr et al., 2007; Schuetz et al., 2007) 
that is based on the minimization of the sum of squared errors between identified fluxes from 
experimental and simulated data. A drawback of this method is that it involves a non-convex 
constrained optimization for which local optima are possible (Burgard & Maranas, 2003; Knorr et al., 
2007). Furthermore, the location of these multiple optima will be sensitive to the choice of limiting 
constraints. 
Knorr et al. (Knorr et al., 2007) developed a Bayesian-based method for selecting the most suitable 
objective function for E. coli growing on succinate and producing acetate. Among 5 possible objective 
functions, the minimization of the production rate of redox potential resulted in a better model in terms 
of its ability to fit the data, and was the only objective function capable of prediction of the acetate 
production by the cells. 
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The Biological Objective Solution Search (BOSS) method is an additional reported bi-level 
optimization algorithm for inference of the objective function that does not require assumptions of 
candidate objectives (Gianchandani, Oberhardt, Burgard, Maranas, & Papin, 2008; Mahadevan et al., 
2002). However, this method was found to lead to overfitting of experimental data and to the finding 
of objective functions that do not have a particular biological meaning but are rather a particular 
combination of certain metabolic fluxes. Furthermore, the resulting bi-level optimization is non-convex 
and computationally expensive (Gianchandani et al., 2008; Sanchez & Saez, 2014). 
FBA models are often referred as being “constraint-based” since they rely on biological constraints that 
represent the limited ability of the cell to consume certain nutrients or produce certain byproducts 
(Llaneras & Picó, 2008). These constraints can be categorized into two groups: non-adjustable and 
adjustable. Non-adjustable constraints such as stoichiometric constraints, enzyme, and transporter 
capacities are time independent and describe intrinsic characteristics of the cells under consideration. 
On the other hand, kinetic and regulatory constraints may change as a function of environmental 
conditions and therefore are reasonable to adjust in order to match the model predictions to the 
experimental observations (Llaneras & Picó, 2008).  
In an earlier work by the authors (Nikdel & Budman, 2016), the limiting constraints were found by 
inspecting the values of the Lagrange multipliers and assessing from them whether particular 
constraints are active or inactive at the solution. The disadvantage of that approach is that we had to 
decide on threshold values for the Lagrange multipliers as these values could not be systematically 
related to actual uncertainty/noise in the measurements.  
An additional challenge in our earlier study was related to multiplicity of solutions that is also common 
in FBA models due to a large number of reactions that are considered versus the limited number of 
measured variables that are used to constrain the problem. In the literature, the addition of both ad-hoc 
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chosen capacity constraints and/or thermodynamic constraints have been proposed to limit the solution 
space (Maranas, Zomorrodi, & Wiley Online Library, 2016). In our previous work, it was necessary to 
choose by trial and error a set of loose constraints to limit the solution space to address multiplicity. 
In this work, we propose a novel optimization-based algorithm to systematically and simultaneously 
identify both the limiting adjustable constraints (that is, an additional set of constraints to limit the 
solution space) and the biological objective function. For the limiting constraints, the objective is to 
identify the metabolites for which a change in their uptake or production rates significantly affects the 
value of the objective function and as a result on the estimated flux values. Constraints that are used to 
limit the solution space are also systematically identified from the proposed optimization. The 
significance of all the constraints is directly related in this work to measurement error. For the objective 
function, we investigate various probable objective functions by considering them simultaneously 
within the proposed optimization to find the solution of this problem that results in the best fit for 
describing the data. Then, after identifying the necessary constraints and biological objective function, 
a predictive model is formulated where the identified constraints are related to the corresponding 
metabolite concentrations and the future metabolite concentrations can be predicted using the fluxes 
resulting from the optimization into dynamic mass balances of all metabolites. 
This chapter is organized as follows. Section 6.2.1 presents the mathematical algorithm for identifying 
the limiting constraints and objective function, and Section 6.2.2 formulates a predictive model of 
metabolites based on the identified objective function and constraints. Section 6.3 presents 
experimental methods used to collect data for the B. pertussis case study and how to generate the in 
silico data used for the E. coli study. Section 6.4 presents the Results followed by Conclusions in 
Section 6.5.  
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 Theoretical and Experimental Methods 
The development of the DFBA model in this study involves two steps:  
1) An identification algorithm of limiting constraints and the biological objective function 
2) The development of a predictive DFBA model based on the identified constraints and 
biological objective function. 
These two steps are discussed separately below.  
 Identification algorithm 
The proposed identification algorithm was formulated to meet 3 main goals: 
1) Formulate the identification problem as a single-level optimization. 
2) Find limiting constraints such as the level of fit that can be directly related to the measurement 
error. 
3) Integrate into the algorithm a search for a biologically motivated objective function that results 
in best fit between data and model predictions. 
Regarding Goal 1, as mentioned in the Introduction, some approaches that were proposed for 
identifying DFBA models are based on bi-level optimization formulations which can be numerically 
challenging due to the existence of local minima. This problem is especially important for the objective 
of simultaneously identifying the objective function and the set of limiting constraints. Bi-level 
formulations derive from the need to minimize some measure of the quality of fit of model predictions 
and experiments while maximizing a biological objective as required in DFBA formulations as shown 
in equation (6-1). The measure of the fit, e.g. the sum of squared errors, is calculated with the input 
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data which generally consist of the concentrations of extracellular metabolites at different time 
intervals. To avoid a bi-level formulation, a key idea for the approach proposed in the current study is 
that the data (concentrations of extracellular metabolites) are represented by convex sets whereby, at 
each time interval, data points are limited by upper and lower bounds. For example, Figure 6-1 shows 
the evolution of glucose concentration during a batch where at each time interval the glucose level lies 
between an upper and lower limit.  
The use of convex sets to represent biological experimental data has been recently reported in several 
studies dealing with identification of biological models (Borchers et al., 2013; Nikdel & Budman, 
2016). In this approach, the experimental data within the convex set is generally assigned the same 
probability to occur. Experimental data in biological experiments are highly variable due to 
measurement noise or lack of exact repeatability due to unmeasured disturbances such as variability in 
initial conditions. Then, if the number of experimental repeats is not large, it is reasonable to ascribe 
the same probability to the values contained between the bounds at each time interval as shown in 
Figure 6-1. 
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Figure 6-1 Convex set constraints for glucose concentrations of E. coli diauxic metabolism with 
10% error bound 
Since the convex sets can be formulated as inequality constraints within an optimization, there is no 
need in our proposed approach to use a dedicated optimization level for minimizing the errors in fitting 
between data and model predictions. Hence, by using set constraints, a bi-level optimization 
formulation is avoided. 
The key idea for ﬁnding the limiting constraints in the DFB model by this method is to represent the 
data by convex sets. To this purpose, it is assumed that because of measurement error or unmeasured 
disturbances, the metabolite concentrate-actions are bounded by upper and lower limits at each time 
interval for which data is collected. For example, typical set regarding Goal 2, to identify a model that 
is robust with respect to uncertainty in measurements, the key idea is to perform an optimization with 
respect to two different sets of fluxes: one set of fluxes (⁡𝑱𝑻) that satisfies the convex sets’ inequalities 
without measurement uncertainty and a second set of fluxes (𝑱𝑹) that satisfies these inequalities with 
an accuracy related to the measurement error. This means that the original convex sets (used to solve⁡𝑱𝑻) 
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represent lack of repeatability of batches due to unmeasured disturbances, e.g. unmeasured changes in 
inoculum amount and population content, unmeasured changes in minor species, etc.  
In addition to these unmeasured disturbances there is measurement noise of magnitude epsilon. The 
flux vector 𝑱𝑹 is solved by satisfying the original convex sets with the added noise. 
Then, we seek a minimal set of constraints by adding to the optimization objective one term that it is 
related to the error between ⁡𝑱𝑻 and ⁡𝑱𝑹 and additional terms that penalize the activation of the limiting 
constraint. By minimizing the resulting objective function, we are minimizing the number of constraints 
that will be active at the solution while at the same time minimizing the error between the ideal set of 
fluxes ⁡𝑱𝑻 and the uncertain set of fluxes⁡𝑱𝑹. 
Regarding Goal 3, the search for the most suitable biologically meaningful objective function for 
solving the DFBA is conducted by adding different candidate functions, e.g. growth rate, redox 
potential etc., into the overall objective. Then, to force the solution towards one specific candidate, the 
cross-products of the candidates’ biological functions are also added to the objective function such as, 
at the solution of the minimization, these cross-products will be driven to zero and only one particular 
candidate will be left. 
Following the above considerations, the resulting optimization is 
min
𝑱𝑹,𝑱𝑻,𝒘𝑳,𝒘𝑼,𝒘𝒄
(𝑱𝑻 − 𝑱𝑹)
T𝐇(𝑱𝑻 − 𝑱𝑹) − ∑ (𝑤𝑐𝑖)
𝑁𝐶
𝑖=1 𝒄𝒊
T𝑱𝑻 − ∑ (𝑤𝑐𝑖)𝒄𝒊
T𝑁𝐶
𝑖=1 𝑱𝑹 +⁡⁡
1
2
∑ (𝑤𝑐𝑖)(𝑤𝑐𝑗)
𝑁𝐶
𝑖=1
𝑗=1
𝑖≠𝑗
+
(∑ 𝑤𝑖
𝐿 − ∑ 𝑤𝑖
𝑈)
𝑁𝑚
𝑖=1
𝑁𝑚
𝑖=1
𝑛𝑔
𝜀𝑁𝑚
         (6-2a)  
subject to: 
𝑑ѱ𝒊⁡
𝑑𝑡
|
𝑙
𝑤𝑖
𝑙 ≤ 𝑺𝒊⁡𝑱𝑹𝑋𝑘 ≤
𝑑ѱ𝒊⁡
𝑑𝑡
|
𝑢
𝑤𝑖
𝑢       (6-2b)  
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𝑑ѱ𝒊⁡
𝑑𝑡
|
𝑙
 ≤ 𝑺𝒊⁡𝑱𝑻𝑋𝑘 ≤
𝑑ѱ𝒊⁡
𝑑𝑡
|
𝑢
        (6-2c) 
1⁡≤ 𝑤𝑖
𝑢 ≤⁡1 + 𝜀          (6-2d) 
1 − 𝜀 ≤ 𝑤𝑖
𝑙 ≤⁡1          (6-2e) 
⁡𝑱𝑹 ≥⁡0           (6-2f) 
⁡𝑱𝑻 ≥⁡0           (6-2g) 
ѱ𝒌⁡ ≥ 𝟎          (6-2h) 
0 ≤ 𝑤𝑐𝑖 ≤⁡1          (6-2i) 
∑ 𝑤𝑐𝑖
𝑁𝑐
𝑖=1 = 1          (6-2j) 
We defined  
𝑑ѱ𝒊⁡
𝑑𝑡
|
𝑙
=
ѱ𝑖
𝑙,𝑘+1−ѱ𝑖
𝑘
∆𝑇
  and  
𝑑ѱ𝒊⁡
𝑑𝑡
|
𝑢
=
ѱ𝑖
𝑢,𝑘+1−ѱ𝑖
𝑘
∆𝑇
 . The first term in the objective function (6-2a) 
is a quadratic term that minimizes the sum of square errors between the assumed two sets of fluxes 𝐽𝑇 
and 𝐽𝑅, 𝑱𝑻 represents the fluxes that satisfy tight constraints on metabolites’ concentrations or 
consumption and production rates of these metabolites as observed from the limited data available, and 
𝑱𝑹 are the fluxes that satisfy relaxed constraints for which it is assumed that the data are uncertain. The 
𝑺𝒊⁡is the row of the stoichiometric matrix representing metabolite⁡𝑖, and 𝑋𝑘 is the biomass value at 
time⁡𝑘. The Hessian is 
𝐇 = 𝑢𝑤 [
𝐈 −𝐈
−𝐈 𝐈
]         (6-2k) 
the sum of square errors between the elements of the vector 𝑱𝑻 and the elements of the vector  𝑱𝑹 
weighted by the scalar⁡𝑢𝑤that is selected sufficiently large so as for at the solution the first term in (6-
2a) is smaller than a tolerance (10−4) that is of the order of the noise 𝒏𝒈 in the biological objective (e.g. 
the measurement noise of the growth rate if the latter is used as the biological objective). 
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To account for the uncertainty in consumption/production rates, the bounds on the relaxed constraints 
are obtained by multiplying the bounds on the tight constraints by weights 𝑤𝑖
𝑢 and 𝑤𝑖
𝑙 ⁡ in Eq. 6-2a. 
These weights change between 1 to 1+𝜀 or 1–𝜀  to 1 for the upper or lower constraints respectively 
(equations (6-2d) and (6-2e)) where 𝜀 is chosen to reflect the expected uncertainty in the measurements 
of consumption/production rates of metabolites.  
The second and third term in the cost function (6-2a) describe the biological objective functions to be 
maximized in a DFBA model computed as a function of either the⁡⁡𝑱𝑻 or the 𝑱𝑹 vectors of fluxes that 
satisfy either the tight and relaxed constraints respectively. 𝑁𝐶  is the number of the objective functions’ 
candidates for the problem and the 𝑤𝑐𝑖 are the weight coefficients corresponding to the candidates of 
the objective function.  
The fourth term in Eq. (6-2a) are cross-products of the corresponding weights of any two candidate 
biological objective functions. The minimization in (6-2a) is expected to force these cross-products 
close to zero values thus only leaving one nonzero value of the weights⁡𝑤𝑐𝑖. This non-zero value of a 
𝑤𝑐𝑖will indicate which one of the candidate biological objectives is the one to be chosen for the problem, 
i.e. the goal is that at each time interval only one of the weight coefficients which has the highest impact 
will be driven to one and the rest will tend to zero. Mathematically there may be a situation that the 
resulting bilinear optimization will give fractional values, especially in the case that the sum of the 
cross-products of the weights is not significant as compared to the other terms in the objective function 
of the problem. If this happen it could be resolved by weighting the cross-products with a higher scalar 
weight.  
The fifth term in Eq. (6-2a) is to drive as many constraints as possible to non-active status, i.e. the 
redundant ones so as to identify only the necessary ones. It should be noticed that 1⁡≤ 𝑤𝑖
𝑢 ≤⁡1 + 𝜀 and 
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1 − ε ≤ wi
l ≤⁡1 and these inequalities imply that the extreme values of the weights are  𝑤𝑖
𝑢 = 1⁡ + ⁡𝜀⁡ 
and the smallest⁡𝑤𝑖
𝑙 = 1 − 𝜀. Thus, the minimization of the 5th term (∑ 𝑤𝑖
𝐿 − ∑ 𝑤𝑖
𝑈)
𝑁𝑚
𝑖=1
𝑁𝑚
𝑖=1 ⁡will drive 
as many as possible 𝑤𝑖
𝑙 to  1 − 𝜀 or 𝑤𝑖
𝑢⁡ to 1⁡ + ⁡𝜀⁡ respectively and thus, when they are active at these 
extreme values, the corresponding constraints are not necessary (not active) for the given noise. Hence 
if I can expand the bounds on the consumption/production rates up to the limit of the noise without 
affecting the error 𝑱𝑻 − 𝑱𝑹 in a significant way, this means that the corresponding constraints are not 
necessary to explain the data. Since the fifth term is of the order of 𝜀𝑁𝑚 (the ones are cancelling out 
with each other), we must introduce the factor,  
𝑛𝑔
𝜀𝑁𝑚
,⁡that ultimately render this term of the order of the 
assumed noise in the growth rate of magnitude⁡𝑛𝑔. 
In fact the first and the fifth terms are introduced in the objective function of the optimization (Eq. (6-
1)) to achieve a tradeoff between the error (𝑱𝑻 − 𝑱𝑹) and the limiting constraints active at the solution 
of 𝑱𝑻 and 𝑱𝑹.  
Constraints (6-2b) and (6-2c) are the key elements for the development of a predictive DFBA model 
presented in the next subsection. The idea is to find for which amino acid constraints (6-2b) and (6-2c) 
become active and to eventually replace these constraints by their corresponding kinetics functions to 
be able to predict future concentrations. More details for this process has been explained in Section 2.2. 
The objective function in (6-2a) is nonlinear involving a bilinear term and a quadratic term, and the 
constraints are all linear. Since the bilinear term involves products of weights that are each bounded 
between 0 and 1, the term is convex. Thus, overall this formulation results in a nonlinear convex 
optimization that can be solved by common optimization solvers such as fmincon in MATLAB. 
Accordingly, the optimization search must be conducted for different initial guesses. 
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For the special case that the biological objective function is known or assumed a priori and only the 
active constraints need to be identified, the nonlinear optimization of Eq. (6-2) that results from the 
presence of bilinear terms (terms 2 and 3 in Eq. (6-2a)) converts into the simple quadratic optimization: 
min
𝑱𝑹,𝑱𝑻,𝒘𝑳,𝒘𝑼
(𝑱𝑻 − 𝑱𝑹)
T𝐇(𝑱𝑻 − 𝑱𝑹) − 𝒄
T(⁡𝑱𝑻 + 𝑱𝑹) + (∑ 𝑤𝑖
𝐿 − ∑ 𝑤𝑖
𝑈)
𝑁𝑚
𝑖=1
𝑁𝑚
𝑖=1
𝑛𝑔
𝜀𝑁𝑚
  (6-3a) 
subject to: 
𝑑ѱ𝒊⁡
𝑑𝑡
|
𝑙
𝑤𝑖
𝑙 ≤ 𝑺𝒊⁡𝑱𝑹𝑋𝑘 ≤
𝑑ѱ𝒊⁡
𝑑𝑡
|
𝑢
𝑤𝑖
𝑢       (6-3b) 
𝑑ѱ𝒊⁡
𝑑𝑡
|
𝑙
≤ 𝑺𝒊⁡𝑱𝑻𝑋𝑘 ≤
𝑑ѱ𝒊⁡
𝑑𝑡
|
𝑢
       (6-3c) 
1⁡≤ 𝑤𝑖
𝑢 ≤⁡1 + 𝜀                             (6-3d) 
1 − 𝜀 ≤ 𝑤𝑖
𝑙 ≤⁡1                         (6-3e) 
⁡𝑱𝑹 ≥ 0                              (6-3f) 
⁡𝑱𝑻 ≥⁡0                          (6-3g) 
ѱ𝒌⁡ ≥ 𝟎         (6-3h) 
This quadratic optimization can be solved, for example, using cplexqp (IBM CPLEX) in a MATLAB-
compatible code. If the fluxes ⁡𝑱𝑹 = 𝑱𝑻 at the solution of the QP then the quadratic term in (6-3a) 
vanishes and the solution is identical to the solution of an LP that corresponds to the original 
formulation of a DFBA model equation (6-1) augmented by the second term that represents added 
uncertainty to the biological objective as explained before in this section. 
A main negative consequence of the multiplicity of solutions is that, for some problems such as the B. 
pertussis case study in this work, some of the rate constraints in equation (6-2b) and (6-2c) become 
active only on isolated time intervals along a batch fermentation and this sporadic activation of 
constraints depends highly on the initial guesses assumed for the optimization. On the other hand, it 
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should be remembered that one of the expected benefits of the DFBA model is to predict concentrations 
using only a few kinetic constraints so a small number of kinetic parameters would be needed. The 
sporadic activation of many constraints defeats this purpose since it would require constraining many 
amino acids and calibration of many corresponding kinetic expressions.  
A way to address this situation is by limiting the solution space for the optimization through the 
imposition of upper bounds on consumption or production rates of metabolites. Sometimes, these 
bounds are available from the literature. In the case that these bounds are not available, we propose to 
find the bounds from a modification of the optimization in (6-2a): 
min
𝑱𝑹,𝑱𝑻,𝒘𝑳,𝒘𝑼,𝒘𝒄,𝒘𝒔𝒄
(𝑱𝑻 − 𝑱𝑹)
T𝐇(𝑱𝑻 − 𝑱𝑹) − ∑ (𝑤𝑐𝑖)
𝑁𝐶
𝑖=1 𝒄𝒊
T⁡𝑱𝑻 − ∑ (𝑤𝑐𝑖)𝒄𝒊
T𝑁𝐶
𝑖=1 𝑱𝑹 +
1
2
∑ (𝑤𝑐𝑖)(𝑤𝑐𝑗)
𝑁𝐶
𝑖=1
𝑗=1
𝑖≠𝑗
+
(∑ 𝑤𝑖
𝐿 − ∑ 𝑤𝑖
𝑈)
𝑁𝑚
𝑖=1
𝑁𝑚
𝑖=1
𝑛𝑔
𝜀𝑁𝑚
 − (∑ 𝑤𝑖
𝑠𝑐)
𝑁𝑠𝑐
𝑖=1
𝑛𝑔
𝑊𝑈𝑁𝑠𝑐
       (6-4a) 
subject to: 
𝑑ѱ𝒊⁡
𝑑𝑡
|
𝑙
𝑤𝑖
𝑙 ≤ 𝑺𝒊⁡𝑱𝑹𝑋𝑘 ≤
𝑑ѱ𝒊⁡
𝑑𝑡
|
𝑢
 𝑤𝑖
𝑢        (6-4b) 
𝑑ѱ𝒊⁡
𝑑𝑡
|
𝑙
≤ 𝑺𝒊⁡𝑱𝑻𝑋𝑘 ≤
𝑑ѱ𝒊⁡
𝑑𝑡
|
𝑢
         (6-4c) 
1⁡≤ 𝑤𝑖
𝑢 ≤⁡1 +⁡𝜀          (6-4d) 
1 − 𝜀 ≤ 𝑤𝑖
𝑙 ≤ 1          (6-4e) 
𝑱𝑹 ≥ 0            (6-4f) 
𝑱𝑻 ≥⁡0            (6-4g) 
ѱ𝒌 ≥ 𝟎           (6-4h) 
0 ≤ 𝑤𝑐𝑖 ≤⁡1           (6-4i) 
∑ 𝑤𝑐𝑖
𝑁𝑐
𝑖=1 = 1           (6-4j) 
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|𝑺𝒊⁡𝑱𝑻𝑋𝑘| ≤ 𝑤𝑖
𝑠𝑐          (6-4k) 
0 ≤ 𝑤𝑖
𝑠𝑐 ≤ 𝑊𝑢          (6-4l) 
The optimization (6-4a), in contrast with (6-2a), includes a sixth term in the objective function whose 
purpose is to maximize at each instance the absolute consumption/production rate of each metabolite 
(defined in 6-4k) towards an upper bound 𝑊𝑢 as defined by (6-4l). It can be easily verified that the 
additional term in (6-4a) is also of the order of the noise,𝑛𝑔 since the term is normalized by the 
maximum allowable value 𝑊𝑢 (Eq. 6-4l) and by the total number of metabolites⁡𝑁𝑆𝐶 . To constrain the 
solution space, it has been often proposed in the FBA literature to bound all the fluxes by a value of the 
order of the largest known consumption rate of the limiting nutrients (Maranas et al., 2016). In this 
work, we have used a similar criterion to choose the value of⁡𝑊𝑢. In principle, this value can be 
iteratively adjusted by executing the optimization in (6-4a)–(6-4e) for different values of 𝑊𝑢 until a 
satisfactory fitting between the vectors of fluxes 𝐽𝑇 and ⁡𝐽𝑅 is obtained. 
The fundamental difference between constraints (6-4b)–(6-4c) with respect to the constraints (6-4k)–
(6-4l) is that the former are tight constraints of the order of the noise (𝜀) on the metabolite 
consumption/production rates that are frequently active along a batch whereas the latter are loose rate 
constraints related to the noise 𝑛𝑔 in the biological objective that are only important in isolated time 
intervals along the batch. In principle, the additional term in (6-4a) together with constraints (6-4i)–(6-
4l) result in time-varying values of the weights 𝑤𝑖
𝑠𝑐 for each metabolite⁡𝑖. For the purpose of limiting 
the solution space of a predictive model, one time-independent upper bound is found for each 
metabolite 𝑖 from 
𝑤𝑖
𝑠𝑐,𝑚𝑎𝑥 = max⁡[𝑤𝑖
𝑠𝑐(𝑘)],        (6-5) 
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where 𝑘 ranges from 0 to 𝑇. Selecting the maximum bound is justified since, for the worst case that all 
𝑤𝑖
𝑠𝑐 = 𝑊𝑢, the effect of the sixth term in (6-4a) is guaranteed to be no larger than 𝑛𝑔, i.e. the noise in 
the biological objective function. Then, the bound 𝑤𝑖
𝑠𝑐,𝑚𝑎𝑥
 for each metabolite, 𝑖 is used as an upper 
bound for the rate of that metabolite in the predictive model that is presented in the next section. 
 Predictive DFBA model  
The predictive DFBA model is given by  
At each time instance 𝒌 (𝒌 = 𝟏,… , 𝑻) 
max
𝒗𝒌
𝒄T𝒗𝒌,          (6-6a) 
subject to: 
|𝑺𝒎𝒊𝒗𝒌| ≤ 
𝑉𝑚𝑖,𝑚𝑎𝑥.ѱ𝑚𝑖,𝑘
𝐾𝑚𝑖+ѱ𝑚𝑖,𝑘
mmol
g∙dw∙hr
   (i = 1, 2,…,Nm;  Nm is the number of metabolites) (6-6b) 
𝒗𝒌 ≥ 𝟎           (6-6c) 
|
𝑑𝜑𝑖
𝑑𝑡
| ≤ 𝑤𝑖
𝑠𝑐,𝑚𝑎𝑥
         (6-6d) 
ѱ𝒌 ≥ 𝟎           (6-6e) 
ѱ𝑘⁡= ѱ𝑘−1 + 𝑆𝑣𝑘𝑋𝑘∆𝑇 ≥ 0        (6-6f) 
where 𝑺 is the stoichiometric matrix and 𝑺𝒎𝒊 is the row of the stoichiometric matrix associated with the 
metabolite i.⁡ Equations (6-6a)–(6-6f) are a modified version of the optimization (6-4a)–(6-4k) with 
respect to four elements: 
The objective function (6-6a) includes only the biological objective (second term in 6-4a). This 
objective is based on the assumption that, at the optimal solution of (6-4a), the first term vanishes since, 
at 𝑱𝑻 ≈ 𝑱𝑹, the third term becomes identical to the second term, the fourth and sixth terms are neglected 
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since they are of the order of the noise⁡𝒏𝒈, and the fifth term also vanishes since only one 𝒘𝒄𝟏 = 𝟏 and 
the rest are zero. 
The limiting constraints identified, as explained above, the upper and lower bounds in (6-4b) and (6-
4c), are replaced by explicit functions (6-6b) of the corresponding metabolites concentrations at time⁡𝒌. 
Constraints (6-4i) and (6-4l) are replaced by upper bound constraints (6-6d) using the value𝒔⁡𝒘𝒊
𝒔𝒄,𝒎𝒂𝒙
 
calculated from (6-5). 
Equations to predict the concentrations of metabolites over time (Eq. 6-6f) is formulated based on mass 
balances. That is, Equation (6-6f) are time-discretized mass balances for all metabolites that are used 
to integrate the concentrations over time. 
The optimization (6-6a)–(6-6f) is an LP that is solved with the CPLEX optimization software. A 
fundamental advantage of the proposed model (6-6a)–(6-6f) is that the parameters in the kinetic 
expressions corresponding to the limiting constraints (6-6b) can be separately identified for each 
metabolite. This is particularly advantageous as compared to previously reported algorithms where the 
parameters corresponding to all the kinetic expressions involved in the constraints of the DFBA 
problem must be simultaneously identified from bi-level optimization formulations. 
The ability to identify the kinetic expression separately is due to the fact that, at each time instance, the 
solution of the optimization (6-4a) provides which constraint i is active; it is possible to find the 
corresponding values of the gradients, either 
𝑑ѱ𝒊⁡
𝑑𝑡
|
𝑢
 or 
𝑑ѱ𝒊⁡
𝑑𝑡
|
𝑙
, that are active at the constraint. Then, 
Michaelis-Menten expressions  
𝑑ѱ𝑖
𝑑𝑡
=
𝑉𝑖,𝑚𝑎𝑥.ѱ𝑖
𝐾𝑖+ѱ𝑖
𝑋         (6-7a) 
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or alternative types of kinetic expressions can be found to correlate the bounds on the uptakes or 
production rates (
𝑑ѱ𝑖
𝑑𝑡
) of the metabolite as a function of its concentration⁡(ѱ𝑖)⁡ at every time interval, 
where 𝑉𝑖,𝑚𝑎𝑥, 𝐾𝑖⁡ are the kinetic parameters that should be identified. For example, if it is found that 
glucose is a limiting constraint, then a kinetic expression can be used to represent the relation: 
𝑑𝐺𝐿𝐶
𝑑𝑡
=
𝑉𝐺𝐿𝐶,𝑚𝑎𝑥.𝐺𝐿𝐶
𝐾𝐺𝐿𝐶+𝐺𝐿𝐶
𝑋         (6-7b) 
Then, the two parameters 𝑉𝐺𝐿𝐶,𝑚𝑎𝑥 and 𝐾𝐺𝐿𝐶 can be found from time data of glucose alone since the 
gradient of glucose on the left-hand side of Eq. (6-5) and the corresponding concentration of glucose at 
each time interval are available 
If Michaelis-Menten kinetics are assumed, graphical methods such as the Lineweaver-Burk are used to 
identify the parameters in the kinetic expressions (6-7a) or (6-7b) (Shuler & Kargi, 1992). For other 
types of kinetic expressions, nonlinear regression is done using the Curve Fitting Toolbox in the 
MATLAB environment.  
 Experimental and in silico data Used in the Case Studies 
The proposed method is applied in two case studies for two model microorganisms. The first study is 
the batch fermentation of E. coli system for which a DFBA model has been reported by Mahadevan et 
al. (Mahadevan et al., 2002).The model was used to generate in silico data consisting of simulated data 
with superimposed white noise. Since the DFBA model with the required biological objective function 
and constraints was available a priori, this case study serves to verify whether our methodology is able 
to identify the correct objective function and limiting constraints. 
For the second case study, we studied the fermentation of Bordetella pertussis (B. pertussis) used to 
produce the antigens of the whooping cough vaccine. The metabolic network for this organism involves 
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49 reactions. This process was assumed to operate initially in batch and, after depletion of the main 
nutrient, in fed-batch mode. Glutamate was the main nutrient for this microorganism. For this example, 
we use actual measurements of sixteen amino acids concentrations measured by HPLC. 
 Results 
 Case Study 1: E. coli 
The DFBA model describing the diauxic growth of an E. coli system involves four species: glucose, 
acetate, oxygen, and the biomass in its network. All species except the biomass are considered as 
potentially active constraints. 
The model proposed by Mahadevan et al. (Mahadevan et al., 2002) is based on a simplified metabolic 
network of four reactions involving the four aforementioned species shown in Appendix A. 
Mahadevan’s model assumes that the growth rate is maximized at each time interval subject to two 
kinetic limiting constraints on glucose and oxygen consumption: 
At all-time instances k: 
max
𝒗
𝒄T𝒗                                                                                                                                     (6-8)  
|𝐒𝐆𝐥𝐜𝒗| ≤
𝑉𝐺𝑙𝑐,𝑚𝑎𝑥.ѱ𝐺𝑙𝑐,𝑘
𝐾𝐺𝑙𝑐 + ѱ𝐺𝑙𝑐,𝑘
mmol
gdw ∙ hr
 
|𝐒𝐎𝟐𝒗| ≤ 𝑂𝑈𝑅 
mmol
gdw ∙ hr
 
This model was simulated for a total of 10 hr to simulate experimental conditions. Gaussian noise was 
added to the metabolites responses at a level of 5% of the total range of change of each metabolite 
during the batch. These simulated values were used as in silico data to test the proposed identification 
methodology as given by equations (4a)–(4e). The sampling interval used for discretization was 0.1 hr 
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and the oxygen uptake rate was OUR=10.Initial condition for metabolites and biomass at time zero was 
glucose (10.4mM), acetate (0.4mM), oxygen (0.21mM) and biomass (0.001g).  Based on this level of 
noise, 𝜺 was set equal to 0.1 and the upper bound in constraint (4k), 𝑊𝑢, was set to 10 mM/hr∙gdw. 
The weight 𝑢𝑤 defining the Hessian as per equation (2j) was set to 0.01. As mentioned in the 
methodology section, this weight is selected large enough such as the first term in (4a) at the optimum 
is of the order of 𝒏𝒈 (estimated noise in the growth rate). We used interior-point algorithms with 
cplexqp and cplexlp function in CPLEX for MATLAB toolbox. 
In order to test our methodology, we assume that any of the nutrients (glucose, acetate, or oxygen) can 
be potentially limiting. In addition, we assume two possible candidate biological objectives for 
maximization: (1) growth rate as given by equation (8), i.e. 𝒄𝟏
T = [1⁡1⁡1⁡1]⁡(see equation 4a) and (2) 
maximal consumption rate of acetate, which is represented by 𝒄𝟐
T = [39.43⁡⁡⁡0⁡⁡⁡ − 1.24⁡⁡⁡ − 12.12] in 
eq. (4a). 
The solution over time of the weights 𝑤𝑖
𝑢 and 𝑤𝑖
𝑙 for all the species is identified. These values indicate 
which rate constraints are considered at each time interval according to equations (4b) and (4c). 
Following the solution of problem (4a), it was found that the upper bound of oxygen depletion rate is 
active from 𝑡 = 0 until the end of the batch whereas the upper bound in glucose becomes active after 
𝑡 = 4.2 hr and thereafter. These results coincide with Mahadevan’s model where the limiting rate 
constraints are glucose and oxygen while acetate is not limiting, thus corroborating the ability of the 
method to identify the constraints. 
The weights involved in constraints (4k) and (4l) which are introduced to limit the solution space were 
found to be equal to their upper bound, i.e. 𝑤𝑖
𝑠𝑐 = 𝑊𝑢, for all the 4 species and for the entire duration 
of the batch. The weights 𝑤𝑐1 and 𝑤𝑐2 that correspond to the growth rate and to the acetate objectives 
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in equation (4a) are 1 and 0 for the entire duration of the batch, thus correctly identifying the growth 
rate as the objective to be maximized. This again verifies the ability of the proposed approach to identify 
the correct biological objective function. For the purpose of formulating the predictive model according 
to equations (6a)–(6f), it is necessary to identify kinetic expressions of the two identified limiting rate 
constraints as a function of the corresponding metabolite concentrations, i.e. the rate constraints in 
glucose and oxygen are expressed as a function of the corresponding glucose and oxygen concentrations 
respectively. Figure 6-2 shows the consumption rate of glucose obtained at each time interval as a 
function of the corresponding glucose concentration. For this plot, a Michaelis-Menten kinetic 
expression was identified using the Lineweaver-Burk graphical method. The resulting kinetic 
parameters for the glucose are as in the following table 6-1. It should be noted that these results are 
almost identical to the non-linear parametric estimation.  
Table 6-1 Estimated and original values of the parameters 
Parameter Original Value Estimated Value 
𝑉𝐺𝑙𝑐,𝑚𝑎𝑥 10 11.11 
𝑘𝐺𝑙𝑐 0.015 0.02 
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Figure 6-2 Kinetic curve of glucose (glucose uptake rate vs glucose concentration) in E.coli 
example 
The procedure identifies, in accordance with Mahadevan’s model used to generate the in silico data, 
Michaelis-Menten kinetics for the glucose consumption rate bound whereas a constant upper bound for 
the consumption of oxygen is identified. The numerical values of the kinetic constants are slightly 
different from Mahadevan’s model because they were identified by the procedure in (6-4a)–(6-4l) from 
simulations of the original model with superimposed noise. 
Figure 6-3 shows the comparison between the time evolutions of the 4 species as a function of batch 
time obtained from the original model without the noise (red line) and the identified model (blue line). 
The simulated results are slightly different between the original and identified models due to the 
differences in the kinetic rate expressions for the limiting constraints that resulted from the assumed 
noise. 
 
9.89
9.9
9.91
9.92
9.93
9.94
9.95
9.96
9.97
9.98
9.99
10
0 2 4 6 8 10 12
U
p
ta
k
e 
ra
te
(m
m
o
l/
g
d
w
.h
r)
 
Glucose Concentration(mM)
Glucose kinetic curve
 118 
 
 
Figure 6-3 Metabolite concentration profiles of E. coli case study red line is the simulated 
original model and the blue line is our identified model 
 Case Study 2: B. Pertussis 
Bordetella pertussis is a gram-negative, aerobic, and pathogenic bacteria causing Pertussis or whooping 
cough (Thalen et al., 2006). In this case, our algorithm is used for systematic identification from 
experimental data of limiting constraints and a suitable biological objective function of a B. pertussis 
fed-batch culture. Glutamate is the main carbon source used for the feeding of this culture, which is 
started at time 0 in batch operation until depletion of glutamate occurs and then the fed-batch operation 
is started with a constant glutamate feed rate of 4.3 g/h. A metabolic network involving 49 metabolites 
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and 50 reactions was available from a previous study by Budman et al.(Budman et al., 2013). The 
reactions that were considered are listed in Appendix B. HPLC measurements of 16 amino acids were 
available for a fifty hours fermentation process at 8 time instances: 0, 6, 24, 29, 31.1, 32, 34, 48.3 hr. 
The data is shown by circles in Figure 6-4. Due to confidentially reasons, all the presented data in this 
figure have been normalized based on the initial concentration of glutamate which is the main nutrient 
in this fermentation process.   
A nonlinear polynomial interpolation function was applied to interpolate the data between the available 
measured values. The sampling interval used for the identification procedure given by equations (6-
4a)–(4l) was 0.1 hr. The level of noise in the HPLC measurements was estimated as 10% of the full 
range of change of each amino acid and this value was used to estimate the 𝜀 = 0.1 used in the rate 
constraints (6-4b) and (6-4c). The upper bound 𝑊𝑢 in constraint (6-4l) was set to 10 mM/hr∙mM as in 
the previous case study. In principle, this value can be iteratively further adjusted as explained in 
Section 2. The weight 𝑢𝑤 defining the Hessian in equation (6-2j) was set to 0.01. 
Two candidates were considered as possible biological objectives for maximization: maximization of 
the growth rate and maximization of the lactate production rate. The growth rate is defined by the 
stoichiometric relations derived from the reactions listed in Appendix B.  
The identification procedure given by equations (6-4a)–(6-4l), was applied to the data to identify the 
objective function and limiting constraints. Among constraints (6-4bc), only one constraint is active for 
the entire duration of the batch corresponding to the upper bound in the consumption rate of 
phenylalanine. The biological reason for phenylalanine being the limiting active constraint might be 
due to the fact that phenylalanine is not produced by B. pertussis and should be externally supplied in 
the medium. 
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A key difference between the current case study and the previous case study is that here only a fraction 
of the species involved in the network is measured whereas in the previous study all species were 
measured. Thus, the current case study is highly under-determined and consequently, constraints (6-
4k)–(6-4l) that are used to limit the solution space become important. These constraints were found to 
be important for limiting the solution space for both consuming and producing species that are not being 
measured. 
The weights 𝑤𝑖
𝑠𝑐 (constraint 6-4k) were identified at each time interval and accordingly 𝑤𝑖
𝑠𝑐,𝑚𝑎𝑥
 was 
calculated using equation (6-5).  
 Six of the amino acids can be produced according to the metabolic reactions listed in Appendix B: 
Alanine, Aspartate, Glutamate, Isoleucine, Arginine, and Proline. However, it was found from the data 
that the concentration of these metabolites did not exhibit any noticeable increases in time. The reason 
is that these metabolites start to be synthesized only after they are completely depleted so as to further 
generate biomass, i.e., the production of these amino-acids is exactly balanced by their consumption 
towards biomass, especially during the fed-batch phase. In principle, an upper bound of 0 could have 
been assumed for the production rates but it was found that due to Euler discretization that it was 
difficult to satisfy the positivity constraint (6-6e) when the produced amino acids concentrations are 
very close to zero. For these six amino acids, having a constant upper bound with the value of 10−4 
was necessary. The preferable objective function was found to be the growth rate. This coincides with 
the objective function that has been prevalent if previous bacterial models and also corresponds to the 
objective function used in a B. Pertussis model reported in Budman et al. (Budman et al., 2013). 
Using the growth rate as the biological objective, it is possible to formulate the optimization problem 
as a QP as explained in equation (6-3a). Solving the problem as a QP serves to verify the nonlinear 
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optimization used to solve the problem in (6-3a)–(6-3h). The cplexqp solver in MATLAB was used to 
solve this quadratic optimization. The results were very similar to the results of the nonlinear 
optimization except for small differences in the values of the weights⁡𝑤𝑖
𝑠𝑐. 
To formulate a predictive model as given by equations (6a)–(6f), a kinetic expression was sought 
relating the maximum consumption rate in phenylalanine as a function of its concentration. From the 
relation between the measured consumption rates and the corresponding concentrations, it was 
concluded that a Michaelis-Menten relation is not suitable. Instead, as assumed in our earlier work 
(Nikdel & Budman, 2016), a Hill-type function (Weiss, 1997) was used to describe the maximal uptake 
rate of the phenylalanine by 
𝑟Phe =
0.0066⁡ѱPhe
3.2
0.0223.2⁡ѱPhe
3.2         (6-9) 
The values of the parameters in this expression were found using the lsqcurvefit of MATLAB. 
The bounds 𝑤𝑖
𝑠𝑐,𝑚𝑎𝑥
 used in constraints (6-6d) are obtained from the calculated values of the 
corresponding 𝑤𝑖
𝑠𝑐 according to equation (6-5). 
The simulated results for the 16 measured amino acids using equations (6a–f) using the phenylalanine 
expression in equation (9) and the constraints (6b) are shown in Figure 4. The sum of squared errors 
between simulations and measured values is SSE = 6.25. This error is significantly lower as compared 
to our earlier model of SSE = 15.42 (Budman et al., 2013) where the limiting constraints in developing 
the DFBA model was based on trial and error in contrast with the systematic approach proposed in this 
work. The reason that our model is not able to give a perfectly prediction for some of the metabolites 
might be due to the inaccuracies in the stoichiometric matrix and in the calculation of biomass amino 
acids’ composition.  
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In order to test further the predictive ability of the model, no constraints were included for biomass. 
The goal was to test whether the model without any biomass-related constraints could correctly predict 
the biomass evolution over time. This test is significant since all amino acids contribute to the 
composition of biomass and thus predicting correctly the evolution of biomass implies also a certain 
level of fidelity in the prediction of the amino acids. Biomass measurements were available for two 
different feeding rates of glutamate 4.3 g/hr and 4.7 g/ hr. The model predictions of biomass for both 
feeding rates show very good agreement between measured and predicted values (Figure 6-5). 
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Figure 6-5 Metabolite concentration profiles of B-Pertussis case study resulted from the DFBA. 
It also should be noted that the accuracy of the model could be increased by including more 
measurements in the identification step.  
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Figure 6-6 Biomass profile of B. Pertussis in fed-batch mode: red, blue, and green lines are 
model predictions with the fed-batch rate of 4.3, 6, and 7.4 g/h glutamate; circle, ×, and pink 
dots mark experimental data points for the feed rate of 4.3, 6, and 7.4 g/h glutamate. 
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 Conclusion 
The formulation of a dynamic metabolic flux balance model requires the identification of a suitable 
biological objective function to be maximized or minimized and active limiting constraints. In this 
contribution, we propose a systematic approach to identify both of these attributes for developing 
DFBA models. A key advantage of the proposed approach is that its formulation as a one-level 
optimization that simultaneously maximizes the biological objective together with terms that are related 
to the limiting constraints on consumption and production rates of amino acids. Proper weighting of 
these additional terms allows the constraint to be related to the relative errors incurred in measuring 
both amino acid concentrations as well as the biological objective variable. The use of set-based 
constraints ensures fitting between the data and the model predictions while avoiding the need for two-
level optimization formulations. Two case studies were investigated. In the first case study for E. coli 
for which a priori known model was used to generate in silico data, the proposed approach successfully 
recognized the correct objective function and constraint of the model. In the second case study that 
involved experimental data of B. pertussis fermentation, the scarcity of data and the complexity of the 
metabolic network rendered the problem underdetermined. Additional constraints were required in 
order to only allow realistic solutions. In this case, our approach systematically identified a single 
kinetic rate bound on one amino acid (phenylalanine) and a set of constant upper bounds on 
consumption and production rates where the latter served to limit the solution space. 
The resulting model was able to predict the evolution of biomass concentration with time whereas 
biomass values were not used for model calibration. 
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Chapter 7 
Inhibitory pH effect in culturing CHO cells  
3This chapter is the contribution of the author of this thesis as the second author of the paper titled: 
”Modeling of cell culture damage and recovery leads to increased antibody and biomass productivity 
in CHO cell cultures” (Naderi et al., 2014) so only an introduction and my main contribution to the 
paper has brought here.  In this paper, a mathematical model was proposed for the investigation of cell 
damage of a Chinese hamster ovary (CHO) cell culture secreting recombinant anti-RhD monoclonal 
antibody (mAb). Reduction of pH was found to be a responsible factor for irreversible cell damage. A 
Tessier-based model was used to describe this irreversible damage to cellular function. In this model, 
the actively growing fraction of cells is dependent on an intracellular metabolic product acting as a 
growth inhibitor.  To further verify the model, an offline model-based optimization of mAb production 
in the cell culture was carried out, with the goal of minimizing cell damage and thereby enhancing 
productivity through intermittent refreshment of the culture medium. An experimental implementation 
of this model-based strategy resulted in doubling of the yield as compared to the batch operation and 
the resulting biomass and productivity profiles agreed with the model predictions. 
                                                     
3 This chapter is based on the paper:  Naderi, S., Nikdel, A., Meshram, M., McConkey, B., 
Ingalls, B., Budman, H., & Scharer, J. (2014). Modeling of cell culture damage and recovery 
leads to increased antibody and biomass productivity in CHO cell cultures. Biotechnol J, 9(9), 
1152-1163. doi: 10.1002/biot.201300287 
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 Introduction 
Cell death following exponential growth in culture is still a major obstacle for efficient and economical 
production on an industrial scale. Cell death is primarily caused by apoptosis, a form of programmed 
cell death that can be triggered by environmental causes, such as depletion of essential nutrients, 
accumulation of metabolic by-products (ammonia, lactate and carbon dioxide), changes in pH, oxygen 
limitation, and hyperosmolality (Han, Kim, Kim, & Lee, 2010; Laken & Leonard, 2001). Autophagy, 
another death process, has been attributed to nutrient exhaustion (Hwang & Lee, 2008). Lysozymes 
released upon cell death affect both the titer and glycosylation, thus impacting both the quantity and 
quality of mAbs (Chee Furng Wong, Tin Kam Wong, Tang Goh, Kiat Heng, & Gek Sim Yap, 2005). 
An understanding of the mechanism and dynamics of these cell death processes will be crucial for the 
development of robust strategies for optimization of culture yield. 
Fed-batch and perfusion operations are two efficient process strategies that are often applied to mitigate 
the stressful conditions that occur during batch culture. In both culture techniques, controlled nutrient 
feeding, either continuously or at regular intervals, is performed; spent medium (either in part or in 
whole) is removed in the perfusion mode (Rodrigues, Costa, Henriques, Azeredo, & Oliveira, 2010). 
These strategies result in longer cell viability and higher recombinant protein production (Burky et al., 
2007; Zhang, Shen, & Zhang, 2004). However, formulating an optimal operating strategy (i.e. 
frequency and volume of feeding and medium removal) requires a detailed understanding of cell 
metabolism and physiology. Due to the complexity of cell metabolism and the many unknown 
intracellular factors involved in regulating cellular mechanisms, most strategies applied to date have 
been based on trial-and-error (Altamirano, Paredes, Illanes, Cairo, & Godia, 2004). 
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In another work the effect of key nutrients—glucose, glutamine, and asparagine on cell growth, 
maximum population density, cell death and longevity of the culture; given adequate initial reserves, 
these effects were found to be insignificant (Naderi et al., 2011a). Subsequently, the response of 
cultures to periodic feeding strategies was addressed in an attempt to improve culture conditions by 
compensating for the possible exhaustion of nutrients. Due to uncertainty about the identity of limiting 
nutrient(s), supplementation with complete medium was used. These earlier studies revealed that 
supplementation does not have a significant impact on mAb productivity. To model cell growth, a 
logistic model was used, because a limiting nutrient could not be identified. 
Excursions in pH levels are common and very significant in large scale bioreactors, even when operated 
under closed loop pH control, due to spatial gradients within the vessel (Nienow, 2006). In this present 
work, we provide evidence suggesting that the accumulation of a pH reducing compound results in cell 
damage. Towards these objectives, a set of experiments were carried out involving partial or complete 
replacement of the spent medium to mitigate the effects of the observed inhibition. Periodic complete 
replacement of the spent medium—a method often referred to as intermittent harvesting (Ozturk & Hu, 
2006)-  can mitigate cell damage and may increase cell longevity and productivity. Moreover, it appears 
that some cells may undergo replicative senescence rather than direct transition to apoptosis. As 
described below, once stationary phase was reached, most cells were committed to growth arrest, but 
there was a small fraction of cells that reverted to growth after each period of intermittent harvesting. 
This effect may be related to oncogene-induced growth arrest or replicative senescence under 
unfavorable environmental conditions, which has been reported previously (Ruiz et al., 2008).  
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 Materials and Methods 
 Cell Line and Culture Process 
A CHO (DHFR-) cell line, containing a fully human IgG-Variant gene for anti-RhD mAb, was provided 
by our industrial partner, Cangene Corporation, Winnipeg, MB. This recombinant mAb (IgG1-r9B8) 
has shown a relatively high affinity for the human RhD antigen, making it suitable for therapeutic 
application. The CHO cells were cultured in SFX-CHO (Hyclone) medium, supplemented with 1% 
serum (Invitrogen) and L-glutamine (Sigma) to a final concentration of 1 mM. No animals or human 
subjects were used in this research. 
 Analytical Methods 
Viability assays were carried out with Trypan Blue staining followed by cell counting on a 
hemocytometer. The glucose content of cell culture samples was measured enzymatically using a 
glucose test kit (Megazyme Glucose Test Kit). Lactate was assayed with a Lactate Plus meter from 
Nova Biomedical. The dissolved ammonia concentration was measured using a pH/ISE meter equipped 
with an Ammonia Ion-Selective electrode (VWR, model 710A). Dissolved oxygen (DO) was measured 
using VWR Symphony Dissolved Oxygen meters and corresponding probes. Electrode calibration was 
performed in water-saturated air in a special calibration chamber. The pH of the broth was measured 
by VWR SympHony SP21 meter. 
 Experimental Design 
To corroborate and model the adverse effect of pH on growth for the cell line under consideration, 
experiments were conducted in T-flasks at different initial pH values using 1N HCl for pH adjustment. 
Cell growth and pH were measured routinely in each flask. The culture was adherent in T-flasks.  
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Cell culture experiments were conducted in 500 ml spinner flasks (Bellco, USA) in a humidified CO2 
incubator (Sanyo IR Sensor, 37°C, 5% CO2) at 100 rpm. The inoculum density was approximately 0.2 
×106 cells/mL. In this series of experiments, pH was left intentionally uncontrolled. Samples were taken 
daily for immediate and offline analysis of cells and metabolites. 
Inhibitory effects of pH on growth of mammalian cells have been reported previously (Link et al., 2004; 
Lipscomb, Palomares, Hernandez, Ramirez, & Kompala, 2005). To verify the effect of pH levels on 
cell growth in the system under study, 3 sets of culture at different initial pH were prepared. Initially, 
the pH of 3 shaker flasks containing fresh medium (SFX-CHO) was adjusted at 7.6, 7.1 and 6.8, 
respectively, with 1N HCl. The initial cell density of CHO cell seeded in each shaker flask was 0.2x106 
cells/mL with 1% serum and 1mM glutamine. 
The culture from each shaker flask was split into 5 T-flasks 20 mL of cell culture in each. All 15 T-
flasks were incubated at 37°C and 5% CO2.  During the 5 days incubation period, cell concentration and 
pH of one T-flask in each set were measured. The results in Fig.7-1A and Fig.7-1B show that a 
reduction in pH results in significant reduction in cell growth. The differences were statistically 
corroborated by an ANOVA test (p=0.05) for the 3 pH levels tested for the viable cell densities 
measured at 63 hrs and 85 hrs which correspond to the maximal densities. On the other hand, the 
differences among the cultures at the beginning or end of the T-flask experiments are not statistically 
significant.  
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Figure 7-1 A Total viable cell concentration in T-flask. 1 ml of each flask was used for cell 
counting by Trypan Blue staining. Two repeats were done for each of a total of three pH levels. 
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Figure 7-1B pH of the culture in T-flask. 2 ml samples from each flask were used for pH 
measurement. Two repeats were done for each of a total of three pH levels. After measurements 
of cell count and pH the corresponding flask was discarded. 
To assess the effect of gaseous (oxygen/carbon dioxide) mass transfer effects on the pH, a series of 
experiments were performed in spinners at differing surface area to volume ratios (250 mL and 500 
mL) at identical agitation speeds (100 rpm) and at initial pH=7.6 adjusted by base addition. It was 
hypothesized that, for different culture volumes, mass transfer conditions may lead to different rates of 
accumulation of acidic metabolites. The use of different culture volumes at identical stirring speeds 
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provided a simple and convenient means to evaluate the potential effect of gas/liquid mass transfer on 
basal metabolism. The expected differences in pH levels for spinners with different culture volumes 
were fully corroborated as shown in Table 7-1 and in Figure 7-2, which indicates that for the 500 mL 
spinner consistently lower level of pH were attained as compared with the 250 mL spinner. The 
differences in pH between the two volumes were corroborated by a t-test (p=0.05) for all pH data 
obtained after time=48 hours (F=5.5 and Fcritical=3.2). Periodically a portion of the spent culture (50mL 
in the spinner containing 250 mL and 100 mL in the spinner containing 500 mL) was withdrawn and 
substituted with an equivalent amount of fresh medium. Before each withdrawal, we allow the cells to 
settle down (~15 min.) so as to minimize cell loss during withdrawal. It was expected that, if an 
inhibitory compound were accumulating in the supernatant, each withdrawal would help to renew 
growth by reducing the level of such compound.  
 
Table 7-1. Dissolved oxygen concentration (DO %) and pH of culture for two different 
volumes in 500 mL capacity spinner flasks. 
 V=250mL V=500mL 
Time (h) DO% pH DO% pH 
145 33.2 6.62 38.6 6.46 
196 27.0 6.50 40.1 6.32 
244 49.1 6.43 55.3 6.37 
293 43.9 6.44 46.5 6.36 
338 45.6 6.47 49.9 6.37 
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Figure 7-2 pH profile during partial intermittent feeding culture at volumes of 250 ml and 500 
ml. Feeding volume of 50ml and 100 ml at the times of 145, 196, 244 and 293 (hours) 
The total viable cell density assays for these two spinners are presented in Fig.7-3A. The differences in 
cell density between the two volumes were corroborated by a t-test (p=0.05) for densities collected after 
t=49 hrs (F=5.31 and Fcritical=2.53). Following the first withdrawal, the cultures recovered and reached 
cell density maxima and cell viability close to those achieved before dilution (almost equal, for the 
spinner containing 250 mL). This behavior is consistent with the hypothesis that the accumulation of 
an acidic compound results in pH reduction, leading to growth inhibition. However, no improvements 
in viability were observed in the subsequent withdrawal steps. The time course of viability in the 250 
mL and 500 mL cultures is shown in Figure7-3B. A progressive decline in viability was observed in 
spite of intermittent partial refreshment of the medium. Dissolved oxygen concentration measurements 
given in Table 7-1 for both spinners confirmed that dissolved oxygen was not in the limiting range, 
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even at peak cell density. The levels ranged between 30%-90% of air saturation at which DO has no 
significant effect on cell metabolism (Trummer et al., 2006). On the other hand the pH levels, also 
shown in Table 7-1, were found to be below the range of 6.80-7.60, which has been reported as optimal 
for other CHO cell lines (Link et al., 2004; Yoon, Choi, Song, & Lee, 2005).   
 
Figure 7-3A Harvesting operation at two different volumes. V=250 mL, ΔV=50 mL, V=500mL, 
ΔV=100 mL. Harvesting occurred at the times of 145,196,244,293 hours. Three repeats were 
done for 250 ml and two repeats for 500 ml.  
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Figure 7-3B Viability graph. Harvesting operation at two different volumes. V=250 mL, ΔV=50 
mL, V=500mL, ΔV=100 mL. Harvesting Occurred at the times of 145,196,244,293 hours. Three 
repeats were done for 250 ml and two repeats for 500 ml. 
Figures 7-3C and 7-4A-B show the metabolic condition observed in the spinners operating with 250ml 
and 500ml working volume, respectively. As shown, the higher cell density in the low-volume spinner 
led to a higher relative consumption rate of glucose in the post-exponential phase. They also show 
lactate and ammonia concentrations are nearly identical and below inhibitory level in both cultures. 
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Figure 7-3C Glucose profile for 250 and 500 mL flasks. Harvesting operation at two different 
volumes. V=250 mL, ΔV=50 mL, V=500mL, ΔV=100 mL. Harvesting Occurred at the times of 
145,196,244,293 hours. Three repeats were done for 250 mL and two repeats for 500 mL. 
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Figure 7-4A Lactate profile for 250 and 500 mL flasks. Harvesting operation at two different 
volumes. V=250 mL, ΔV=50 mL, V=500mL, ΔV=100 mL. Harvesting Occurred at the times of 
145,196,244,293 hours.  
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Figure 7-4B Ammonia profile for 250 and 500 mL flasks. Harvesting operation at two different 
volumes. V=250 mL, ΔV=50 mL, V=500mL, ΔV=100 mL. Harvesting Occurred at the times of 
145,196,244,293 hours. Three repeats were done for 250 mL and two repeats for 500 mL 
The observed decline in viable cell concentrations during intermittent harvesting operation (Fig.7-3A) 
suggests that an irreversible growth arrest occurred during long-term periodic operations.  This steady 
decline in viability rate coincided with a decrease of pH to growth-inhibiting level as shown in Table 
7-1 (pH< 6.6). Oncogene-induced growth arrest or replicative senescence has been reported to occur 
under harsh environmental conditions and it is often related to p53 regulation (Ruiz et al., 2008) and 
the effect of low pH on the regulation of p53 and cell damage has been clearly established (Xiao, Li, 
Yang, & Liu, 2003) . 
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To further assess whether the reduction in growth is due to depletion of a substrate or whether there is 
accumulation of an inhibitory compound in the medium two additional experiments were conducted as 
follows: (i) a fed-batch culture supplemented with 5× concentrated feed; and (ii) a full harvesting 
operation. The full harvesting culture was prepared with 500 mL of 2× concentrate SFX-CHO medium; 
the fed-batch culture employed an initial volume of 300 mL normal (1×) SFX-CHO medium. Once the 
cell density had reached an approximate maximum (80 h), the culture conditions were manipulated. In 
the full harvesting spinner, complete renewal of the culture supernatant was performed (by centrifuging 
of the total culture, discarding the supernatant and returning the cells in a same volume of fresh 
medium). In the fed-batch spinner, four feedings of 50 mL concentrated 5× SFX-CHO were added 
every 48 h, starting at 80 h. The results are shown in Fig. S1A–D (See Appendix D). Figure S1A, which 
shows viable cell concentration illustrates the growth-inhibition effect of pH at different working 
culture volumes. Until the peak in cell concentration is reached (~80 h) these experiments are equivalent 
to the experiments described in Fig. 7-3 and Fig 7-4. While both spinners started with equal cell density, 
a higher peak cell level was achieved in the fed-batch spinner, which started with a volume of 300 mL 
compared with the 500 mL culture used for intermittent harvesting. However, in the fully harvested 
spinner, not only was cell growth renewed after the harvesting event (80 h), but the cells maintained 
higher density for a significant time (~100 h). Conversely, in the fed-batch run, no improvement in 
viability was observed after each feeding, and the cells gradually entered a decline phase during which 
viable cell density and total viability decreased. Metabolite levels for these runs are shown in Fig. S1B–
D. The glucose level (Fig. S1-C) never falls below the limiting concentration, due to refreshing of the 
culture. The glutamine consumption rate in the full harvesting culture was low (Figure S1-D), while 
glutamine was depleted in the fed-batch culture due to consumption and dilution. Figure S1-B shows 
lactate production, revealing a high value of lactate at the early stage of the culture (which may have 
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been caused by the high initial cell density). In the full harvest culture, lactate was produced quickly 
after the medium replacement event: the concentration increased from near zero to over 10 mM in 24 
h. This rapid production of lactate demonstrates how quickly culture conditions can be changed by the 
metabolic activity of a high viability culture. In a separate experiment, an attempt was made to improve 
growth in a fed-batch mode by controlling pH at 7.1–7.2 by manual addition of NaOH (Data not 
shown). Although the growth in this pH-controlled culture was slightly higher than for cultures without 
pH regulation, a metabolic shift toward glycolysis gave rise to a very large specific consumption rate 
of glucose, almost 6 times larger than the consumption rates for cultures without pH regulation. Glucose 
was completely consumed after 3 days at which time the growth stopped and the lactate levels reached 
45 mM. In principle, we could have added more glucose after its depletion but this would have resulted 
in further lactate accumulation and so it could not lead to improvements in yield. Thus, for improvement 
of yield, we concluded that an intermittent harvesting operation is a better approach. 
  Conclusion 
This chapter describes the development of a comprehensive dynamic model for Chinese hamster ovary 
(CHO) cells producing anti-RhD monoclonal antibody (mAb) that accounts for metabolic behaviour 
over time. Development of the model required identification of the underlying parameters that play key 
roles in cell viability and monoclonal antibody productivity.  
It was found that a decrease in pH, attributed to the accumulation of an acidic compound, significantly 
inhibited cell growth. Although this suppression effect can be temporarily mitigated by partial or full 
replacement of culture with fresh medium, the culture rapidly returns to unfavorable conditions (due to 
high cell density and subsequently high metabolic activity).  As a consequence, cells gradually—and 
irreversibly—lose their capacity for regeneration.  
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We extended our previously published model to account for the cumulative reduction in pH and 
consequent growth inhibition.  The model accounts for the effects of several significant factors on cell 
growth and metabolic activity, and model simulations successfully reproduce the time profile of cell 
populations and major external metabolites. It should be noticed that the model does not account for 
effects that have not been explicitly tested in the experiments such as glucose depletion. To test the 
accuracy of the mathematical model it was used as the basis for an offline optimization of an 
intermittent harvesting schedule. Our experimental results showed that the predicted intermittent 
refreshment of the medium at optimal instances minimized cell damage and significantly improved 
productivity as compared to a batch operation.  The novel description of accumulated cell damage 
presented here can be used to incorporate the dynamics of this crucial mechanism into models of CHO 
cell culture, thus improving the accuracy of model-based predictions of culture yield. 
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Chapter 8 
Identification of a dynamic flux balance model of a CHO cell culture 
Mathematical models are essential tools for improving the understanding of cell metabolism and cell 
culture behavior and for their use in model-based bioprocess optimization. Dynamic flux balance 
analysis (DFBA) type of models are based on the premise that biological cells have adapted through 
evolution to optimally allocate resources to achieve certain biological goal subject to some limitations. 
A key challenge in the formulation of a DFBA is to identify from experimental data the specific 
biological goal that the cell seeks to optimize (objective function) and a minimal set of kinetic bounds 
(constraints) so as to avoid overfitting of the data used for model calibration. This paper applies a 
systematic methodology for identifying an objective function and constraints necessary for describing 
a dynamic culture of mammalian CHO (Chinese Hamster Ovary) cells. Using this approach we are able 
to calibrate a model that describes the data up to an a priori known margin of noise and which provides 
rational explanations for biological phenomena such as the excessive production of lactate by anaerobic 
fermentation during the growth phase of the cell culture referred to as the “Warburg effect”. The model 
that best explained the data during the exponential phase of growth is based on the maximization of 
growth rate combined with the minimization of NADH production in the cytoplasm and minimization 
of NADPH consumption in mitochondria and requires constraints on the consumption/production rates 
of only 5 metabolites. 
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 Introduction 
The success of monoclonal antibodies has significantly increased their demands and created a need for 
improving production yield through the optimization of cell lines and manufacturing processes. 
Mammalian cells, in particular, Chinese Hamster Ovary cells, are the host of choice for monoclonal 
antibody production.  
In order to optimally manipulate mammalian cell systems whether at the genetic or at the bioprocess 
level, it is imperative to understand the metabolic behavior of the biosystem under study and a 
mathematical model is a good tool to gain such understanding. 
A very common approach in biochemical modeling is kinetic modeling of the main reactions involved 
in the process. These models are based on a system of differential equations that describe the evolution 
of specific metabolites with respect to time by empirical mass balances where the consumption of the 
metabolite towards biomass or towards another metabolite or the production rates or by-products are 
determined by empirical Monod kinetic terms and yields. Each one of these kinetic expressions involve 
maximal rate coefficients, half saturation constant and yield coefficients thus resulting in a large 
number of calibration parameters that need to be identified from available experimental data.  
Therefore, these types of models are generally heavy parameterized when many metabolites are 
considered thus rendering them very sensitive to noise and inaccurate especially when data is scarce. 
Furthermore, the numerical estimation of parameters for these models from the solution of nonlinear 
optimization problems is challenging due to the large number of parameters and the nonlinearity of the 
kinetic expressions that may lead to the occurrence of multiple minima. 
An alternative modelling approach is based on the Dynamic Flux Balance Analysis (DFBA) algorithm 
(Mahadevan et al., 2002) DFBA is based on the formulation of an optimization problem where a 
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particular flux distribution in a metabolic network is sought such as a specific objective function is 
optimized subject to certain constraints. The rationale behind DFBA is that natural evolution had 
conditioned the cell to act as an agent that allocates resources such as a biological objective is 
optimized.  Being based on an optimization with few limiting constraints, DFBA models have been 
reported to be advantageous over other aforementioned modelling approaches because for certain 
micro-organisms such as bacteria the have often required a smaller number of calibration parameters  
A DFBA model can be formulated as follows: 
@ each sampling time i 
max 𝑐𝑇𝑣  
        subject to 𝑣𝑖 >⁡0         (8-1) 
     𝑓(𝜓𝑖) ≤ ⁡
1
𝑇𝑋𝑖
(𝛹𝑖+1 − 𝛹𝑖) =A. 𝑣𝑖 ≤ 𝑔(𝜓𝑖) 
     𝛹𝑖+1 = 𝛹𝑖  + A. 𝑣𝑖  𝑋𝑖 T  (T= time interval)       
Where  ?̅? is the average biomass concentration, 𝑋𝑖⁡is the biomass at time interval i, 𝑓(𝜓𝑖)⁡ and 𝑔(𝜓𝑖)r   
are lower and upper consumption or production rates of constraining metabolites concentration. These 
metabolic rates can be defined as a function of the concentration of a metabolite participating in the 
corresponding reaction. These rate constraints must be determined from experiments. The sampling 
time interval, T is selected to discretize the mass balances for the purpose of numerical integration 
(Budman et al., 2013; Mahadevan et al., 2002). 
Although in the past researchers have chosen the objective function and constraints in model (8-1) by 
trial and error, in our recent work (Nikdel & Budman, 2016) we have proposed a systematic approach 
for finding those from data and illustrated this method for a culture of microbial (non-mammalian) 
systems. For bacterial and microbial organisms typical objectives that can be successfully used to 
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describe experiments are maximization of growth and/or maintenance of a particular redox potential. 
However, suitable optimization objectives they have not been proposed as yet for dynamic metabolic 
models of mammalian cells due to their relative more complex behavior as compared to bacteria. For 
example, mammalian cells exhibit particularly regulatory mechanisms such as programmed cell death 
(apoptosis) that have to be taken into account when defining an objective function for optimization.  
Accordingly, systematic approaches for identifying DFBA models for mammalian cells have not been 
reported as yet.  
A key challenge in the identification of dynamic metabolic flux models from data is that they require 
minimizing a sum of square errors between data and model predictions over the duration of the 
experiment while satisfying at each time interval the optimization in (8-1) thus resulting in an overall 
bi-level optimization problem. Since the resulting bi-level optimization is numerically challenging and 
prone to convergence to local minima, we proposed (Nikdel & Budman, 2016) instead a single level 
optimization algorithm, briefly summarized in Section 2, to identify DFBA models based on the idea 
of set based description of the experimental data. In this study we apply this methodology, which 
previously was used for a microbial systems, to mammalian cell data. The goal here is finding a suitable 
objective function and a set of kinetic constraints to describe the behavior of mammalian cells by a 
DFBA model. Another key objective of the current study is to assess whether a dynamic metabolic flux 
model of mammalian cells is indeed will require a significantly lower of tuning parameters as compared 
to previously reported dynamic models (Naderi et al., 2011a). 
This chapter is organized as follows. In Section 2 the algorithm proposed by authors (Nikdel & 
Budman, 2016) for identifying the DFBA constraints, is summarized. Section 3 discusses the 
mammalian cells study including the metabolic network used and the experimental data. Section 4 
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presents the identification of the mammalian cell DFBA model and discusses the results followed by 
Section 5 with Conclusions. 
 Summary of the algorithm for identifying DFBA constraints  
The method for finding the limiting constraints is based on representing the data by convex sets.  It is 
assumed that because of sensor noise or unaccounted disturbances, the metabolites levels are bounded 
by upper and lower limits at each time interval for which data is collected. For example, set constraints 
for glucose concentrations during a batch culture that consumes glucose are illustrated in Figure 8-1. 
 
Figure 8-1 set constraints for glucose concentrations during a batch culture  
Thus, the actual value of metabolites concentrations at each time interval are bounded within constraints 
that are referred heretofore as sets.  
Using this set-based description of the data a 3-step procedure is used to find a DFBA model as follows: 
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Step 1: Calculate at each time interval a flux distribution from (8-1) that maximizes the objective 
function to be chosen for the process, e.g. maximization of growth subject to the set based constraints. 
Mathematically, the problem is expressed based on (8-2) as follows: 
 
@ all T intervals  (k=1,…,T)      (8-2) 
     max
𝐯𝐤
𝐜𝐓. 𝐯𝐤⁡  
        Subject to: 
        
−1
∆𝑡.𝑋𝑘
(ѱ𝑘 − ѱ𝑘+1
𝐿 ) ≤ 𝐒. 𝐯𝐤 ≤
−1
∆𝑡.𝑋𝑘
(ѱ𝑘 − ѱ𝑘+1
𝑈 ) 
Where matrix S is the stoichiometric coefficients, 𝐯𝐤 = (𝒗𝟏,𝒗𝟐, … , 𝒗𝒏)𝐤 is the vector of fluxes⁡⁡of n 
metabolites at the time interval of k. 𝒄𝑻. 𝐯𝐤 is the cost to be maximized or minimized (objective 
function),⁡ѱ𝑘 and 𝑋𝑘 represent measured concentrations of extracellular metabolites and biomass at the 
time of k. The inequality constraints in (8-2) are derived from Euler discretization of the general mass 
balance equation for each metabolite ѱ𝑚 (
𝑑𝝍
𝑑𝑡
= 𝐒𝒗𝑋) as done in (8-1). The inequality directions in 
equation 8-2 are applied for a metabolite that is being consumed whereas the directions are inverted for 
a metabolite that is being produced. It should be noticed that while in (8-1) the constraints are given as 
a function of the concentrations through the vector functions f and g to present kinetic limitations on 
the rate of reactions, in (8-2) the functions are unknown at this stage and they must be identified. Instead 
the production/uptake rates in (8-2) given by 𝐒. 𝐯𝐤 are constrained based on the upper and lower bounds 
identified directly from data, ѱ𝑘+1
𝑈  and ѱ𝑘+1
𝐿  respectively. 
Step 2: Identify a minimal number of metabolites which uptake/production rates need to be constrained 
as in (8-2) in order to fit the experimental data described by convex sets.   
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To find the uptake/production rates which are limiting the solution space of equation (8-2), a Lagrange 
multiplier approach(Bertsimas & Tsitsiklis, 1997) is formulated as follows: 
 𝐯𝐤=argmin
𝐯𝐤
(−𝐜𝐓𝐯𝐤)         (8-3) 
S.t:                      GLI(𝐯𝐤) ≤ 0  
GLI(𝐯𝐤) ≤ 0 are the inequality constraints lower and upper bounds of the production or the uptake rate 
of measured metabolites . If the Lagrangian is defined as follows: 
𝐿(𝐯𝐤, λ) = ⁡ 𝐜
𝐓𝐯𝐤 − λ⁡GLI(𝐯𝐤)  
The Lagrange multipliers and the optimal solution 𝐯𝐤 to (8-3) can be obtained from the following set 
of conditions: 
𝜆≥ 0           (8-4a)  
GLI(𝐯𝐤) ≤ 0          (8-4b) 
𝜆× GLI(𝐯𝐤) = 0          (8-4c) 
∇𝐯𝐤L(𝐯𝐤, 𝜆)=0          (8-4d) 
Where GLI(𝐯𝐤) is an inequality constraint, 𝐯𝐤 is the optimal solution of the fluxes. By solving equations 
(4a-4d) the value of the Lagrange multipliers (λ) for each of the constraints can be calculated. Equation 
(4c) represents the complementarity condition that forces either the Lagrange multiplier or the 
corresponding inequality to be zero. Based on the interpretation of the Lagrange multipliers a λ = 0 
implies that by relaxing the corresponding constraint the value of the function which is intended to be 
maximized does not change indicating that, this constraint is not active. In contrast, a large value of the 
Lagrange multiplier is an indicator that the constraint is active. From the active constraints, it is possible 
to assess which metabolite’s consumption or production rates are limiting constraints at each interval 
of the solution of the DFBA. 
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Step 3- Find kinetic expressions as a function of metabolites’ concentrations that can describe the time 
evolution of the active constraints found in step 2. To accomplish this, at each time interval, the active 
constraints are formulated with a particular type of kinetic expressions e.g. Michaelis-Menten or other 
as a function of the concentration of metabolite that participates in the reaction associated to the active 
constraint as follows: 
dѱm
dt
=
Vm,max.ѱ𝑚
Km+ѱ𝑚
𝑋         (8-5) 
Where, 
𝑑ѱ𝑚
𝑑𝑡
 is the uptake or production rates of a metabolite (active constraints) identified in step 2 as 
a function of its concentration ѱ𝑚⁡at each corresponding time interval and Vm,max, Km⁡ are the kinetic 
parameter values to be identified as described. 
The identification of the parameters in (8-5) is done by regression of the values of the production/uptake 
rates
−1
∆𝑡.𝑋𝑘
(ѱ𝑘 − ѱ𝑘+1
𝑈 ) and/or 
−1
∆𝑡.𝑋𝑘
(ѱ𝑘 − ѱ𝑘+1
𝑈 ) that were identified as active in step 2 with respect to 
the corresponding value of the metabolite concentration ѱ𝑘 . Using these parameters it is possible to 
generate a predictive dynamic metabolic flux model as shown in Equation (8-1) where expressions (8-
5) are used as the functions f or g in (8-1). 
The main numerical advantages of this three-step approach, are: i- step 1 and step 2 involve the 
solutions of a linear programming problems and therefore are simple to compute and ii-step 3 involves 
separated fitting of each metabolite profile as compared to other modelling approaches that require 
fitting of all the metabolites by simultaneous calibration of a larger number of model parameters. 
The linear programs defined in this section (8-2)-(8-4) were solved using the cplexlp solver (‘interior-
point’ algorithm) of IBM ILOG CPLEX for MATLAB Toolbox.  
In an earlier work (Nikdel & Budman, 2016) showed that the above 3 step procedure is able to 
successfully identify an assumed dynamic metabolic flux model of E.coli from in silico data generated 
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by that model thus corroborating the ability of the algorithm in identifying the model used for 
generating the in silico data.  
 Mammalian cells study: metabolic network and experimental data 
 Metabolic network of reactions used to formulate the matrix S in equations (8-1) 
and (8-2). 
The stoichiometric matrix S, in (8-1) and (8-2) is obtained from the main stoichiometric reactions for 
the mammalian cell under study. The metabolic network in this study it was taken by combining group 
of reactions used in different studies that were considered relevant to describe experiments with CHO 
cells (Naderi et al., 2011a; Zamorano, Wouwer, & Bastin, 2010) such as TCA cycle, glycolysis, amino 
acids’ synthesis reactions and transamination reactions. The glutamine synthesis reaction was added 
since the cell line used in the current work is able to synthesize glutamine. This resulting network 
involves 38 reactions including one reaction describing the formation of biomass as a function of amino 
acid contributions.  The reactions considered account for the main contributors to the carbon and 
nitrogen balances. For simplicity and since they were not measured, the balances for co-metabolites 
such as ATP/ADP and NADH/NAD+ are not explicitly considered at this stage. 
Since the model calibration and comparisons have been limited in this study to the growth phase only, 
mechanisms of cell necrosis which are predominant during the post-exponential phase were not 
explicitly considered. However, we have considered in the model the occurrence of apoptosis 
(programmed cell death) which is expected to occur in different degrees from the beginning of the batch 
culture. 
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 Experimental data used for model calibration/validation 
The data was obtained with a CHO (Chinese Hamster Ovary) cell line modified GS producing anti-
rabies IgG. This cell line is able to synthesize glutamine so the latter does not have to be added for 
growth.  
Two different experimental media from (MilliporeSigma, St. Louis, MI, USA) - medium 1 and medium 
2 were used for experimental purposes. Cells were in their exponential phase when inoculated for the 
actual experiment. Cells were inoculated at the cell density of about 1.1 million cells/mL for medium 
1 and 2.4 million cells/mL for medium 2 in a 3 liter bioreactor with 1.5 liter working volume. 
Experiment one was continued for 50 hours and experiment two using medium 2 that had a richer 
medium was continued for 96 hours. 
Cell density and viable cell density of the cultures were obtained from a Trypan blue exclusion method. 
Glucose, lactate, ammonia, and glutamine concentrations were measured with a Nova BioProfile 
analyzer. Amino acids were measured by HPLC. Due to the nature of the analytical methods data 
included amino acids and biomass concentrations were only available once per day. On the other hand, 
this data sampling frequency was insufficient for generating smooth estimates of the uptake rates 
bounds.  Therefore, we used non-linear polynomial regression in MATLAB to interpolate the data and 
generate smoother estimates of metabolites’ rates of production or consumption. 
 Identification of DFBA model for CHO cells  
One of the main goals of the current work was to identify a DFBA model that can explain some of the 
particular behavior exhibited by most mammalian cell systems such as very high production of lactate 
during the growth phase and cell death due to apoptosis (programmed cell death).   
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Flux balance models have generally adopted the optimality assumption of evolutionary biology 
whereby cells are using resources optimally to maximizing or minimizing a specific objective function 
in order to survive. Maximization of growth or biomass (Orth et al., 2010) has been commonly used 
for most studies dealing with bacteria. The steady-state FBA modeling studies that have been reported 
involving different objective functions have been mostly done E.coli. Here we show that defining the 
right objective function can greatly impact the DFBA model prediction accuracy for mammalian 
systems. 
 The formulation of the DFBA model involves identifying a suitable objective function 𝑐𝑇𝑣 equations 
8-1 and 8-3, and rate limiting constraints corresponding to particular amino acids as per the method 
presented in Section 2. 
The approach adopted in this work is to test the 3-step identification procedure with different objective 
functions 𝑐𝑇𝑣  (equation 8-3) and check a posteriori the sum of square errors between model predictions 
and data in order to choose a best model, i.e. most suitable objective function and set of limiting 
constraints. 
Mammalian cells must accomplish a much more diverse set of functionalities during their time 
evolution as compared to bacteria that seems to be targeted only to grow faster. For example, during 
their growth phase, mammalian cells make very inefficient use of resources in terms of ATP production 
since most of the glucose is initially converted to lactate instead of being consumed toward ATP 
production in the TCA cycle. This preferential consumption of glucose towards lactate is referred to as 
the Warburg effect. On the other hand fast nutrient depletion occurring during the growth phase in batch 
operation may induce apoptosis which results in high cellular death rate. It is known that apoptosis may 
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be enhanced through high TCA cycle activity occurring in the mitochondria (Fleury, Mignotte, & 
Vayssiere, 2002).  
Following the above, to assess which objective function and constraints best fit the experiments and 
successfully capture some of the phenomena described above, e.g. Warburg effect, we identified DFBA 
models with the 3-step method shown in Section 2 for 3 candidate objective functions as follows: 
O1-Maximization of growth rate at each time. 
O2-Minimization of NADH production in the cytosol plus minimization of NAD(P)H consumption in 
mitochondria at each time interval. 
O3-Combination of O1 and O2  
O1 is the objective function typically used for bacteria for which it is assumed that natural evolution 
had driven the microorganisms to the ultimate goal of growing as much as possible despite 
environmental conditions. One can argue that O1 is also a rational choice for mammalian cells during 
the exponential phase of growth where cells exhibiting mostly a growth pattern with a minimal amount 
of dead cells. 
Objective O2 arises from the observation mentioned above that self-programmed death apoptosis is 
largely correlated to the levels of cytochrome-C that is a key protein in the respiratory electron 
transport chain responsible for the synthesis of ATP. Then, since the electron transport reactions are 
coupled to the TCA cycle through NADH/FADH, the minimization of NADH production is 
tantamount to the cells striving to minimize the occurrence of apoptosis (programmed death). 
Although our stoichiometric matrix did not include a specific balance for NADH/FADH, its 
production could be inferred from the sum of the fluxes of the reactions producing NADH in cytosol 
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and reaction consuming NAD(P)H in mitochondria =⁡𝑣(R5) +⁡𝑣(R8) +𝑣(R11) ⁡𝑣⁡(R13)⁡+⁡𝑣(R34) 
+⁡𝑣(R40)+ 𝑣(R43). 
Where the corresponding reaction numbers are given in the Appendix C. 
Objective O3 combines both O1 and O2 to describe the possibility that cell attempt to simultaneously 
maximize its growth while reducing the occurrence of apoptosis.     
To test which objective function is most suitable and to find the corresponding limiting constraints, we 
apply the 3-step identification procedure (Section 2) to the data thus obtaining 3 different models each 
corresponding to the 3 objective functions considered in the study. Then, the models were compared in 
their ability to fit the data for the duration of the batch runs based on the Sum of Squared Errors (SSE) 
between the models’ predictions and the data. 
Following the 3-step method outlined in section 2, step 1 was implemented to find set based constraints 
from data for each of the 3 objective functions.  Secondly, using these set based constraints, the limiting 
constraints were found from the values of the Lagrange multipliers (see Section 2, Step-2) that for all 
the 3 models the active constraints corresponded to exactly the same 5 metabolites: alanine, glutamate, 
lactate, ammonia, and glycine. 
It should be noticed that although the same metabolites must be constrained in the model, the observed 
dependency of the consumption/production rates as a function of the current concentration (found as 
per Step 3 in Section 2) of the corresponding metabolite were different among the 3 models. 
Following the identification of the active constraints and in order to formulate a predictive model it is 
required to calibrate Monod or another type of kinetic expressions to the calculated values of 
consumption/production rates as a function of a corresponding metabolite concentration.  
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Different types of kinetic models, e.g. Monod, Hill and etc. were tried in order to fit the consumption 
production rates as a function of the metabolite concentrations. Although the model predictions using 
the identified kinetic models for the 5 constraints were acceptable, some of the predicted errors were 
found to be slightly higher than the measurement errors expected for the metabolites.  To further 
improve the fitting we decided to use for the 5 identified constraints, look up tables that will provide 
the specific consumption/production rates as a function of concentration values. Since one of the 
objectives of formulating a predictive model was to optimize the process with respect to the feeding of 
nutrient concentrations we develop look-up tables as a function of the main nutrient for this process 
which is glucose. It should be noticed that two of the identified constraints are by-products: lactate and 
ammonia. Then, the proposed dependency of the specific production rates of these two by-products as 
a function of glucose can be justified metabolically by the fact that in reality, some intermediate 
metabolite of glycolysis is actually limiting but it is not measured and therefore, it cannot be used 
explicitly to formulate a predictive model. 
In principle, the 5 constraints would suffice for defining a dynamic metabolic flux model as given in 
(8-1). However, it was found that with these constraints only the optimization problem in (8-1) resulted 
in multiple solutions thus necessitating the addition of coarse constraints to limit the solution space of 
the model. We found that these additional coarse constraints could be given as a function of constant 
upper bound values on the rate of consumption/production of all metabolites. 
It should be noticed that the need for such additional coarse constraints to limit the solution space of 
dynamic models has been recognized and reported before by other researchers (Zakrzewski et al., 
2012). 
 Using the kinetic constraints and the coarse constraints, 3 different models were obtained.  
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First, it was observed that all the 3 models based on the 3 objective functions and their corresponding 
constraints could be fitted reasonably well to the data. Table 8-1 shows the SSE for each of the models 
corresponding to each objective function.  
Table 8-1: Sum of Squared Errors (SSE) for each model (number of parameters are all the 
same) 
Objective Function SSE 
O1-max (growth) 1.49 
O2-min (NADH in the cytosol)-min 
NAD(P)H consumption in mitochondria 
8.74 
O3-combination O1 and O2 
1.3 
  
It is evident from Table 8-1 that O2 results in the worst fit. On the other hand, O1 and O3 provide a 
similar level of fit but O3 results in an improvement in the SSE as compared to O1. 
Figure 8-2 shows a comparison between the data and the predictions obtained with objective O3, i.e. 
maximization of (growth-production of NADH in cytoplasm-NAD(P)H consumption in mitochondria). 
As shown in Figure 8-2 the agreement is very good and the maximal observed errors between the data 
and the model predictions were of the order of up to 10% of the maximal variation in each metabolite. 
These maximal errors are of the order of the expected measurement errors in HPLC (amino acids) or 
the Bioprofile (Glucose, Lactate). 
It is of interest to inspect why the model based on objective function O3 resulted in the best fit to the 
data. To that purpose, it should be recalled that one of the salient characteristics of CHO cells used for 
cell culturing is their high production of lactate during the exponential phase of growth. This 
phenomena, referred to as the Warburg effect is particularly counterintuitive since the higher production 
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of lactate is occurring at the expense of reduced flow of glucose into the TCA cycle where the latter is 
very effective in the production of ATP/mol of glucose. 
Then, to explain the higher suitability of objective function O3 as compared to the other objective 
functions we run the 3 models corresponding to the 3 objective functions with constraints on all 
metabolites but without imposing any constraint on lactate levels and we subsequently tested the 
amount of lactate produced by each of the models.  Figure 8-3 shows the lactate as a function of time 
for the duration of the batch as predicted by the 3 models and as measured by the BioProfile. It is 
evident that objective 3 correctly predicts the large production of lactate which is a key feature in CHO 
cell cultures. 
 160 
 
 
 161 
 
 
Figure 8-2 Dotted lines are the interpolation of experimental data of CHO cell culture number 
1 and solid lines are the DFBA model predictions. 
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Figure 8-3-a Dotted lines are the experimental data of CHO cell culture number 2 and solid line 
are the model predictions 
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Figure 8-3-b Dotted lines are the interpolation of experimental data of CHO cell culture number 
2 and solid line are the model predictions 
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Figure 8-4 Prediction for lactate with two different objective functions: Dot line in the presence 
of objective function O3 and solid line when the objective function is considered O1, Dashed 
line is the experimental data 
It should be noticed that the models obtained in this work are definitely advantageous in terms of the 
lower number of metabolites that have to be modelled in terms of kinetic behaviour as compared to 
other mammalian cell models. However, at this point not necessarily the required number of parameters 
is smaller as compared to other models in the literature since this number depends on the number of 
rows of the lookup tables formulated to describe the dependency of specific consumption/production 
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rates of 5 metabolites as a function of glucose concentrations. At this point, we have not optimized 
these tables so as to minimize the number of entries and this is left for future study. 
Regarding the choice of objective function, although objective O3 is able to correctly predict the lactate 
production when constraints on all other metabolites are used and it also results in the lowest SSE, it 
may not be the best possible objective to be used for a CHO cell system. For instance, it should be 
noticed that objectives O1 and O2 were combined with an equal weight into objective O3. However, it 
is possible that an alternative objective that combines O1 and O2 with different relative weighting may 
result in a better model than the one obtained for objective O3. The search for such optimal relative 
weighting that could reflect ATP or NADH equivalents of growth rate or apoptosis is left for future 
investigation.  
 Conclusion 
A dynamic metabolic flux model for mammalian cells was identified directly from data using a 3-step 
identification approach based on set based constraints. The model is able to correctly predict the 
measured metabolites while only 5 metabolites need to be described by kinetic expressions and used as 
constraints within the optimization problem describing the model. Three objective functions were 
investigated that represented the maximization of growth, the minimization of apoptosis and the 
combination of both objectives. It was found that the combination provides the best fitting to the data. 
A plausibility argument for the superiority of the objective function that simultaneously maximizes 
growth and minimizes apoptosis was that this constraint results in the superior prediction of the 
Warburg effect where lactate is produced in large amounts at the expense of ATP production by the 
electron transport chain. 
  
 166 
 
Chapter 9 
Conclusions and recommendations 
The optimal operation of bioprocesses requires mathematical models to develop optimal operating 
recipes. Most mathematical models proposed in the literature that describe the time profiles of nutrients 
and by-products during cell cultures require a large number of parameters for fitting experimental data. 
Recognizing that the over-parameterization of these models make them very sensitive to noise and 
impact their prediction ability we investigated in this work the use of a particular type of models, 
dynamic metabolic flux models, that have been often reported as more compact in terms of the number 
of parameters that need to be identified. Thus, based on preliminary studies in the literature, our working 
hypothesis was that dynamic metabolic flux models would be able to describe the behavior in cell 
culture of different microorganisms with fewer parameters. To objectively assess this hypothesis we 
developed mathematical approaches that will be able to describe experiments with a minimal number 
of parameters.  
The final goal of the thesis was to apply the proposed mathematical approaches to mammalian cell 
cultures. The focus on CHO was motivated by an earlier study that I conducted on cell death in CHO 
cell cultures as a continuation of the work of another member of our research group (S. Naderi). In a 
preliminary study of my thesis, I conducted experiments on CHO cell cultures at different pH for I 
identified carbonic acid as a limiting factor for growth and that intermittent media replacement was 
instrumental to extend the viability of the culture. Following these initial experiments and based on the 
fact that the models of Naderi (Naderi et al., 2011b) were highly parameterized we sought for more 
parsimonious models for CHO cell cultures. Also, the finding that intermittent media replacements 
were notably advantageous for operating CHO cell cultures motivated me to look further into 
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continuous perfusion as a logical continuation of intermittent perfusion operation. Following these 
goals, we were also able to establish a collaboration with Sigma-Aldrich in St Louis, Missouri that 
provided a high producing CHO cell line, growth media for culturing and maintained close 
communication with us on the directions of the project.  
This thesis includes both theoretical and experimental part. In terms of theory the development of 
dynamic flux balance models requires finding a meaningful biological objective function to be 
maximized/minimized and active constraints. To address these challenges two main mathematical 
algorithms were suggested in this thesis which were published in separate papers. The algorithms were 
used initially to describe bacterial cultures, E.coli and B. pertussis but then were also applied CHO cell 
cultures. Following the recognition of the potential of perfusion for increasing cell growth, in the 
experimental section, I developed a bioreactor perfusion system for culturing CHO cells in a higher cell 
density.  
The thesis includes 9 different Chapters involving the different theoretical and experimental aspects of 
the work. Chapter 2 reviewed the relevant literature and Chapter 3 presents the relevant experimental 
and theoretical methods and materials. In the first part of Chapter 4 I reviewed the perfusion mode of 
operation, cell retention systems and challenges that I faced when developing the perfusion bioreactor 
system with an ATF filtration system. Here I have clearly identified challenges that have not been 
properly addressed in the literature such as methods to provide enough DO and for stripping the carbon 
dioxide while controlling the foam formation. Following the identification of these challenges, I have 
formulated a series of practical solutions that help me to develop a high cell density CHO cell culture 
in a 3 liter bioreactor. I performed experiments with this perfusion system where a maximum cell 
density of around 50 million cells per mL culture was achieved and I also showed the ability of the 
system to control the level of potentially toxic by-products such as lactate and ammonia. Although 
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companies are currently conducting perfusion operations of CHO cultures the particular problems 
associated with these operations have not been thoroughly reported. Hence, a paper summarizing our 
findings regarding the perfusion practical challenges and solution is currently in preparation.   
In chapter 5, two algorithms for identifying active constraints for developing DFBA models were 
presented and compared. These algorithms are based on two different concepts: 1- sensitivity analysis 
and 2- identification of active constraints using Lagrange multipliers. These algorithms were initially 
applied for building DFBA models for two case studies of E.coli and B. pertussis in batch and fed-batch 
mode of operation. The E.coli case study used in silico (simulated) data and was purposely developed 
to check the ability of the algorithm to converge to a dynamic metabolic flux model that was a priori 
known. A simplified metabolic network of E.coli containing four reactions was used for this case study. 
The second case study was using B.pertussis producing four antigens required for manufacturing the 
whooping cough vaccine. Data for different batch and fed batch cultures were provided by a company. 
Both of these proposed methods were capable of identifying the active kinetic constraints for E.coli 
example but the one based on the sensitivity analysis was found to be not efficient for the B.pertussis 
case that had a larger metabolic network. The disadvantages of the sensitivity analysis method were as 
follows: i- the method involved the solution of a non-convex bi-level optimization problem that was 
very difficult to solve and require numerous initial guesses to converge to a best solution and ii- the 
sensitivity had to be tested around specific nominal values of the parameters that were not known a 
priori. Hence the method require an iterative procedure where initial nominal parameter values must be 
identified, then the sensitivity is tested around these values and constraints are identified and then with 
these constraints a new set of nominal values have to be calculated and so on.   
While sensitivity analysis has been used before in the context of dynamic flux models, the second 
method that we proposed is novel and it is based on the idea of set-based constraints. The representation 
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of the data by this type of constraint greatly facilitates the identification procedure since it leads to a 
one level optimization problem. Moreover, we show that after identifying the constraints based on the 
values of Lagrange multipliers associated to each constraint, the fitting of a kinetic expression to 
describe the active constraint as a function of metabolite concentration can be done separately for each 
metabolite. This greatly simplifies the identification of the kinetic expressions necessary to formulate 
a predictive model. Although this algorithm based on Lagrange multiplier was shown to be very 
effective it was also found that it resulted in a multiplicity of solutions for the B. Pertussis case due to 
the large dimension of the metabolic network. To address this multiplicity time-independent upper 
bound constraints on the metabolites’ consumption or production rates were required. An additional 
challenge for this algorithm is that the activity/inactivity of the constraint depends on a threshold value 
of the Lagrange multiplier. Hence the activity of the constraint had to be decided by testing the 
sensitivity of the Lagrange multipliers to different levels of noise. This chapter has been published in 
the Biotechnology Progress Journal. 
Thus, two main challenges encountered with the algorithm presented in Chapter 5: 1- the algorithm in 
Chapter 5 find the constraints for an assumed biological objective that is maximized by the DFBA and 
2- the algorithm in 5 required correct assessment of the effect of noise on the Lagrange multipliers and 
this was found to be a laborious task. In Chapter 6 a new set-based algorithm was suggested to address 
these problems for simultaneously finding the biological meaningful objective function together with 
the active constraints through one single optimization problem and noise was directly accounted for in 
the optimization. This method was advantageous compared to prior as it was capable of finding the 
active constraints, objective function, and the upper bound constraints simultaneously using a bilinear 
optimization formulation.  This method was also verified using two case studies of E.coli and B. 
pertussis. After corroborating the accuracy of the algorithm with the simulated E.coli case study we 
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applied the algorithm to data from a B. pertussis case study (experimental data was provided by Sanofi 
Pasteur). The maximization of the biomass was identified as the best objective function and the uptake 
rate of phenylalanine was discovered as the single active constraint.  Thus the algorithm was able to 
find a highly compact model with one single kinetic expression. This algorithm is particularly 
advantageous as compared to the algorithm in Chapter 5 since it formally addresses the level of noise 
and its effect on the measured consumption/production rates in the optimization problem. However, the 
problem of multiplicity of solutions and the need to limit the solution space of the optimization problem 
by adding time –independent upper bounds on the metabolites’ consumption and production rates still 
remains as a challenge to be addressed in future research.  The results in Chapter 6 were reported in a 
paper published in the journal Bioprocesses and Biosystems Engineering. 
Chapter 7 reports my above mentioned contribution as a second author with a study dealing with cell 
damage due to the accumulation of carbon dioxide in cell culture flasks. By performing experiments at 
three different pH, I was able to identify that a reduction in pH significantly reduces the cell growth. 
Another experiment in shaker flask at two different volumes of 250 and 500mL was performed to study 
the effect of gaseous carbon dioxide. This experiment was performed in a semi-perfusion mode by 
substituting a portion of spent medium with fresh media at different times. The initial pH in the two 
spinner flask were the same but a higher pH drop was observed in the 500 mL flask as compared to the 
250 mL flask that hinted at an accumulation of an acidic compound in the spinners affecting growth.  
Based on pH and pK calculations we were able to identify carbonic acid with the pka=6.4 as the most 
plausible compound affecting cell growth. 
In chapter 8, the algorithms developed in chapter 6 for finding active constraints and biological 
objective function were used to develop a DFBA model for CHO cells in a batch experiment. At this 
point, we have only been able to fit the model for the exponential phase of growth. A key finding in 
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this chapter is that the biological function for mammalian cells that can be used to best describe the 
data is not as simple as for bacterial systems where only growth rate was maximized. In the case of 
mammalian cells, the simultaneous maximization of growth rate and minimization of NADH 
production in the cytoplasm and minimization of NADPH consumption in the mitochondria resulted in 
a better fit of the data. We have explained this finding by the fact that the production of NADH in the 
TCA cycle is correlated to apoptosis and thus the mathematical minimization of NADH production it 
describes the ability of the cell to optimize its chances for survival by minimizing apoptosis. Constraints 
on 5 metabolites were necessary to describe the data. Following fitting of the consumption/production 
rates of the limiting metabolites with standard kinetic expressions (e.g. Michaelis-Menten, Hill) it was 
found that the errors between data and model predictions were acceptable but not as accurate as 
expected considering the measurement error. To improve the fitting look-up tables were used that 
describe the consumption/production rates corresponding to the active constraints as a function of 
interpolated values among few glucose concentrations. 
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 Future work 
 Genome-scale DFBA models 
Following the publication of the genome sequence of CHO cells, the current models could be extended 
to include gene regulatory mechanisms. Following the multiplicity of solutions observed in some of the 
studies it would also be important to include constraints other than kinetic constraints considered in the 
current work e.g. thermodynamic constraints, protein expression constraints, gene expression related 
constraints etc. 
 In-silico Metabolic Engineering 
One important application of the developed DFBA model would be to develop in silico metabolic 
engineering approaches for designing better CHO cell lines producing more desired proteins and fewer 
by-products such as lactate. For example, DFBA models could be used for investigating the gene-
deletion targets in CHO cells based on identified constraints.  By combining the DFBA model with the 
method OptKnock(Burgard, Pharkya, & Maranas, 2003) that has been proposed by for gene-deletion 
in bacterial strains one could dynamically optimize cell line productivity.  
 Cell culture design and process optimization 
Finding the best combinations of nutrients in the cell culture media has always been an important goal 
in the biopharmaceutical industry. DFBA models can provide insights in terms of limiting external 
metabolites, intracellular metabolites and metabolites that are not easy to measure such as vitamins and 
trace elements. The model will be useful to ensure that sufficient amount of these elements are available 
in the media. Nowadays the most common technique for media optimization is black-box modelling 
based on techniques such as multivariate statistical tools.  By combining the information from DFBA 
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model with multivariate data analysis based models into hybrid models (empirical+mechanistic) the 
growth medium could be optimized. 
  Optimizing the protein quality and Quality-by-Design approaches 
Protein quality and lot-to-lot variability are important issues in the biopharmaceutical industry.  One of 
the important protein quality attributes is glycosylation. Models have been developed that link the 
concentration of extracellular metabolites to glycosylation models but due to a higher number of 
parameters to be estimated developing such models has been very difficult. Using DFBA models with 
less parameters compared should be helpful in developing models that couple the cell metabolism with 
glycosylation processes. 
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Appendix A 
 
J1   39.43 Ac + 35O2⁡→⁡X 
J2   9.46Glc + 12.92O2⁡→⁡X 
J3   9.84 Glc + 12.73O2⁡→⁡1.24Ac + X 
J4   19.23Glc⁡→⁡12.12Ac +X 
 
 
  
O2 
V1 
V2 
V3 
V4 
Ac 
Glc 
X 
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Appendix B 
Metabolic network of B.Pertussis 
J1   Pyruvate → PEP 
J2   Pyruvate + CoA → Acetyl-coA + CO2 
J3   Acetyl-CoA + H2O +oxaloacetate → citrate + CoA 
J4   citrate →α-ketoglutarate + CO2 
J5   α-ketoglutarate + enz-N6 → succinyl transf. + CO2 
J6   Succinyl transf. + CoA → succinyl-CoA + enz-N6 
J7   Succinyl-CoA + phosphate → CoA + succinate 
J8   Succinate + acceptor → fumarate + reduction acceptor 
J9   Fumarate + H2O → malate 
J10   malate → oxaloacetate 
J11   glutamate + NH3 → phosphate + glutamine 
J12   2 glutamate ← glutamine + α-ketoglutarate 
J13   glutamate + H2O →α-ketoglutarate + NH3 
J14   proline + 2H2O → glutamate 
J15   oxaloacetate + glutamate → aspartate + α-ketoglutarate 
J16   aspartate + NH3 ← aspargine 
J17   PEP+HCO_3^-  → phosphate + oxaloacetate* 
J18   lactate → pyruvate 
J19   acetate + CoA ← acetyl-CoA + phosphate 
J20   2 acetyl-CoA → CoA + acetoacetyl-CoA 
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J21   acetoacetyl-CoA → PHB 
J22   glucose-6-phosphate + 3 glyceraldehyde-3-phosphate → 3 ribose-5-phosphate 
J23   acetyl-CoA + carrier-protein → acetoacetyl-carrier + CoA + CO2 
J24   Threonine + 3 pyruvate + 2 glutamate + acetyl-CoA + H2O → NH3 + 3CO2 + 2H2O + isoleucine 
+ α-ketoglutarate +valine + CoA + leucine 
J25   serine + tetrahydrofolate ←→ 5,10-methylenetetrahydrofolate + glycine + H2O 
J26   serine ←→ pyruvate + NH3 
J27   threonine ←→ glycine + acetaldehyde 
J28   aspartate→threonine + phosphate 
J29   hydrogen sulfide + acetyl-CoA + serine → CoA + cysteine + acetate 
J30   glutamate + pyruvate ←α-ketogultarate + alanine 
J31   aspartate + pyruvate + glutamate + succynyl-CoA → phosphate + α-ketogultarate + succinate + 
lysine + CO2 + CoA 
J32   malate → pyruvate + CO2 
J33   amino acids → biomass 
J34   amino acids → pertactin 
J35   PEP → glyceraldehyde 3-P + phosphate 
J36   2GAP + H2O→glucose 6-P + phosphate 
J37   J3 
J38   amino acids → Pertussis toxin 
J39   amino acids → fimbria 
J40   amino acids → FHA 
J41   Inverse of J14 
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J42   Inverse of J27† 
J43   Inverse of J30 
J44   2 glutamate + aspartate → fumarate + α-ketoglutarate + arginine 
J45   Glucose + 6-P GAP + 2 PEP + glutamate → tyrosine + D-xylose + α-ketoglutarate 
J46   Inverse of J26 
J47   valine + α-ketoglutarate → glutamate + 4 methyl-2-oxopentanoate 
J48   2 pyruvate +serine + aspartate + cysteine → CoA + 3 CO2 + glycine 
J49   Inverse of J18 
Stoichiometry of Purines 
Adenine: pyruvate + 2 glutamine + 2 aspartate + glycine → adenine + 2 glutamate + fumarate 
Guanine: pyruvate + 3 glutamine + aspartate +glycine → guanine + 3 glutamate + fumarate 
Stoichiometry of Pyrimidines  
UMP (Urydilic acid): glutamine + HCO_3^-+ aspartate + ribose-5-phosphate →UMP + CO2 + 
glutamate 
CMP (Cytidilic acid): glutamine +HCO_3^- þ aspartate + ribose-5-phosphate + NH3 → CMP +CO2 + 
glutamate 
TMP (Tymidilic acid): HCO_3^- + serine + glutamine + aspartate + ribose-5-phosphate → glycine + 
TMP + glutamate + CO2 
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Appendix C 
Metabolic network of CHO 
R1 Glc → G6P  
R2 G6P → 2·3phosphaglycerate  
R3 3phosphoglycerate →Pyr  
R4 Pyr → Lac  
R5 Pyr → AcCoA + CO2  
R6 AcCoA + Oxal → Cit  
R7 Cit →  KG + CO2 
R8 KG →SucCoA + CO2  
R9 SucCoA → Suc  
R10 Suc → Mal  
R11 Mal → Oxal  
R12 Mal → Pyr + CO2  
R13 Thr →Gly + AcCoA  
R14 Trp → Ala + NH4 +2·AcCoA  
R15 Lys → NH4 + KG  
R16 Ile → Glu + AcCoA + SucCoA  
R17 Leu → 2·AcCoA + 2·CO2  
R18 Tyr → Mal + Oxal + CO2  
R19 Ser + Met → Cys + NH4  
R20 Val → SucCoA + KG  
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R21 Glu + Oxal → Asp + KG  
R22 Glu → KG + NH4  
R23 Glu + Pyr → Ala + KG  
R24 Cys → Pyr  
R25 Ser → NH4 + Pyr  
R26 Gly → NH4 + CO2  
R27 Ser + Thr → SucCoA  
R28 Glu + 3phosphoglycerate → Ser + KG  
R29 Ser → Gly  
R30 Phe → Tyr  
R31 Asn → Asp + NH4  
R32 Gln → Glu + NH4  
R33 Arg → Glu  
R34 Glu → Pro  
R35 His → Glu + NH4  
R36 Gln + Asp → Glu + Asn  
R37 0.0208·Glc + 0.0377·Gln + 0.0006·Glu + 0.007·Arg + 0.003·Hist + 0.0084·Ile + 0.0133·Leu + 
.0101·Lys + 0.0033·Met + 0.0055·Phe + 0.008·Thr + 0.004·Trp + 0.0096·Val + 0.0133·Ala + 
0.026·Asp + 0.0004·Cys + 0.0165·Gly + 0.0081·Pro + 0.0099·Ser + 0.0077·Tyr →Biomass 
R4, R21, R22, R23, R29, R30, R31, R32 and R36 are assumed reversible 
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Appendix D 
 
Figure S-1-A-D Single full harvesting and fed-batch culture 
 
 
